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Is the Increasing Frequency of Laparoscopic 
Bile Duct Injury Justifiable?
Roger G. Keith, MD, FRCSC
Chairman, Department o f Surgery, University o f  Saskatchewan, Saskatoon, Sask. Coeditor, 
Canadian Journal of Surgery
I n this issue (pages 509 to 516) Roy and colleagues report on 21 
cases of serious bile duct injuries 
managed at two Canadian Universi­
ty centres between June 1991 and 
June 1993. During that time the 
majority of general surgeons in the 
two catchment areas changed from 
open to laparoscopic cholecystecto­
my as the procedure of choice for 
biliary tract disease. Because the 
population at risk is indeterminate 
for this study, a true incidence of 
bile duct injury during laparoscopic 
cholecystectomy could not be as­
sessed. None the less, this report 
has merit in identifying a problem 
of increasing frequency.
Girard and Morin1 studied over 
10 000 open cholecystectomies ac­
crued between 1971 and 1990 at 
one of the university centres con­
tributing to the present report. 
Twenty-four (0.26%) bile duct inju­
ries occurred in 9339 patients hav­
ing cholecystectomy alone; howev­
er, only 7 (0.07%) of the injuries 
involved transection or resection si­
milar to those reported by Roy and 
colleagues. Extrapolation of the 
higher injury frequency to average 
accrual for Girard and Morin’s se­
ries would yield 1.26 injuries in 492 
open cholecystectomies per year.
The number of bile duct injuries 
reported by Roy and colleagues is 
10.5 per annum. To recognize an 
incidence comparable to that for 
open cholecystectomy, it would re­
quire that 4100 laparoscopic chole­
cystectomies be performed annually 
in the catchment area served by the 
authors. If the data of Deziel and 
associates,2 who reported on 
77 604 laparoscopic cholecystecto­
mies performed in the United States 
at hospitals with over 50-bed capac­
ity, were taken into consideration, 
Roy and colleagues would require 
that all bile duct injuries from lapa­
roscopic cholecystectomy in 60 hos­
pitals be referred to the two report­
ing centres.
Whether the incidence of biliary 
injury has plateaued or is increasing 
is debatable. Regardless, the com­
bined rate of early and late biliary 
injuries is higher than that which 
became tolerable for open cholecys­
tectomy during the past decade.
In 1991, Cuschieri and associ­
ates3 reported a 0.33% rate of bile 
duct injury from seven European 
centres of excellence for laparo­
scopic cholecystectomy. Other good 
results2-4'6 report incidences .of up to 
0.6%. Recently, Moosa and col­
leagues,7 Adams and associates8 
and Davidoff and associates9 have 
reported an alarmingly high fre­
quency of bile duct injuries after 
laparoscopic cholecystectomy. 
Wexler and colleagues,10 in a Cana­
dian survey, noted that injuries oc­
curred beyond the learning curve.
As Roy and colleagues indicate in 
their paper, the nature of bile duct 
injuries associated with laparoscop­
ic cholecystectomy is more serious 
than that with the open technique. 
Frequently the bile duct is resected, 
the proximal injury is high and the 
duct diameter is small. The high 
failure rate after attempted primary 
duct-to-duct anastomosis must be 
emphasized because the subsequent 
repairs will be at the level of the 
hilum or above. Recurrent stricture, 
biliary cirrhosis and transplantation 
can be avoided by technically expert 
biliary enteric reconstruction when 
the injury is first repaired. Referral 
should not be considered an admis­
sion of inability but rather evidence 
of wise judgement.
The responsibility of surgical de­
partments during the new era in 
health care delivery will include 
critical audit as part of the changes 
engendered by quality management. 
Lowered incidence of biliary injury 
associated with laparoscopic chole­
cystectomy will be expected as part 
of continuous quality improvement. 
In order to comply, it will be neces­
sary to record accurately the fre­
quency of injury per case volume 
per surgeon, institution and region. 
Prospective data collection may 
yield true figures for purposes that 
are not necessarily aligned with 
clinical research. It is justifiable to 
report, within the profession, the 
concerns expressed by Roy and col­
leagues so that the surgical com­
munity will recognize the need for 
self-modulation without legislation.
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MacLean-Mueller Prize
Jonathan L. Meakins, MD. FRCSC; Roger G. Keith, MD, FRCSC
Coeditors, Canadian Journal of Surgery
The Editorial Board of the Cana­dian Journal o f  Surgery (CJS) 
and the Director of Publications of 
the Canadian Medical Association 
take pride in announcing the cre­
ation of the MacLean-Mueller 
Prize. This award will be presented 
annually for the best manuscript 
written by a resident or fellow from 
a specialty program affiliated with 
one of the five sponsoring associa­
tions and societies of the CJS.
The prize recognizes the contri­
butions made by Drs. C. Barber 
Mueller and Lloyd D. MacLean dur­
ing their terms as coeditors of the 
Journal. They have been responsi­
ble for sustaining broad support
and contributions to the Journal 
from the Canadian surgical special­
ty societies, which currently con­
tribute in financial terms, through 
scholarly editorial input and sub­
mission of papers. It is fitting that 
this award will be presented for the 
work of residents who are contrib­
uting to surgery through publica­
tion, a medium to which these two 
pillars of Canadian surgery made a 
lifelong commitment.
The Canadian Medical Associa­
tion, as publisher of the CJS, has 
established an award of $1000, and 
the prize winner will also receive a 
certificate. At the time of submis­
sion of the manuscript, the resident
7. Moosa AR, Easter DW, van Sonnen- 
berg E et al: Laparoscopic injuries to 
the bile duct. Ann Surg 1992; 215- 
203-205
8. Adams BD, Borowicz MR, W ooton FT 
et al: Bile duct complications after lapa­
roscopic cholecystectomy. Surg Endosc 
1993; 7: 79-83
9. Davidoff AM, P appas TN, Murray AE 
et al: Mechanisms of major biliary injury 
during laparoscopic cholecystectomy. 
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10. Wexler MJ, Hinchey EJ, Sampalis J et 
al: Canadian laparoscopic surgery sur­
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or fellow must not have completed 
training nor have assumed a faculty 
position. Deadlines for each calen­
dar year will be in keeping with 
those of annual meetings or resi­
dent research presentations of the 
specific societies, but papers must 
be in the Journal’s Saskatoon office 
by Oct. 1, 1994, for the first com­
petition. Papers should be submit­
ted through the sponsoring society. 
The winning paper will be published 
in the first issue of the CJS of the 
succeeding year.
The coeditors are pleased to in­
form the readership of this award 
on behalf of the Editorial Board and 
the Canadian Medical Association.*
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Anterior Mediastinal Masses 
After Cancer Therapy: 
Recurrences or Benign 
Lesions?
To the editors. The development of 
an anterior mediastinal mass in the 
follow-up of a patient treated for 
malignant disease is always wor­
risome for the clinician. Although 
recurrent malignant disease is al­
ways a possibility, an increasing 
number of reports have raised the 
possibility of a benign lesion of the 
thymus. Recently, we have seen two 
cases of thymic lesions, in patients 
treated for lymphomatous disease.
Case Reports
Case 1
A 40-year-old woman was first 
seen in November 1989 for investi­
gation of an enlarged cervical node 
and lower-limb edema. A complete 
work-up, including computed to­
mography (CT) of the chest and 
abdomen, gallium scanning and 
bone marrow and cervical node bi­
opsies revealed a nonHodgkin’s 
lymphoma of the mixed diffuse and 
nodular type, classified as stage 
IIIA (the National Panel Working 
Formulation classification1). Over a 
6-month period, this woman re­
ceived seven cycles of combination 
chemotherapy, including cyclophos­
phamide, vincristine, prednisone, 
bleomycin, Adriamycin and procar­
bazine (COP-BLAM). Follow-up CT 
of the chest and abdomen in May 
1990 showed no abnormalities. 
However, repeat follow-up CT 1 
year later revealed a large mass in 
the anterior mediastinum measuring
504
5 X 3 X 2  cm. The patient was 
asymptomatic. Gallium scanning 
showed an abnormal uptake in the 
upper chest. Sternotomy with thy­
mectomy revealed a massive thymic 
hyperplasia with no evidence of ma­
lignant disease.
Case 2
A 17-year-old previously healthy 
patient was admitted in September 
1990 for investigation of a right 
supraclavicular mass and an en­
larged mediastinum. There were no 
other palpable lymph nodes. After a 
complete work-up, which included 
lymphangiography, CT of the chest 
and abdomen, gallium scanning, a 
bone marrow biopsy and a biopsy of 
the supraclavicular mass, a diagno­
sis of stage I1A Hodgkin’s disease 
of the sclerosing nodular type, with 
“bulky mediastinal disease” was 
made. The patient received six cy­
cles of combination chemotherapy, 
including, mechlorethamine, vin­
cristine, procarbazine, prednisone, 
Adriamycin, bleomycin, vinblastine 
(MOPP/ABV) followed by mediasti­
nal and cervical irradiation over a 
25-day period for a total of 36 Gy.
Follow-up CT of the abdomen 
and thorax in July 1991 showed a 
large mass, 7 cm in dimension, in 
the anterior mediastinum. Gallium 
scanning gave negative results. The 
mass was excised and found to be a 
combination of thymic involution 
scarring and multiple retention 
cysts. As of September 1992 he was 
free of disease.
Comment
When masses develop after thera­
py for cancer, recurrence of the
malignant disease has to be ruled 
out first. If the mass is in the 
anterior mediastinum, thymoma is a 
possibility, although most of the 
cases followed immunosuppression 
with cyclosporine in experimental 
animals and in transplant patients.2 
Thymic hyperplasia was reported 
after chemotherapy in children and 
adolescents as a rebound phenome­
non.3 Some authors4'5 have postu­
lated that the development of thym­
ic hyperplasia after treatment of 
malignant disease is a good prog­
nostic sign because it indicates res­
toration of the host’s immunity. 
Surgery in these cases was required 
in the early experience from the 
M.D. Anderson Hospital in Hous­
ton, Tex., but in the later cases a 
steroid test eliminated the need for 
biopsy.6 In adults, most of the cases 
have been reported after treatment 
for lymphomas or germ cell tu­
mours,7'8 and in most cases, surgery 
was performed through a thoracot­
omy or a sternotomy to excise the 
abnormal mass. Gallium scanning in 
these situations is not helpful be­
cause abnormal uptake is seen both 
in recurrence and thymic hyperpla­
sia. Recognition of the possibility of 
thymic hyperplasia and steroid test­
ing will eliminate unnecessary sur­
gery.46 In fact, as Ford and associ­
ates6 showed, these patients should 
be treated with predisone, orally, at 
a dosage of 60 mg/m2 daily for 7 
days if the initial diagnosis is not 
steroid-sensitive leukemia or lym­
phoma. If the mediastinal changes 
regress, the patient should be fol­
lowed up by serial chest radiogra­
phy. If the mass remains unchanged 
or enlarges, then an open biopsy of 
the mass should be performed.
continued on page 536
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Beware of the Trendelenburg Position 
During Prolonged Laparoscopic Procedures
Josee Gagnon MD; Eric C. Poulin MD, FRCSC
M any laparoscopic surgical pro­cedures are currently being 
evaluated. Some, like laparoscopic 
sigmoid resection, require place­
ment of the patient in the Tren­
delenburg position to maintain the 
small bowel above the pelvic rim 
and to improve exposure during 
surgery. This increases the possibil­
ity of brachial plexus injury during 
prolonged surgery, as our recent 
experience demonstrated.
Case Report
A 48-year-old woman underwent 
an uncomplicated 3-hour laparo­
scopic sigmoid resection for recur­
rent diverticulitis. The next morn­
ing it was obvious that she had 
sustained a left brachial plexus inju­
ry. She had a flaccid and numb left 
arm and forearm and a partial Horn­
er syndrome with complete involve­
ment of the plexus. Her condition 
resolved completely over a period of 
5 months.
Comments
The patient’s positioning had 
been standard for a general surgical 
procedure. Her head had been cen­
tred and her upper extremities 
placed at 80° on armboards with a 
locking mechanism to forestall 
hyperextension.
The cause of most peripheral 
nerve injuries in anesthetized pa­
tients is ischemia of the vasa ner­
vorum. This results from stretching 
of a nerve and then compression of 
that already vulnerable nerve. Inju­
ries occur more readily during gen­
eral anesthesia when muscle tone is 
diminished and when the uncon­
scious patient cannot respond to 
postural insults. Nerve palsy can be 
produced within 30 minutes if the 
patient is in an unfavourable posi­
tion.
The brachial plexus is the most 
susceptible of all nerve groups to 
damage from malpositioning during 
anesthesia. It has a long, mobile, 
superficial course in the axilla be­
tween two firm points of fixation — 
the vertebrae and the axillary fascia. 
It also lies close to a number of 
freely movable bony structures. 
Damage is produced by any factor 
that increases the distance between 
the points of fixation. The plexus 
may be depressed caudally by being 
stretched over the head of the hu­
merus with the extremity abducted 
when the patient is in the Tren­
delenburg position (Fig. 1). Five
situations are then especially haz­
ardous:1
•  When the patient’s head is in 
dorsal extension and lateral flexion 
to the opposite side. This widens 
the angle between the head and the 
shoulder and stretches the plexus.
•  When the upper extremity is 
abducted from the table at an angle 
of more than 90°. The plexus is 
then stretched by the head of the 
humerus and coracoid process, es­
pecially if the extremity is external­
ly rotated and dorsally extended.
•  When shoulder braces are
FIG. 1. Diagram of relationship be­
tween brachial plexus and surrounding 
bony structures. Arrows indicate direc­
tions of pressure applied.
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used and placed too medially. In 
this situation they depress the clavi­
cle caudally and posteriorly, com­
pressing and stretching the plexus.
•  When shoulder braces are 
placed too laterally, pushing the 
humeral head downward, carrying 
the plexus with it.
•  When the patient is held by 
wristlets. In this case the humeral 
head is pulled downward, carrying 
the plexus with it.
Other factors that enhance the
risk of nerve injury include the 
following: abnormal anatomy (hy­
pertrophy of the scalenus muscles, 
cervical rib), pre-existing metabolic 
conditions such as diabetes, athero­
sclerosis, anemia, blood dyscrasias 
and anticoagulant therapy, hypo­
thermia, hypotension and the dura­
tion of malposition.2
After decades of use of the Tren­
delenburg position for diagnostic 
laparoscopic procedures in gynecol­
ogy, brachial plexus injury was not
even mentioned as a complication in 
a 1982 survey of 125 560 laparo­
scopic sterilizations.3 The explana­
tion may be that this procedure is 
of shorter duration or that in the 
gynecologic setting armboards are 
seldom used. In general surgery, 
since we cannot avoid using the 
Trendelenburg position for some 
laparoscopic procedures, special 
precautions should be taken.
•  The upper limbs should be 
kept at the patient’s side, with the 
palms down or facing the thighs 
and a draw-sheet extending well 
above the elbows to hold the posi­
tion. Wristlets should not be used 
to restrain the extremity.
•  Shoulder braces should not be 
used to prevent the patient from 
sliding on the operating table. If the 
mattress is held firmly to the oper­
ating table, the patient seldom 
slides on the mattress. If braces are 
used, they must be placed over the 
acromia, and they should never be 
used with an abducted upper ex­
tremity.
•  The patient’s head should re­
main in the midline.
•  The extreme Trendelenburg 
position should be avoided.
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But it is the beautifully repro­
duced paintings and photographs
addition to your library.
The Illustrated History o f Medicine 
Professor Jean-Charles Sournia 
ISBN 1-872457-05-3
© Harold Starke Publishers Limited, 1992 
Size: 246mm x 326mm, 
hardbound and jacketed
^es, please send m e_______copies of The Illustrated History of Medicine today!
GMA members: $199 (includes shipping by Priority Post and handling). O thers: $220 plus $24 shipping and 
handling. Please add 7% GST to total. All orders must be prepaid.
□  Cheque or money order enclosed (payable to the Canadian Medical Association)
□ Credit card O  VISA O  MasterCard O  American Express
Card number_______________ ____ _____________________________ Expiry date
Name (pleaseprint)________________ ________ _____________—----------------------
Address__
City_____
Postal code 
Signature _
Province___________________
Telephone ( )___________
Total amount (including GST)
Mail to: Membership Services
Canadian Medical Association 
1867 Alta Vista Drive 
Ottawa, ON K1G 3Y6
Credit card payments may be made by-
phone: 731-9331, ext. 2307 (Ottawa and area)
toll free: 1-800-267-9703, ext. 2307 (outside Ottawa area)
fax: 1-613-523-0937
GST registration #121 765 705
Gammex^ • Sensi-Touch- • NuTex
There are a lot of companies out there selling 
surgical gloves, but there’s only one that’s
made them 
a specialty.
Ansell.
At Ansell, 
w e’ve made
• Sensi-Derm - • No Powder • Orthopedic • DERMA-PRENE
Worldwide leader in medical gloves.
it our busi­
ness to provide the broadest range of gloves 
available to the medical profession. In addi­
tion to our family of standard surgical gloves, 
we have a variety of specialty, hypoallergenic, 
powder-free, and non-latex gloves available. 
No matter what you’re looking for, there’s an 
Ansell glove to fit the job.
Our sales representatives are specialists as 
well. Experienced O.R. nurses, they under­
stand what it’s like to wear surgical gloves all 
day. So they can provide you with in-depth 
knowledge and top-notch service.
As the world’s largest producer of latex 
gloves, Ansell has also taken a leading role in 
developing a safer working environment. 
We’re sponsoring the “Ansel|Cares” program, 
a multi-institutional, multinational research ini­
tiative to address the issues of latex sensitivity 
and barrier protection in the years ahead. For 
more information on latex allergies and a free 
subscription to the Ansel|Cares newsletter, 
call 1- 800- 363- 8340.
Ansell Medical
*
ORIGINAL ARTICLES 
ARTICLES ORIGINAUX
Bile Duct Injury During Laparoscopic 
Cholecystectomy
Andre F. Roy, MD, FRCSC;* Ronald B. Passi, MD, FACS, FRCSC;* Real W. Lapointe, MD, FRCSC;t 
Vivian C. McAlister, MD, FRCSC, FRCSI;* Michel H. Dagenais, MD, FRCSC;t William J. Wall, MD, FRCSC*
Objective: To determine the nature of bile duct injuries during laparoscopic cholecystectomy, the 
treatment of these injuries and patient outcome.
Design: Case series review.
Setting: Two tertiary care hospitals.
Patients: Twenty-one patients (average age 37 years) who sustained bile duct injuries during 
laparoscopic cholecystectomy over a 2-year period. Two groups were analysed: patients whose injury 
was recognized intraoperatively (9 patients) and patients in whom it was diagnosed postoperatively (12 
patients).
Interventions: Laparoscopic cholecystectomy, duct-to-duct repair over a T  tube, Roux-en-Y 
hepaticojejunostomy, endoscopic cholangiopancreatography (ERCP), percutaneous transhepatic 
cholangiography (PTC).
Results: Misidentification of the common duct during laparoscopic cholecystectomy, resulting in 
accidental division or resection of a portion of the duct, and obstruction of the duct by hemodips were 
the most common types of injury. Pain, jaundice and bile collections were the typical presenting 
features of injuries that became evident after laparoscopic cholecystectomy. ERCP and PTC accurately 
defined the injuries. Immediate duct-to-duct repair over a T tube was associated with a high failure 
rate. Twenty of the 21 patients required Roux-en-Y hepaticojejunostomy for definitive treatment. There 
were no deaths.
Conclusions: Proper identification of the pertinent anatomy will prevent the majority of these injuries. 
Prompt radiographic visualization of the biliary tract is indicated in patients who have pain, jaundice 
and bile collections postoperatively. A hepaticojejunostomy is the procedure of choice for repair of 
these bile duct injuries.
Objectif: Determiner la nature des lesions du choledoque qui surviennent durant une cholecystectomie 
laparoscopique, comment ces lesions sont traitees et avec quels resultats.
Conception : L’examen d’une serie de cas.
Contexte : Deux hopitaux de soins tertiaires.
Patients : Vingt-et-un patients (age moyen, 37 ans) qui, au cours d’une periode de 2 ans, subirent des 
lesions du choledoque durant une cholecystectomie laparoscopique. Deux groupes ont ete analyses : les 
patients dont les lesions furent reconnues durant l’intervention (9 patients) et ceux chez qui elles 
furent diagnostiquees en postoperatoire (12 patients).
Interventions : Cholecystectomie laparoscopique, reparation bout a bout sur tube en T , 
hepaticojejunostomie de Roux en Y, cholangiopancreatographie endoscopique (ERCP), 
cholangiographie transhepatique percutanee (CTP).
Resultats : Les lesions les plus frequentes etaient reliees a une mauvaise identification du choledoque 
durant la cholecystectomie laparoscopique, resultant en une division ou une resection accidentelle 
d’une partie du canal, ou a l’obstruction du canal par une pince hemostatique. Douleur, ictere et 
collections de bile representaient les signes cliniques caracteristiques des lesions qui se manifesterent 
apres l’ intervention. Une ERCP et une CTP permirent de definir les lesions avec precision. Une 
reparation immediate bout a bout sur un tube en T donna le plus haut taux d’echec. Vingt des 21
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patients necessiterent une hepaticojejunostomie de Roux en Y comme traitement definitif. II n’y eut 
aucun deces.
Conclusions : Une bonne identification anatomique permettrait de prevenir la majorite de ces lesions. 
Une visualisation radiographique immediate est indiquee chez les patients qui presentent de la douleur, 
de 1 ictere ou des collections biliaires en postoperatoire. Une hepaticojejunostomie est l’intervention de 
premier choix pour reparer ces blessures du choledoque.
Over the past 3 years, laparo­scopic cholecystectomy (LC) 
has replaced open cholecystectomy 
(OC) as the preferred surgical man­
agement for symptomatic gall­
stones. The distinct advantages of 
LC for patients in terms of short 
hospital stay, minimal pain and 
quick recovery have been amply and 
convincingly demonstrated.1-4 An 
overall complication rate of approxi­
mately 5% has been reported, and 
most complications are minor.1’56 
The most serious complication of 
LC, excluding death, is injury to 
the bile duct. During the era of OC, 
large surveys reported injury to the 
common duct in 1 to 2 cases per 
thousand cholecystectomies.7-9 It 
has become evident that the inci­
dence of common duct injuries is 
several times higher with LC.1 Al­
though some reports document that 
injury of the duct tends to be more 
common earlier in a surgeon’s expe­
rience with the operation,110 a re­
cent Canadian survey suggests that 
the incidence may not decrease with 
experience.11 Regardless of whether 
injuries of the duct will become less 
frequent, it is important to docu­
ment how they occur and how they 
are managed. Only through this 
type of analysis will it be under­
stood how bile duct injuries are best 
avoided during LC and, just as 
importantly, what is the ideal way 
to manage the injuries when they 
occur.
We report on 21 patients who 
sustained injury to the bile duct 
during a 2-year period and were 
referred for management to Univer­
sity Hospital, London, Ont., and to 
the Hopital Saint-Luc, Montreal, 
Que.
Patients
Twenty-one patients (18 women, 
3 men) underwent LC between June 
1991 and June 1993. The mean age 
was 37 years (range from 22 to 53 
years). All operations were elective. 
Dissection was done with elec­
trocautery in every instance. None 
of the patients was excessively 
obese.
The patients were divided into 
two groups. In nine patients an 
injury to the bile duct was recog­
nized during LC (group 1). In the 
remaining 12 patients the injury 
was diagnosed postoperatively 
(group 2). For a classification of the 
level of the injury to the common 
duct, we adopted the Bismuth clas­
sification12 of strictures of the com­
mon duct: type I — hepatic duct 
stump more than 2 cm long, type II 
— hepatic duct stump less than 2 
cm long, type III — no hepatic duct 
but confluence intact, type IV — 
right and left duct separated and 
type V — involvement of sectorial 
right duct with or without injured 
common duct.
Findings
Group 1 (Table I)
In none of these cases was the 
LC described as difficult, and there 
was no indication that anomalies 
were present to confuse the anato­
my. In seven patients injury of the 
bile duct resulted because the com­
mon duct was erroneously identified 
as the cystic duct. Only after the 
bile duct had been clipped and di­
vided or a portion of it had been
excised was the injury recognized. 
A frequent observation was persis­
tent bile staining of the operative 
field or visualization of a “second 
duct” after division of what had 
been interpreted as the cystic duct. 
In two patients perforation of the 
bile duct occurred as a result of the 
application of electrocautery with 
the dissecting hook. The perfora­
tions were recognized when contin­
ued bile leakage was noted in the 
operative field.
In three patients who had acci­
dental resection of a portion of the 
common duct, a drain was placed 
when the injury was recognized, 
and they were transferred the same 
day for management of the injury. 
Each patient had a laparotomy and 
underwent a Roux-en-Y hepaticoje- 
junostomy within 24 hours. Opera­
tive identification of the proximal 
bile duct was not difficult with 
these fresh injuries. The patients 
recovered without complication and 
were well at follow-up 2, 8 and 23 
months later.
Four patients had conversion of 
the LC to a laparotomy and a 
duct-to-duct anastomosis over a 
T tube. The operative notes indicat­
ed that the ducts were uniformly 
small in calibre, and the anastomo­
sis was often described as being 
under slight tension. In two of the 
four patients, leakage of contrast 
material at the site of the anastomo­
sis was seen on the initial postoper­
ative T-tube cholangiogram. In each 
of these four patients the duct-to- 
duct repair tailed, and strictures 
developed between 6 weeks and 6 
months after the initial repair. The 
patients became jaundiced, and per­
cutaneous transhepatic cholangiog-
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raphy (PTC) demonstrated type III 
strictures in two patients and ty­
pe IV strictures in two patients. In 
each patient the duct-to-duct repair 
was revised with a hepaticojejunos- 
tomy, and they were well at follow­
up 3, 4, 16 and 22 months after 
reconstruction.
The two patients with electrocau­
tery injuries had the LC converted 
to a laparotomy, and a T tube was 
inserted in the common duct. One 
patient (Table I, no. 5) was well 11 
months later, and the other patient 
(Table I, no. 7) had a type I stric­
ture 6 weeks after LC and required 
a hepaticojejunostomy. He was well 
4 months after repair.
Eight of the nine patients in this 
group either initially or ultimately 
had a hepaticojejunostomy to repair 
the bile duct injury.
Group 2  (Table II)
Ten of the 12 patients in whom 
the bile duct injury was diagnosed 
after LC presented within the 1st 
postoperative week. Jaundice was 
present in seven of them, upper 
abdominal pain in five, bile collec­
tions in five and fever in three. Of
the two patients who presented 
after the 1st postoperative week, 
one presented with jaundice 2 
weeks after LC and the other with 
pruritus and jaundice 3 months 
after LC.
In 7 of the 12 patients, the 
operative notes revealed nothing of 
concern noted by the surgeon dur­
ing LC to suggest that an injury to 
the bile duct had occurred. The 
operations were considered to have 
been straightforward. In four pa­
tients, however, troublesome bleed­
ing had been encountered during 
LC; the bleeding was controlled by 
the application of between one and 
two dozen hemoclips. In two of the 
four, the surgeon noted that severe 
inflammation of the gallbladder had 
made the LC difficult. In the re­
maining patient (Table II, no. 19), 
bile was noted in the right upper 
quadrant at the end of LC, and for 
that reason a drain was left in place.
The patients were referred as 
early as 3 days after LC, when it 
was evident there was a problem, 
and as late as 3 weeks after the 
onset of signs or symptoms. Endo­
scopic retrograde cholangiopan­
creatography (ERCP) was attempt­
ed in all patients; it was successful 
in nine patients. It showed complete 
biliary obstruction with visualiza­
tion of the distal bile duct only in 
seven patients and partial obstruc­
tion of the common duct with some 
filling of the proximal duct in two 
patients. In 11 patients PTC dem­
onstrated the proximal biliary tree 
and the level of obstruction. Extra­
vasation of contrast medium into 
the subhepatic space was noted in 
three patients.
Eight of the 12 patients had a 
Roux-en-Y hepaticojejunostomy as 
primary repair of the injuries, and 
the procedure was successful in 7 
of them. One patient (Table II, 
no. 17) subsequently required resec­
tion of the right hepatic lobe for a 
recurrent intrahepatic stricture of 
the right hepatic duct. The biliary 
reconstructions were performed 
from 4 days to 5.5 months after LC. 
When the reconstruction was per­
formed within 1 or 2 weeks of LC, 
the operative findings were usually 
clear enough to determine what 
mishap had occurred during LC. It 
was evident that there had been 
extensive dissection both on and to 
the left of the common duct, and in
Tab le  1. B ile  D uct In ju rie s  R eco g n ized  in G roup  1 P a tie n ts  (D uring  L a p a ro s c o p ic  C h o le c y s te c to m y  [L C ])
P atien t
no.
Age,
V Sex In jury  (le v e l) C ause of injury
T re a tm e n t
S econd rep a ir  
F irs t re p a ir  (m o  a fte r  LC) O u tco m e (m o )
1 30 F S eg m e n t o f  c o m m o n M is in te rp re ta tio n  o f S am e  day N o t re q u ired W e ll (2 3 )
d u c t e xc ised  (II) a n a to m y h e p a t ic o je ju n o s to m y
2 32 F S eg m e n t o f c o m m o n M is in te rp re ta tio n  o f D -D  a n a s to m o s is  o v e r F le p a tic o je ju n o s to m y W e ll (4 )
d u c t e xc is e d  (III) a n a to m y T  tu b e (4 )
3 36 F D iv is ion  o f c o m m o n M is in te rp re ta tio n  o f D -D  a n a s to m o s is  o v e r H e p a tic o je ju n o s to m y W e ll (2 2 )
d u c t (III) a n a to m y T  tu b e (1 .5 )
4 25 F S eg m e n t o f  c o m m o n M is in te rp re ta tio n  o f D -D  a n a s to m o s is  o v e r H e p a tic o je ju n o s to m y W e ll (1 6 )
d u c t e xc is ed  (IV ) a n a to m y T  tu b e (6 )
5 35 F P erfo ra tio n  o f r ig h t E le c tro ca u te ry T - tu b e  in s e r t io n N o t requ ired W e ll (1 1 )
hepa tic  d u c t (V ) a p p lica tio n
6 22 F E xcis ion  o f c o m m o n M is in te rp re ta tio n  o f S am e  day N o t re qu ired W e ll (8 )
d u c t c o n flu e n c e  (IV ) a n a to m y h e p a t ic o je ju n o s to m y
7 52 M Burn and p e rfo ra tio n E le c tro ca u te ry T - tu b e  in s e r t io n H e p a tic o je ju n o s to m y W e ll (4 )
o f c o m m o n  d u c t (I) a p p lica tio n (1 .5 )
8 26 F S eg m e n t o f  c o m m o n M is in te rp re ta tio n  o f S a m e  day N o t re qu ired W e ll (2 )
d u c t e xc is e d  (I) a n a to m y h e p a t ic o je ju n o s to m y
9 46 F D iv is ion  o f p ro x im a l M is in te rp re ta tio n  o f D - D  a n a s to m o s is  o v e r H e p a tic o je ju n o s to m y W e ll (3 )
c o m m o n  d u c t (IV ) a n a to m y T  tu b e (6 )
D - D  =  d u c t- to -d u c t- re p a ir
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two patients the lateral aspect of 
the portal vein had been exposed. 
Segments of the common duct were 
missing or, especially when bleed­
ing had been encountered during 
LC, many hemoclips had been ap­
plied to the common duct and peri­
ductal tissues. When reconstruction 
was not performed until several 
weeks after LC, considerable in­
flammation and scarring were al­
ways present, with hemoclips em­
bedded in the scar and in strictured 
segments of the common duct.
Patient no. 13 (Table II) had a 
laparotomy 5 days after LC when 
an ERCP showed complete obstruc­
tion of the common duct by two 
hemoclips. The two clips intended 
for the cystic duct were found en­
croaching on the common duct near 
the junction of the two ducts. The 
clips were removed, and the patient
was referred for hepaticojejunosto- 
my 7 months later when a stricture 
developed at the site. Presumably, 
the clips had produced enough of a 
crush injury that healing of the 
duct by fibrosis was the result. Two 
patients (Table II, nos. 14 and 19) 
had bilomas drained externally 
without further investigation. The 
bile drainage ceased, but both pa­
tients had common duct strictures 
3.5 and 5.5 months later requiring 
hepaticojejunostomy. One patient 
(Table II, no. 15) underwent explo­
ration of the common duct, and a 
T tube was inserted for a type II 
stricture that was evident 3 months 
after LC. The stricture recurred, 
and revision to a hepaticojejunosto­
my was necessary at 13 months.
All 12 patients in this group 
required a hepaticojejunostomy ei­
ther as the primary method of re­
pair or for revision of a failed initial 
treatment.
Illustrative Cases
Patient 1. Group 1
During LC on this 30-year-old 
woman the surgeon clipped and 
divided what was believed to be the 
cystic duct. As the dissection pro­
gressed additional tissue in the area 
of Calot's triangle was clipped and 
divided, and the gallbladder was 
removed. Gross inspection of the 
gallbladder showed that a segment 
of common duct was attached to 
the cystic duct. The surgeon real­
ized that a portion of the common 
bile duct had been resected, and the 
operation was terminated. After 
awaking from the anesthetic, the
T a b le  I I .  Bile Duct Injuries Recognized in Group 2 Patients (After LC)
P atien t
no.
Age,
yr Sex
P rob lem  
encountered  
during LC
Postoperative  
com plications (d)
Type of T re a ,m e n t  
obstruction / F irst re p a ir  Second rep air  
stric tu re * (d  a fte r  LC) (m o a lte r  LC) O utcom e (m o)
10 23 F Many clips for 
bleeding
Jaundice (5) III Hepaticojejunostomy
(42)
Not required Well (19)
11 37 F Many clips for 
bleeding
Pain, jaundice (4) II Hepaticojejunostomy
(35)
Not required Well (15)
12 36 M Many clips for 
bleeding — 
difficult 
procedure
Jaundice (3) I Hepaticojejunostomy
(4)
Not required Well (13)
13 40 F Nothing noted Pain, jaundice (3) I Laparotomy, removal 
of clips (5)
Hepaticojejunostomy
(7)
Well (15)
14 40 F Nothing noted Pain, fever, biloma 
(3)
III External drainage (12) Hepaticojejunostomy
(5.5)
Well (13)
15 41 F Nothing noted Pruritus, jaundice 
(90)
II ECBD, T-tube insertion 
(3)
Hepaticojejunostomy
(13)
Well (2)
16 45 F Many clips for 
bleeding — 
difficult 
procedure
Jaundice (14) IV Hepaticojejunostomy
(14)
Not required Transient bile 
leak, well (9)
17 53 F Nothing noted Fever, pain, 
peritonitis, 
biloma (3)
V Hepaticojejunostomy
(14)
Right lobectomy and 
hepaticojejunostomy 
to left duct (14.5)
Well (6)
18 30 F Nothing noted Biloma (7) V Hepaticojejunostomy 
to left duct, right 
lobectomy (84)
Not required Well (2)
19 36 F Bile noted, drain 
placed
Biloma, fever, 
jaundice (7)
IV External drainage Hepaticojejunostomy
(3.5)
Well (1)
20 27 M Nothing noted Pain, jaundice (3) II Hepaticojejunostomy
(17)
Not required Well (2)
21 22 F Nothing noted Jaundice, biloma 
(3)
III Hepaticojejunostomy
(11)
Not required Well (2)
'B ism uth classification'2
ECBD =  exploration of common bile duct
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patient was immediately transferred 
for repair of the injury. At laparoto­
my about 4 hours later, the proxi­
mal bile duct was identified, disclos­
ing a type II injury. A Roux-en-Y 
hepaticojejunostomy was per­
formed. The postoperative course 
was uncomplicated, and the results 
of liver function tests 23 months 
postoperatively were normal.
Patient 2, Group 1
A 32-year-old woman underwent 
LC for symptomatic gallstones. 
During the surgery, what was be­
lieved to be the cystic duct was 
clipped and divided. After the cystic 
artery was divided, a third structure
was identified as the cystic duct. 
The surgeon realized that the com­
mon bile duct had been divided, and 
a laparotomy was performed. A ty­
pe III injury was found with a gap 
of about 1 cm in the common duct. 
Duct-to-duct reconstruction over a 
T tube was performed, and the 
anastomosis was described as being 
under slight tension. An intraopera­
tive T-tube cholangiogram showed 
good passage of dye into the duode­
num and a leak of contrast material 
at the anastomosis (Fig. 1). The 
patient was referred postoperatively 
for continued management. The bile 
leak closed after 2 weeks, and the T 
tube was removed 3 months later. 
Four months after LC the patient
became jaundiced, and ERCP and 
PTC disclosed a type IV stricture. A 
hepaticojejunostomy was performed 
and she was well 4 months after 
repair.
Patient 10, Group 2
During LC on a 23-year old wom­
an, bleeding was encountered and 
controlled by the application of ap­
proximately 15 hemoclips. Progres­
sive, painless jaundice and itch de­
veloped postoperatively. Five days 
after LC, the serum alkaline phos­
phatase level was elevated at 
488 U/L (normal 18 to 113 U/L) 
and the serum bilirubin level was 
also elevated at 186 /umol/L (nor­
mal 3.4 to 17.1 pmo\/L). Ul­
trasonography revealed dilated in- 
trahepatic bile ducts. The patient 
was referred 3 weeks postoperative­
ly at which time an ERCP disclosed 
complete bile duct obstruction by 
numerous hemoclips (Fig. 2). PTC 
demonstrated a type III injury 
(Fig. 3). She underwent a Roux- 
en-Y hepaticojejunostomy 6 weeks 
after the LC. The patient remained 
asymptomatic, with normal results 
of liver function tests 19 months 
after surgery.
Patient 14, Group 2
A 40-year old woman with symp­
tomatic gallstones had LC. An in­
traoperative cholangiogram ap­
peared normal. Three days later, 
right upper quadrant pain and fever 
developed. Ultrasonography showed 
a fluid collection, and a biloma was 
drained percutaneously 12 days 
after the LC. This resulted in clini­
cal improvement. ERCP and PTC 
were attempted without success. A 
laparotomy was performed 2 weeks 
after the drainage procedure when 
the patient’s clinical condition wors­
ened. Bile peritonitis with dense 
adhesions was found. The leak was 
coming from a divided common
FIG. 1. Patient no. 2, group 1. Operative T-tube cholangiogram shows leak of dye 
from anastomosis (white arrow). Because proximal limb is in left hepatic duct (black 
arrow), there is no opacification of right hepatic duct.
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duct. Because of the local inflam­
mation and the instability of the 
patient, a catheter was inserted into 
the proximal bile duct to create a 
controlled external biliary fistula. 
Cholangiography through the cath­
eter demonstrated a type III injury. 
A Roux-en-Y hepaticojejunostomy 
with separate anastomoses to the 
right and left hepatic ducts was 
performed 5.5 months after the LC. 
The postoperative course was com­
plicated by thrombosis of the right 
subclavian vein and spontaneous 
hemopericardium after anticoagula­
tion. She recovered after 7 weeks in 
hospital and was well, with normal 
liver function, at follow-up 7 
months after biliary reconstruction.
Discussion
The danger of injury to the com­
mon duct during cholecystectomy 
can never be eliminated, whether 
the gallbladder is removed by the 
laparoscopic or the open technique. 
The training of surgeons in the 
Halstedian tradition plus a century
of experience in biliary tract sur­
gery established OC as a technically 
safe operation. As OC is replaced by 
LC, injury of the common duct has 
emerged as a serious problem. Al­
though some series record a very 
low incidence of common duct inju­
ry during LC, others report an 
incidence ranging from 0.6% to 1%, 
several times higher than that ex­
pected with OC.13-16 The tendency 
for accidents to be frequent early in 
a surgeon’s experience with LC is 
best exemplified by the study of 
Davidoff and associates.10 In that 
report, 10 of 12 bile duct injuries 
during LC occurred within the re­
ferring surgeon’s first dozen laparo­
scopic procedures. A similar finding 
was reported by the Southern Sur­
geons Club.1
The injuries in our series demon­
strated several characteristic fea­
tures. When the injury was recog­
nized during LC, the error that was 
most commonly responsible was 
misinterpretation of the common 
duct for the cystic duct. This mis­
take was the most frequent cause of 
injury in other reports too.1017 Hun­
ter18 has emphasized the impor­
tance of proper orientation of Ca- 
lot’s triangle in setting up the oper­
ative field to avoid this error. Later­
al and inferior rather than upward 
retraction on Hartmann’s pouch 
opens up Calot’s triangle and in­
creases the angle between the cystic 
and common ducts. This manoeuvre 
avoids cephalad tenting of the com­
mon bile duct, making it less likely 
to be mistaken for the cystic duct. 
The use of the 30° angle scope also 
permits a more en face view of 
Calot’s triangle and provides better 
distinction between the relative po­
sitions of the cystic duct and the 
common duct. Only after the cystic 
duct and artery have been both 
dissected should either structure be 
clipped and divided. Precise adher­
ence to the surgical principle of 
correct identification of the anato-
FIG. 2. Patient no. 10, group 2. Endoscopic retrograde cholangiography shows 
complete occlusion of common bile duct by multiple hemoclips (large white arrow). 
Air bubbles are seen in lower bile duct (small white arrow).
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my would have avoided injury in 
most of these cases. Persistent bile 
staining of the operative field and 
visualization of a “second duct” 
after division of what was identified 
initially as the cystic duct were 
common operative findings during 
LC that pointed to an injury of the 
bile duct.
The second commonest cause of 
injury during LC was dissection on 
and around the common duct that 
included the application of hemo- 
clips to the common duct and the 
tissues surrounding it. The position 
of the common duct relative to the 
other structures should be con­
stantly used as a reference point, 
but it is neither necessary nor desir­
able to actually dissect out the 
common duct. It was evident in this 
series of patients that extensive 
dissections had frequently occurred
along the right side of the hepato­
duodenal ligament, a manoeuvre 
that immediately puts the common 
duct at risk. Dissection in this area 
also increases the risk of bleeding 
by trauma to the hepatic artery or 
its right branch. This invites the 
next commonest mechanism of in­
jury, namely the application of 
many hemoclips near the common 
duct to stop bleeding. The danger 
of applying many hemoclips has 
been reported recently, with a rec­
ommendation that only six hemo­
clips be used during LC and that 
more clips be applied only with 
caution and justification.19 If 
enough hemorrhage occurs that the 
position of the common duct is 
obscured, the repeated application 
of hemoclips to stop the bleeding is 
hazardous. The bleeding may result 
from direct injury to a specific
vessel or it may be due to a severely 
inflamed or scarred gallbladder. Re­
gardless of the cause, such a situa­
tion calls for a critical assessment 
of the need to convert the LC to an 
OC to avoid a bile duct injury.
Electrocautery injury of the bile 
duct was the least common mecha­
nism of injury in this series. Vigor­
ous use of electrocautery anywhere 
close to the common duct must be 
avoided. Thermal injury may create 
a hole that is immediately apparent, 
or the area of burn may heal by 
fibrosis and ultimately result in a 
stricture weeks or months later.10
When the common duct is inad­
vertently divided or a portion of it is 
resected, and the injury is recog­
nized during LC, a duct-to-duct 
anastomosis over a T tube may 
seem the easiest, most expeditious 
solution. This type of repair is re­
ported to have a high failure rate,20 
however, and this was demonstrat­
ed in our patients. Circumferential 
loss of length of the common bile 
duct or common hepatic duct, or 
both, is common, limiting the feasi­
bility of a good duct-to-duct anasto­
mosis without tension. In addition, 
the dissection during LC and burn 
from the electrocautery may have 
impaired the blood supply to the 
ends of the bile duct. The duct is 
usually nondiseased and small, per­
mitting only a narrow calibre anas­
tomosis that is predisposed to ste­
nosis. Our preference for primary 
repair of a divided bile duct recog­
nized during LC would be an imme­
diate Roux-en-Y hepaticojejunosto- 
my. The loop always has a good 
blood supply, the anastomosis is 
without tension and the long-term 
results with this type of reconstruc­
tion are good.21 Although years of 
follow-up are necessary before de­
claring success with any type of 
biliary reconstruction, none of the 
patients in this series who under­
went a hepaticojej unostomy either 
for immediate primary repair or for
FIG. 3. Patient no. 10, group 2. Percutaneous transhepatic cholangiography 
shows Bismuth type III stricture with intact confluence but absence of 
hepatic duct (arrow).
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secondary reconstruction has so far 
needed a revision. If the surgeon 
performing the LC is not prepared 
to perform a reconstruction with a 
Roux-en-Y loop, immediate referral 
should be made to a centre where a 
hepaticojejunostomy can be per­
formed within 24 hours of injury. A 
catheter may be left for interim 
drainage of bile to the exterior 
during the transfer. Insertion of a T 
tube may be appropriate treatment 
if there has been just a partial 
laceration of the bile duct.
Right upper quadrant pain, jaun­
dice and a bile collection within 
days of an LC are a suggestive 
triad. Patients presenting with this 
symptom complex demand immedi­
ate investigation to exclude a bile 
duct injury. It is not adequate to 
drain a postoperative bile collection 
and await events. As shown in this 
series, patients with an injured bile 
duct will have serious signs and 
symptoms within several days after 
LC. A prompt diagnosis would 
allow reconstructive surgery soon 
after the injury, before sepsis and 
infected bile collections create ad­
verse systemic and local conditions. 
Abdominal ultrasonography will 
often show dilatation of the in- 
trahepatic biliary tree, but the most 
important test is a contrast study of 
the ducts. Our preference is an 
ERCP, because it will be diagnostic 
for a bile duct injury and it may be 
therapeutic if jaundice is due to a 
retained stone or if a nasobiliary 
catheter is required to control leak­
age of bile from a cystic duct 
stump. When the ERCP shows ob­
struction to the common duct the 
precise anatomy of the proximal 
duct is essential in planning recon­
structive surgery. An ERCP may 
detail the proximal anatomy when 
the obstruction is incomplete, but a 
PTC is usually necessary to deter­
mine the exact level of injury and in 
particular whether the confluence 
of the right and left hepatic ducts is
intact. This information is needed 
to ensure that all obstructed ducts 
will be adequately drained at the 
time of reconstruction. Placement 
of a percutaneous transhepatic 
catheter in the proximal bile duct 
immediately before reconstruction 
may make identification of the duct 
easier at the time of surgery.22 The 
best chance at repair of an injured 
duct is the first attempt, and factors 
that are important in the ultimate 
outcome after biliary reconstruction 
include the level of the stricture and 
prior attempts at reconstruction.23
More than half the patients in 
this series were in their third or 
fourth decade of life, and in more 
than half of them the injury or 
stricture was high (type III or 
above). Collectively, they will have 
many decades to test the effective­
ness and durability of their biliary 
repairs. This underscores the key 
message, namely, that prevention 
has to be regarded as the real 
solution to bile duct injuries during 
LC.
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U se  of the External Fixation Apparatus 
for Percutaneous Insertion of Pins 
in the Distal One-Third of the Radius: 
an Anatomic Study
Ronald Vandersluis, MD;* Robert S. Richards, MD, FRCSC;t James H. Roth, MD, FRCSC, FACS*t
Objective: To assess the risk of soft-tissue injury during percutaneous placement of external fixation 
pins in the proximal radius.
Design: An anatomic study with embalmed cadaver limbs.
Setting: Hand and upper limb centre at a university-affiliated hospital.
Interventions: Two 4-mm Hoffman half pins were percutaneously placed along the dorsoradial ridge of 
the radius, four finger breadths proximal to the radial styloid process.
Main Outcome Measures: Injuries to soft tissues including tendons, nerves and vessels were noted. 
Results: Nerve or tendon injuries occurred in 7 of 26 forearms. Three pins transfixed either the 
superficial branch of the radial nerve or lateral antebrachial cutaneous nerves. Tendon injuries 
included the brachioradialis in two forearms, the extensor carpi radialis brevis in three forearms, and 
the extensor carpi radialis longus an "he abductor pollicis longus in one forearm each.
Conclusions: Percutaneous pin placement in the distal radius is unsafe. The authors recommend open 
pin placement for fractures of the distal radius.
Objectif: Evaluer le risque de blessure des tissus mous durant l’insertion percutanee d’une tige de 
fixation externe du radius proximal.
Conception : Une etude anatomique utilisant des membres embaumes de cadavres.
Contexte : Le centre du traitement des mains et les membres superieures, dans un hopital universitaire. 
Interventions : Deux demi-tiges Hoffman de 4 mm ont ete inserees par voie percutanee le long de la 
Crete dorsoradiale du radius, a quatre largeurs de doigt de l’apophyse styloi'de du radius.
Principaux effets mesures : Les lesions des tissus mous incluant tendons, nerfs et vaisseaux furent 
notees.
Resultats : Des lesions des nerfs ou des tendons sont survenues dans 7 avant-bras sur 26. Trois tiges 
ont traverse soit la branche superficielle du nerf radial, soit les nerf brachiaux cutanes internes 
lateraux. Les blessures tendineuses comprennent des lesions du brachioradialis dans deux avant-bras, 
de l’extensor carpi radialis brevis dans trois avant-bras, et de l’extensor carpi radialis longus et de 
l’abductor pollicis longus dans un avant-bras chacun.
Conclusions : L’insertion percutanee de tige dans la partie distale du radius n’est pas sure. Les auteurs 
proposent la pose ouverte de tiges dans les fractures du radius distal.
Distraction of the wrist with li- gamentotaxis provides a good 
method of stabilizing comminuted 
or unstable fractures of the distal 
radius. This can be accomplished 
with pins and plaster12 or with an
external fixator.3'4 Although the 
complication rate associated with 
the use of an external fixator is 
lower than that with pins and plas­
ter,13 use of an external fixator can 
cause complications. These include
pin infection, loosening, fracture of 
the radius, nerve injury, neuroma 
and tendon injury.
The purpose of this study was to 
assess the risk associated with per­
cutaneous pin placement in the ra-
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dius and to determine whether a 
safe zone exists.
Methods
Twenty-six forearms (13 right 
and 13 left) from different cadavers 
were used. Two 4-mm self-tapping 
Hoffman (Howmedica Inc., Ruther­
ford, NJ) half pins were placed into 
the radius with a universal hand 
drill. Cooney5 has recommended 
placement of the first pin four fin­
ger breadths proximal to the radial 
styloid process. Therefore, the first 
pin was placed 8 cm proximal to the 
radial styloid. The second pin was 
placed 2 cm proximal to the first. 
The pins were placed percutaneous- 
ly along the dorsoradial ridge of the 
radius parallel to the coronal plane 
of the forearm. No stab incisions or 
predrilling was used. After pin 
placement, skin and subcutaneous 
tissues were dissected with 
3.5-loupe magnification over an 
area extending from the midaxial 
line of the dorsum of the forearm to 
the flexor carpi radialis tendon. The
lateral antebrachial cutaneous nerve 
(LACN) and the superficial branch 
radial nerve (SBRN) were preserved. 
Measurements of the following dis­
tances were made: arm length from 
the radial styloid to the elbow 
flexion crease, the distance from 
the radial styloid to the SBRN at its 
exit from beneath the brachioradial- 
is tendon, the distance from the 
radial styloid to each pin, and the 
distance from the SBRN and the 
LACN to each pin. Injuries to soft 
tissues, including tendons, nerves 
and vessels, were noted and photo­
graphed. The distance from the 
radial styloid to the SBRN was 
compared to the arm length from 
the radial styloid to the elbow 
flexion crease to determine if 
there was a safe zone for percuta­
neous pin placement that would 
protect the SBRN from injury.
Findings
The SBRN was identified within 
the dissection field (Fig. 1) in all 26 
specimens, and the LACN was simi­
larly identified in 8 specimens. The 
distance measurements are shown 
in Table I. The average distance 
from the SBRN to pin 1 was 7 mm 
(range from 0 to 18 mm) and to 
pin 2 was 9 mm (range from 4 to 
14 mm). The average ratio of the 
distance from the radial styloid to 
the elbow crease and the distance 
from the radial styloid to the exit of 
the SBRN from under the brachi- 
oradialis tendon was 0.35 (range 
from 0.28 to 0.44). The SBRN was 
transfixed by pin 1 (the distal pin) 
twice. The average distance from 
the LACN to pin 1 was 6 mm 
(range from 3 to 10 mm) and to 
pin 2 was 6 mm (range from 0 to 
11 mm). The LACN was transfixed 
once by pin 2.
Three tendons were transfixed by 
the pins. The abductor pollicis lon- 
gus and the extensor carpi radialis 
longus were transfixed by pin 1. 
The extensor carpi radialis brevis 
(ECRB) was transfixed by pin 2. 
Four tendons sustained partial ten­
don lacerations. The ECRB was 
injured by both pins, and the bra- 
chioradialis was injured twice by 
pin 1.
The point of nerve emergence 
from beneath the brachioradialis 
varied in relation to the arm length, 
from 28% to 44% of total arm 
length. In other words, it could 
emerge anywhere from the mid­
forearm to the distal one quarter of 
the forearm.
Overall, 7 (27%) of 26 arms sus-
Table I. Measurements Made in 26 Cadaver 
Forearms
Distance, mm
Measurement Average Range
Pin 1 to SBRN 7 0 - 1 8
Pin 1 to LACN 6 3 - 1 0
Pin 2 to SBRN 9 4 - 1 4
Pin 2 to LACN 6 0 - 1 1
Radial styloid to SBRN 88 7 0 - 1 1 2
Arm length 251 2 1 2 - 2 8 5
SBRN =  superficial branch of the radial 
nerve, LACN =  lateral antebrachial cutane­
ous nerve
FIG. 1. Cadaver specimen showing anatomic points of interest in placement of pins 
for percutaneous external fixation of radial fractures. In this specimen elbow is to 
right and wrist to left. Distal external fixation pin is placed 8 cm proximal to radial 
styloid (R). Cephalic vein (C) is seen, with branch of lateral antebrachial cutaneous 
nerve (large arrow) passing in close proximity to pin. Superficial branch of radial 
nerve (small arrow) is seen exiting from beneath brachioradialis tendon (B).
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tained soft-tissue injuries. Three 
nerve (12%) and seven (27%) tendon 
injuries were noted.
Discussion
Complications associated with 
use of the external fixator appara­
tus can be clinical, equipment relat­
ed or multifactorial.6 Clinical com­
plications can be from soft-tissue or 
osseous damage. Pin complications 
include infections and loosening. 
Clinical soft-tissue injuries during 
pin insertion include damage to 
nerves, vessels, muscles and ten­
dons. These complications can be 
avoided with proper insertion tech­
nique, for which intimate knowl­
edge of forearm anatomy is essen­
tial. Attempts have been made to 
make percutaneous pin insertion 
safe by delineating safe, hazardous 
and unsafe corridors. Safe corridors 
without musculotendinous units 
and neurovascular structures occur 
only in the scapula, ulna and meta- 
carpals in the upper limb. Hazard­
ous corridors contain musculotendi­
nous units but no important neuro­
vascular structures. The radius and 
humerus are concentric bones in 
which no safe corridors exist. Pin 
placement here ideally occurs 
through corridors in which mus­
culotendinous units are present 
without neurovascular structures.6
In regard to external fixation of 
the radius, complications involving 
tendon and nerve damage range 
from 5%5 to 11%7 to 18%.8 Cooney5 
believed that the radial sensory 
nerve is not at risk if pins are 
placed four finger breadths or more 
from the radial styloid. He stated 
that in the 10% of his cases in 
which the radial sensory nerve or 
tendons were considered to be at 
risk, an open technique was appro­
priate. Others9’10 have reported that 
proximal pin placement through 
small stab incisions avoids sensory
neuromas. Seitz, Putnam and 
Dick10 believed that small stab inci­
sions with a drill sleeve to protect 
the soft tissues can avoid injury. 
The use of blunt dissection and drill 
sleeves is easily accomplished in 
metacarpal pin placement but can 
be difficult in radial pin placement. 
To date no study has defined risk 
factors or external landmarks that 
predict the location of the SBRN.
In our anatomic study we showed 
that percutaneous pin placement 
was associated with soft-tissue in­
jury in 27% of forearms studied. 
Varying degrees of tendon injury 
occurred, but all injuries involved 
less than 50% of the tendon sub­
stance. Although there were no 
complete tendon lacerations, the 
subsequent scarring may affect re­
habilitation. The incidence of nerve 
injury was 12%. This correlates well 
with reported clinical complication 
rates. Due to the well-established 
degree of overlap11 between the 
LACN and the SBRN, injury to 
either nerve will give similar symp­
toms, and in our opinion both these 
nerves are at risk. We were unable 
to identify external landmarks that 
determined a safe zone for percuta­
neous pin placement. The anatomy 
of the SBRN and the LACN is 
highly variable. Our data show that 
both these nerves are at risk when 
pins are placed anywhere into the 
distal half of the radius. Because of 
the high rate of nerve and tendon 
injuries recorded, we recommend 
open pin placement in this region of 
the radius. Open pin placement al­
lows visualization and protection of 
nerves and tendons and will de­
crease the number of soft-tissue 
complications.
Conclusions
On the basis of cadaver dissec­
tion, a safe zone for percutaneous 
placement of fixation pins in radial
fractures could not be established. 
Injury to both nerves and tendons is 
common after percutaneous pin 
placement in the radius.
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A cute Abdominal Emergencies in Patients 
on Long-Term Ambulatory Peritoneal 
Dialysis
James L. Wellington, MD, CM, FRCSC, FACS; Kelly Rody, RN
Objective: To review intercurrent abdominal emergencies in patients receiving long-term peritoneal 
dialysis on an ambulatory basis.
Design: A chart review.
Setting: Tertiary care referral centre.
Patients: Seven patients receiving long-term peritoneal dialysis, who suffered an acute abdominal 
emergency during a 7-year study period.
Interventions: Laparotomy with appropriate management depending on the findings. Antibiotic therapy 
and dialysate culture.
Results. In all patients the acute abdominal process involved the colon: five patients had perforated 
diverticulitis and two had ischemic colitis. The death rate overall was 57%. Peritonitis in these patients 
was difficult to differentiate from the peritonitis that occurs commonly in patients on long-term 
peritoneal dialysis. As a result there was a delay in the initiation of therapy ranging from 2 to 27 days. 
Conclusions: Coincidental abdominal emergency should be considered when patients receiving 
long-term peritoneal dialysis on an ambulatory basis present with peritonitis that does not respond to 
established antibiotic protocols and when culture results show evidence of multiple enteric organisms.
Objectif: Etudier les urgences abdominales intercurrentes qui surviennent chez les patients soumis a 
une dialyse abdominale de longue duree administree en ambulatoire.
Conception : Une etude retrospective des dossiers d’hopitaux.
Contexte : Un centre d’acheminement pour soins tertiaires.
Patients : Sept patients sous dialyse peritoneale de longue duree qui ont presente une urgence 
abdominale aigue au cours d’une periode de 7 ans.
Interventions : Une laparotomie accompagnee des soins appropries aux observations. Antibiotherapie 
avec culture du dialysat.
Resultats : Dans tous les cas, l’abdomen aigu etait relie a une atteinte du colon: cinq patients avaient 
une diverticule perforee et deux, une colite ischemique. La mortality a ete de 57 %. Chez ces patients, il 
etait difficile de differencier ce type de peritonite des peritonites frequemment observees chez les 
patients sous dialyse peritoneale de longue duree. En consequence, on compte un delai de 2 a 27 jours 
avant de debuter le traitement.
Conclusions : On doit envisager la possibility d’une urgence abdominale intercurrente quand un patient 
sous dialyse peritoneale de longue duree administree en ambulatoire presente une peritonite qui ne 
cede pas aux protocoles d’antibiotherapie etablis et quand les cultures indiquent la presence de 
multiples enterobacteries.
T he role of chronic (long-term) ambulatory peritoneal dialysis 
(CAPD) in the treatment of chronic 
renal failure is rapidly expanding. 
Exogenous infection resulting in
peritonitis is the commonest late 
complication in most CAPD pro­
grams. Such infections are usually 
due to a single organism and re­
spond to established treatment pro­
tocols. However, when peritonitis 
develops because of unrelated intra­
abdominal disease of the gastroin­
testinal tract, the diagnosis may be 
uncertain, and this may lead to
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delay in emergency operation and 
contribute to a high surgical death 
rate. Our experience with seven 
such patients on CAPD, who had 
coincidental emergency surgical 
conditions, is reported.
Patients and Methods
Between May 1984 and October 
1991, seven patients (five men, two 
women) on CAPD were recognized 
as suffering from acute abdominal 
surgical conditions (Table I). The 
diagnosis was verified at operation 
in six and at autopsy in one. Many 
patients were elderly (mean age 69 
years, range from 57 to 83 years). 
They had been on peritoneal dialy­
sis for periods ranging from 1 to 
106 months. Five of the seven 
patients had had peritonitis.
Clinically, the patients with gas­
trointestinal complications could 
not be differentiated from the usual 
patient with CAPD peritonitis. Radi­
ologic investigations were not help­
ful, most patients showing nonspe­
cific bowel distension compatible 
with ileus. No patient had evidence 
of free intraperitoneal air. When an 
acute abdomen developed, treat­
ment was initiated with a standard 
antibiotic protocol consisting of 
cefazolin 1 g, tobramycin 40 mg 
and vancomycin 1 g infused in- 
traperitoneally. Antibiotic therapy 
was modified depending on the cul­
ture results.
Results
In this series, specimens of dialy- 
sate were sent for Gram’s staining
in six of the seven patients. Two of 
these specimens gave negative re­
sults, but the remainder grew gram­
negative bacilli. Cultures of the di- 
alysate from six of the seven pa­
tients grew mixed enteric organ­
isms, including Bacteroides fragilis 
in two and a solitary growth of 
Escherichia coli in one.
At operation or autopsy, all pa­
tients were noted to have conditions 
affecting the large intestine. Five 
patients had perforated sigmoid di­
verticulitis with either paracolic ab­
scess or frank peritonitis, and two 
suffered from ischemic infarction of 
the large bowel. Six patients under­
went some form of colonic resec­
tion: primary anastomosis in one 
and fecal diversion in five. Four 
(57%) of the seven patients died. 
The cause of death was myocardial 
infarction in two and sepsis in two.
Tab le  1. Data on Patients Receiving Chronic Ambulatory Renal Dialysis (CAPD) and Suffering From Acute Gastrointestinal Com plications
P atient
no. Sex
Age,
yr
Duration  
of CAPD, 
mo
P revious  
ep isodes  of 
periton itis , 
no.
R esu lts  of 
G ra m ’s 
sta in ing
R esults of 
culture
Duration  
from  
onset to 
surgery , 
d Find ing s P rocedure O utcom e
L ength  of 
h o s p ita l 
s ta y , d
1 M 63 106 1 Negative MEO
(.Bacteroides 
fragilis)
2 Perforated
d iverticu litis
Local resection 
and
anastomosis
Survived 21
2 M 83 1 0 Gram­
negative
bacilli
MEO 5 Perforated 
diverticu litis  
w ith  pericolic 
abscess
Sigmoid
resection,
colostom y
Survived 79
3 M 69 3 0 Negative Escherichia
co li
I
3 Infarction right 
colon
Right
hemi­
colectomy,
ileostomy
Died (M l) 8
4 M 57 16 2 Gram­
negative
bacilli
MEO
(Bacteroides
fragilis)
27 Perforated 
diverticu litis  
w ith  pericolic 
abscess
Sigmoid
resection,
colostom y
Died
(sepsis)
87
5 F 66 45 2 Gram­
negative
bacilli
MEO 5 Ischem ic colitis 
w ith
perforation
Total
colectomy,
ileostomy
Died
(sepsis)
46
6 M 77 27 2 Gram­
negative
bacilli,
gram­
positive
cocci
MEO No surgery Perforated 
d iverticu litis  
w ith  pericolic 
abscess 
(autopsy)
No surgery Died (M l) 4
7 F 69 34 6 N /A MEO 6 Perforated
d iverticu litis
w ith
peritonitis
Sigmoid
resection,
colostom y
Survived 23
N /A  = not available, MEO = Multiple enteric organisms, Ml =  myocardial infarction
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Three of the six patients who un­
derwent surgery died for an opera­
tive death rate of 50%.
The delay from the time of pre­
sentation to surgery varied from 2 
to 27 days. In four of the six 
patients treated surgically, the delay 
was longer than 5 days. One patient 
(no. 6) died on the 4th day after 
admission and did not undergo op­
eration.
The length of stay from admis­
sion to discharge or death varied 
from 4 to 87 days (mean 38 days).
Discussion
Since it was introduced in 1976,1 
CAPD has been used with increas­
ing frequency as the preferred 
method of home dialysis in patients 
with end-stage renal failure. As ex­
perience with the technique has 
increased, the incidence of compli­
cating peritonitis has fallen. Howev­
er, peritonitis remains the main 
complication in these patients, with 
a reported incidence of approxi­
mately 1.3 episodes per patient per 
year.2 Our incidence of peritonitis at 
the Ottawa General Hospital is low­
er, being 0.45 episodes per patient 
per year with a current peritoneal 
dialysis population of 166 patients.
CAPD peritonitis is usually 
caused by normal skin bacteria, 
notably coagulase-negative staphy­
lococci.3 However, gram-negative 
bacteria may be responsible for as 
many as one-third of all cases of 
peritonitis associated with CAPD.4 
The presence of anaerobes or poly­
microbial peritonitis should raise 
the suspicion of bowel perforation. 
In a series of patients reported by 
Spence and colleagues,5 no patient 
without multiple enteric organisms 
required laparotomy. Conversely, 6
of 10 patients with multiple enteric 
organisms recovered without sur­
gery.
Peritonitis secondary to bowel 
perforation may be difficult to dif­
ferentiate clinically from that of 
peritonitis associated with CAPD. 
Similar findings were reported by 
both Spence and colleagues5 and 
Moffat, Deitel and Thompson.6 The 
presence of severe pain, especially 
when initially localized, should raise 
the suspicion of an intercurrent 
acute abdominal condition. Such 
conditions are frequently associated 
with muscle guarding and absent 
bowel sounds, which are infrequent 
features of the type of peritonitis 
commonly occurring in CAPD pa­
tients. Certainly, pain that persists 
after institution of the usual treat­
ment protocol should alert the phy­
sician to the possibility of peritoni­
tis caused by gastrointestinal com­
plications.
In our series, all patients suffered 
from colonic conditions. Perforated 
diverticulitis was the commonest 
complication, followed in frequency 
by ischemic bowel disease. Delay in 
necessary surgery was almost in­
variable, inviting a poor outcome 
and high mortality. Our operative 
death rate of 50% was identical to 
that reported by Moffat, Deitel and 
Thompson6 who cited nutritional 
depletion as a factor contributing to 
the poor outcome.
The cause for delayed interven­
tion in our series was related to 
prolonged medical treatment for 
what was interpreted as acute sig­
moid diverticulitis without perfora­
tion. Surprisingly, patients in the 
series of Spence and colleagues5 
had an average delay of 7.5 days 
before they underwent operation, 
and all survived. These authors be­
lieved that longer intraperitoneal
administration of antibiotics, by 
producing therapeutic serum levels, 
might have been responsible for the 
increased survival in the treatment 
of patients suspected of having 
CAPD peritonitis.
Summary and Conclusions
Peritonitis remains the common­
est complication of CAPD for pa­
tients with chronic renal failure. 
When such patients present with 
peritonitis that, on culture, demon­
strates multiple enteric organisms 
and does not respond to standard 
treatment protocols, a bowel perfo­
ration should be suspected. Delay in 
surgery is likely to lead to increased 
surgical complications and mortali­
ty. Our experience with seven such 
patients, all with disease affecting 
the large bowel, resulted in an 
operative mortality of 50%.
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Pediatric Free Tissue Transfer: 
an Evaluation of 99 Cases
Howard M. Clarke, MD, PhD, FRCSC, FACS;* Joseph Upton, MD, FACS;f 
Ronald M. Zuker, MD, FRCSC, FACS;* Ralph T. Manktelow, MD, FRCSC*
Objective: To evaluate the results of free tissue transfers in children who undergo reconstructive 
surgery.
Design: Case series chart review. Mean follow-up longer than 2 years.
Setting: Two tertiary care pediatric hospitals.
Patients: Consecutive sample of 99 children.
Interventions: Free tissue transfers for reconstruction of a variety of defects.
Main Outcome Measures: Indications, operations, complications, survival.
Results: The most common indications were for restoration of muscle function and for difficulties with 
soft-tissue coverage. Multiple donor sites were used, with the gracilis muscle, fibula, latissimus dorsi 
and groin flaps predominating. The overall survival rate was 99.0%. Complications were common, with 
an overall rate of 59.6%; most were graded as minor or moderate.
Conclusions: Meticulous planning is paramount in achieving a successful outcome. Complications are 
common but do not include vascular spasm. Free tissue transfers can be successfully completed in small 
children despite the dimensions of the tissues.
Objectif: Evaluer les resultats des transferts de tissu libre chez les enfants qui subissent une chirurgie 
de reconstruction.
Conception : Une revue d’une serie de cas. Le suivi moyen depasse 2 ans.
Contexte : Deux hopitaux de soins pediatriques tertiaires.
Patients : Un echantillonnage de 99 patients consecutifs.
Interventions : Les transferts de tissu libre pour la reconstruction de diverses lacunes.
Principaux effets mesures : Indications, operations, complications, survie.
Resultats : Les indications les plus courantes etaient liees au retablissement de la fonction musculaire 
ou a des difficultes de recouvrement des tissus mous. On eut recours a de multiples zones de 
prelevement de greffons, avec predominance des muscles droit interne de la cuisse, perone et grand 
dorsal, de meme qu'a des lambeaux d’aines. La survie fut de 99 %. Les complications etaient frequentes, 
leur taux atteignant 59,6 %; la plupart de celles-ci furent considerees benignes ou moderees. 
Conclusions : Une planification meticuleuse est de premiere importance pour obtenir de bons resultats. 
Les complications sont frequentes mais ne comprennent pas le spasme vasculaire. Le transfert de tissu 
libre peut etre realise avec succes chez le petit enfant malgre la faible dimension des tissus.
The ability to transfer viable, functional units of tissue about 
the body has greatly enhanced the 
capabilities of reconstructive sur­
gery. The techniques are no better
applied than in children, a popula­
tion in which there is an interesting 
array of congenital deformities and 
acquired defects.
Harii and Ohmori1 were the first
to report on free tissue transfer in 
children. They used free groin-flap  
transfer in two 4-year-old children 
to cover open wounds of the ankle. 
Free tissue transfer has been under-
From the *Division o f Plastic Surgery, The Hospital fo r Sick Children. Toronto, Ont„ and the fD ivision o f  Plastic Surgery, Children's Hospital 
Medical Center, Boston, Mass.
Accepted fo r publication Aug. 3, 1993
Reprint requests to: Dr. Howard M. Clarke. The Hospital fo r Sick Children. 555 University Ave., Toronto, ON M5G 1X8
CJS, VOL. 36, NO. 6, DECEMBER 1993 525
CLARKE ET AL
taken in children as young as 3 
months.2 To date there are two 
large series describing free tissue 
transfer in children. Parry, Toth 
and Elliott3 reviewed 22 cases in 
children ranging from 2 to 14 years 
of age. All but one case was for the 
coverage of soft-tissue defects, and 
15 had massive lower-extremity 
trauma with exposed bone. In their 
series of 21 patients under 20 years 
of age (mean age, 10.6 years) who 
underwent free tissue transfer, 
Serafin and Barwick4 reported on 
22 free flaps used for a variety of 
problems. There was one failure. 
They felt that there were problems 
related to vessel size in small chil­
dren. Further, Banic and Wulff3 
described injuries to the lower limbs 
of 15 children from 3 to 9 years of 
age that were treated by immediate 
reconstruction with latissimus dorsi 
musculocutaneous flaps. Iwaya, 
Harii and Yamada6 recommended 
the groin flap as the preferred 
donor site for coverage of traumatic 
defects on the dorsum of the foot 
and ankle in seven children. Ex­
panded parascapular free skin flaps 
were used by Moghari and col­
leagues7 in four children, with di­
rect closure of the donor wound. 
Superior gluteal flaps of fascia lata, 
muscle and fat and, in one case, 
skin were used to reconstruct hemi­
facial microsomia by La Rossa and 
associates.8 Other reports have in­
cluded a high proportion of children 
but in small numbers.9-13
In reviewing the first 99 free 
tissue transfers undertaken at two 
large pediatric centres we hope to 
indicate the breadth of surgery that 
can be undertaken and the relative 
safety of these procedures.
Patients and Methods
The first 99 consecutive free tis­
sue transfers undertaken in children 
at the Hospital for Sick Children in
Toronto (70 cases) and the Chil­
dren’s Hospital Medical Center in 
Boston (29 cases) were reviewed. 
Half of these children were operated 
on in the first decade of life (mean 
age at operation, 10.8 years, range 
from 17 months to 19 years). The 
hospital charts were reviewed in all 
cases to identify any complications 
in the perioperative period. Further 
recall visits were not feasible. The 
mean follow-up was 25.1 months 
with a maximum follow-up of 6.5 
years.
Results
Indications for Operation
The most common indication for 
operation was restoration of facial 
(20 children) or forearm (9 children) 
animation (Table I). Facial anima­
tion was undertaken in most cases 
for congenital facial palsy or Mobi- 
us’ syndrome. Forearm animation 
was indicated after Volkmann’s 
ischemic contracture as a result of a 
supracondylar fracture of the hu­
merus. Soft-tissue reconstruction 
was undertaken in the head and 
neck (11 children), the upper limb 
(4 children) and the lower limb (13 
children). Hand reconstruction with 
replacement of congenitally absent
Table  1. In d ic a tio n s  fo r  Free T issu e  
T ra n s fe r in C h ild ren
Indication P atien ts , no.
Facial re co n s tru c tio n  
S o ft-tis s u e  co v e r
20
Low er lim b 13
Head and ne ck 11
U pper lim b 4
D ig ita l re co n s tru c tio n 12
Forearm  a n im a tio n 9
P seud a rth ros is 9
B on y  re co n s tru c tio n 9
S o ft-tiss u e  c o n to u r 8
B urn-scar a lo p e c ia 1
C u tis  ap las ia  co n g e n ita 1
S hotgun  in ju ry 1
O vary p re se rva tio n 1
To ta l 99
or traumatically damaged structures 
was undertaken in 12 children. 
Pseudarthrosis of the tibia was 
treated with free fibular transfer in 
nine cases. There were an additional 
nine cases of bony reconstruction 
and eight cases of soft-tissue con­
tour treatment without a cutaneous 
defect.
Planning for Operation
Extensive planning was under­
taken in all cases. A two-team ap­
proach was usually used, one team 
to prepare the donor tissue and the 
other to prepare the recipient site. 
Both teams reviewed the cases pre- 
operatively in the planning phase. 
Angiography was undertaken in 
50% of cases to evaluate either the 
donor site anatomy, as is commonly 
required in tree fibular transfers, or 
the recipient vascular anatomy, as 
in trauma cases. Models and tem­
plates were frequently used.
Variety o f Operations
The gracilis muscle was the most 
common donor tissue used (30 chil­
dren), in many cases for functioning 
muscle transfer (Table II). The fibu­
la was used in 17 children and is 
the preferred bone for microvascu- 
lar transfer in children because the
Tab le  II. D o n o r T is s u e s  U sed
Donor tissues P atien ts , no.
G rac ilis 30
F ibu la r 17
L a tis s im u s  d o rs i 16
G roin 11
S econd  to e 7
F irs t to e 5
T e m po rop a rie ta l fa sc ia 3
P o s te rio r ca lf 2
S capu la r 2
Forearm 1
R ectus a b d om inu s 1
D o rsa lis  ped is 1
S ca lp 1
O varian 1
O m en tum 1
Tota l 99
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dissection is straightforward, can be 
done under tourniquet control and 
provides a long segment of bone for 
reconstruction. It was extremely 
well suited for microsurgical recon­
struction of pseudarthrosis of the 
tibia (nine children). The latissimus 
dorsi was used to cover large de­
fects (16 children). The groin flap, 
known to be a difficult dissection, 
was used less commonly (11 chil­
dren). It is reserved for selected 
cases of soft-tissue contour defor­
mities. First and second toes were 
used in hand reconstruction with 
the second toe often used for con­
genital deformities of the ulnar side 
of the hand.
All patients received increased in­
travenous fluid infusions intraoper- 
atively, and one and one-half their 
normal maintenance requirements 
postoperatively. The fluids were ta­
pered gradually over 5 to 7 days. 
The transfusion rate was 60% and 
included packed red cells, plasma, 
albumin and coagulation factors.
Postoperative anticoagulation 
was not routine, being used in only 
13 of the 70 children in Toronto 
and 20 of the 29 in Boston.
Complications (Table III)
Complete necrosis of the trans­
ferred flap was documented in only 
one case, giving an overall flap 
survival rate of 99%. There were
Table III. Complications
Complication Patients, no.
Bulk or scar 
necessitating revision 23
Recipient wound problems 17
Infection 14
Systemic 10
Donor wound problems 9
Partial or complete flap 
necrosis 5
Vascular compromise 
necessitating 
re-exploration 4
Hypertrophic scar 2
Poor function 2
Total 86
three late deaths, all of which were 
related to recurrence of the original 
condition (rhabdomyosarcoma), and 
there were no operative deaths.
Complications were classified as 
minor, moderate or severe. Minor 
complications (in 28% of the pa­
tients) were those that did not re­
quire reoperation, such as infection 
or delayed healing, and did not 
prolong the hospital stay. Moderate 
complications were seen in 38% of 
cases; more than one-half of these 
were revisions to the flap to correct 
contour or bulk. In some cases it 
was not possible to provide a defini­
tive sizing for the flap at the origi­
nal surgery, thus necessitating this 
reoperation. Severe complications, 
all occurring in groin flap transfers, 
were seen in 3% of patients and 
consisted of loss of a significant 
portion, but not all, of the flap.
Major systemic complications, 
such as pulmonary embolism or 
respiratory failure, were not seen. 
Lesser systemic complications in­
cluded pulmonary problems related 
to prolonged procedures, antibiotic 
sensitivity and fluid and electrolyte 
problems, which were seen in 10 
patients. In total 86 complications 
were seen in 59 patients, an overall 
complication rate of 60%.
Discussion
The indications for free tissue 
transfer in children differ from 
those in adults in that congenital 
anomalies and the specific diseases 
of childhood account for a large 
group of cases. They include the 
reconstruction of congenital hand 
deformities,14 congenital pseudar­
throsis of the tibia,15 hypospadias16 
and tumours such as rhab­
domyosarcoma. The vascular anato­
my may also vary in congenital 
anomalies. The normal arches of 
the .hand may not be present in cleft 
hands or radial ray deformities. Ab­
normal vascular anatomy has been 
noted by Fisher and Jackson9 in 
patients with hemifacial microso­
mia, in whom the carotid bifurca­
tion may be low and the external 
carotid system abnormal.
More delicate technique is re­
quired in small children because the 
structures are smaller than those in 
adults.2-410 The vessels may not be 
smaller in proportion to the child’s 
size but are often more delicate. 
Masquelet and colleagues10 dissect­
ed the vascular pedicle in posterior 
arm flaps without difficulty but 
found that it was less than 1 mm in 
diameter in the two youngest chil­
dren (aged 3 and 6 years) in their 
series. In their opinion the size of 
the vascular pedicle is directly relat­
ed to the age of the patient. Parry, 
Toth and Elliott3 noted that the 
vessels were slightly smaller than in 
comparable flaps in adults. Serafin 
and Barwick4 recommended that 
elective microsurgical procedures 
should be performed after the child 
has reached 3 to 4 years of age 
since the histologic appearance of 
the blood vessels becomes more like 
that of the adult. The vessels may 
be particularly small in hypoplastic 
tissues.8'943 Vascular spasm was not 
a problem in our series or those of 
others.3
The common features of adult 
and pediatric free tissue transfer 
bear emphasis because a successful 
outcome depends on them. The 
planning required in carrying out 
these procedures cannot be overem­
phasized. All the details of the 
procedure should be worked out in 
advance by a microvascular team. 
Anesthetists who are familiar with 
the requirements of children under­
going extended procedures should 
be involved in the planning process. 
Small vessels require appropriately 
fine instruments and sutures. Post­
operative monitoring of fluid status 
and flap perfusion must be under­
taken by experienced nursing and
CJS, VOL. 36, NO. 6, DECEMBER 1993 527
CLARKE ET AL
medical personnel. Shapiro, Ak- 
barnia and Hanel17 recommended 
hydration with twice the usual 
maintenance fluids for 12 hours 
before and 5 days after surgery. We 
recommend one and one-half times 
the usual maintenance fluids.
Complication rates were high in 
our series as in other pediatric17 and 
adult experiences. Morrison, O’Bri­
en and MacLeod18 reported a com­
plication rate of 38% and noted that 
thrombosis was the most serious 
problem.
Given the possible complications 
of transfusion therapy, the transfu­
sion rate of 60% in our series raises 
concern. The risk of giving albumin 
may be extremely small but is con­
sidered none the less.
The postoperative need for an­
ticoagulation. including heparin, 
dextran or acetylsalicylic acid, re­
mains extremely controversial. 
Banic and Wulff5 used anticoagu­
lants in 2 of 15 cases after revision 
of the arterial anastomosis. Parry, 
Toth and Elliott3 related their two 
complications (bleeding into the 
donor site) to the use of low- 
molecular-weight dextran, and they 
used dextran only if there was a 
technical problem with the anasto­
moses. Acetylsalicylic acid was used 
by Shapiro, Akbarnia and Hanel17 in 
all cases for 2 weeks, but they 
acknowledged that there are no 
data to support this practice. Our 
approach is to consider anticoagula­
tion if there are problems with the 
vascular anastomoses or perfusion 
of the flap. The intra-arterial infu­
sion of streptokinase and heparin 
has been suggested for the salvage 
of vascular repairs in children,19 but 
we have no experience with these 
agents.
Conclusions
Both pediatric and adult mi- 
crosurgical procedures must be 
carefully planned and meticulously 
executed. In children, the vessels, 
although smaller, are still of ade­
quate size for reliable anastomosis. 
There is no lower age limit for these 
procedures. Vascular spasm is not a 
problem. Intraoperative complica­
tions have been reduced with the 
establishment of appropriate anes­
thetic protocols. Anomalies of the 
recipient vasculature are often 
found to be critical at surgery.
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Blunt Traumatic Liver Injury Associated 
With Clostridial Infection of Early Onset
Alan W. Hemming, MD;* Charles H. Scudamore, MD, FRCSC;* Gregor I. McGregor, MD, FRCSC;*
David Owen, MD, FRCPath, FRCPCf
Hepatic clostridial infections associated with blunt abdominal trauma are rare. Generally they occur 
from 2 weeks to 3 months after injury and are thought to result from the growth of normal enteric 
organisms, which are carried to the liver by the portal venous system and infect devitalized tissue. The 
authors describe two patients in whom the hepatic infection became established in less than 24 hours 
after injury and was due to Clostridium spp. The patients were successfully treated by hepatic resection 
and combination antimicrobial therapy. Hyperbaric oxygen was used as an adjunct in one case.
Les infections hepatiques a clostridies liees aux traumatismes abdominaux fermes sont rares. Elies 
surviennent generalement de 2 semaines a 3 mois apres la blessure et l’on croit qu’elles resultent de la 
multiplication de bacteries intestinales normales, lesquelles migreraient vers le foie par le systeme 
porte pour aller infecter le tissu devitalise. Les auteurs decrivent deux patients chez qui une infection 
hepatique a Clostridium spp s’est etablie moins de 24 heures apres la blessure. Les patients ont bien 
repondu a une resection hepatique et a une antibiotherapie dissociation. L’oxygene hyperbare fut 
utilise comme traitement d’appoint dans un des cas.
Pyogenic liver abscess is uncom­mon. It is reported to occur in 
approximately 0.03% of all hospital 
admissions.1 Blunt trauma to the 
abdomen and lower chest is the 
third most common cause after pri­
mary biliary tract infection and di­
rect contiguous infection.2 In recent 
years anaerobic organisms have 
been more frequently implicated as 
causative organisms, although 
Clostridium spp. have been isolated.
We present two cases of rapidly 
occuring clostridial hepatic infec­
tion after blunt abdominal trauma 
seen at the Vancouver General Hos­
pital between August 1990 and No­
vember 1991. The limited experi­
ence with clostridial hepatic infec­
tion after blunt abdominal trauma is
reviewed, and the principles of ther­
apy are discussed.
Case Reports
Case 1
A 29-year-old man was involved 
in a roll-over motor vehicle accident 
in a remote area of the province. He 
was not wearing a seat belt. At the 
scene of the accident his blood 
pressure and heart rate were report­
ed to be 80 mm Hg systolic and 110 
beats/min respectively. The patient 
was awake and alert. Transfer to 
the nearest hospital took approxi­
mately 3 hours during which time 
the patient received 5 L of crystal­
loid solution. Upon admission the 
patient was in respiratory distress 
with a blood pressure of 
110 mm Hg systolic and a heart 
rate of 100 beats/min. A flail seg­
ment of ribs four to seven was 
noted on the right side. Right tube 
thoracostomy was performed, and 
the patient was intubated. A chest 
film revealed a large right pulmo­
nary contusion. The findings on 
abdominal examination with the pa­
tient awake and apparently non- 
obtunded was considered to be nor­
mal; however, a contusion measur­
ing 10 cm in diameter was noted 
over the right upper quadrant. Al­
though the patient appeared to be 
in stable condition, he was trans­
ferred to the Vancouver General
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Hospital, which is the level I trauma 
centre for British Columbia.
The patient arrived at the Van­
couver General Hospital approxi­
mately 10 hours after injury. He 
had been intubated, and paralysed 
and sedated for transfer. His blood 
pressure was 100 mm Hg systolic, 
and he had a tachycardia of 
125 beats/min. His body tempera­
ture was 38°C. On admission the 
patient had received 8 L of crystal­
loid solution. A right chest tube 
was in place. A large right pulmo­
nary contusion with fractures of 
ribs four to seven on the right side 
was confirmed by chest radiogra­
phy. Abdominal examination re­
vealed a contusion of the right 
upper quadrant. Diagnostic perito­
neal lavage was grossly positive for 
blood. The hemoglobin value was 
94 g /L  (140 g /L  before transfer). 
The leukocyte count was depressed 
at 3.3 X 109/L  (normal 4.5 to 11 X 
109/L ), with a shift to the left. 
Prothrombin time was prolonged at 
16.5 s (normal 12 to 14 s), with a 
plasma fibrinogen level of 0.77 g/L  
(normal 2 to 4 g/L). The serum 
aspartate aminotransferase level 
was elevated at 1448 U/L (normal 
7 to 40 U/L) and the total serum 
bilirubin elevated at 106 /rmol/L 
(normal 0 to 22 /umol/L.
After receiving 2 g of ceftizox- 
ime, the patient underwent a mid­
line laparotomy, which revealed a 
splenic hilar laceration, requiring 
splenectomy. There was a foul 
odour from the liver, and explora­
tion revealed a large laceration 
(10 cm in dimension) extending to 
the portal hilum. The majority of 
the right lobe was soft, yellowish 
and necrotic and was the source of 
the foul odour. No obvious gas was 
present. Intraoperative Gram’s 
staining revealed gram-positive ba­
cilli. A formal right hepatic lobecto­
my, with an inflow occlusion time 
of 47 minutes, was performed. Re­
section margins were negative for
bacteria. A no. 32 French chest 
tube connected to closed suction 
was used as a subdiaphragmatic 
drain along with two smaller flat 
Jackson-Pratt drains. The patient 
was given penicillin G, 30 million 
units/d and imipenem, 500 mg 
every 6 hours. Microscopic exami­
nation of the liver showed extensive 
areas of coagulative necrosis with 
large numbers of gram-positive, 
spore-bearing rods (Fig. 1). Tissue 
cultures identified a Clostridium sp. 
that could not be grown out for 
subtyping.
Six hours postoperatively the pa­
tient remained tachycardic and fe­
brile, so hyperbaric oxygen therapy 
was instituted. Five dives at 2.5 
atmospheres for 90 minutes each 
were undertaken over the next 3 
days. The patient was returned to 
the operating room on the 2nd 
postoperative day for evacuation of 
a right subdiagphragmatic hemato­
ma. Cultures of this material 
showed no bacterial growth. Antibi­
otics were continued for 12 days at 
which time the patient was afebrile
and had a normal leukocyte count. 
He suffered no further compli­
cations and was discharged from 
the hospital 21 days after his acci­
dent.
Case 2
A pedestrian, a 31-year-old man 
who was intoxicated, was struck by 
a motor vehicle in a remote area of 
the province. About 4 hours after 
the accident he was seen in the 
emergency department of the local 
hospital, complaining of abdominal 
pain. The blood pressure was 
120/50 mm Hg, the heart rate was 
98 beats/min and the body temper­
ature was 38.2°C. Physical exami­
nation revealed a markedly tender 
abdomen especially in the right 
upper quadrant. A chest film 
showed a right pulmonary contu­
sion, fractures of the eighth rib on 
the left side and fractured trans­
verse processes of lumbar vertebrae 
2 and 3. His transfer to the Vancou­
ver General Hospital was delayed 
for 10 hours because of adverse
FIG. 1. Case 1. Excised necrotic liver showing preservation of architecture with 
pyknotic nuclei (arrowheads) (hematoxylin-eosin, original magnification X 100). 
Insert shows gram-positive rods typical of Clostridium organisms (Gram’s stain, 
original magnification X 400).
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weather conditions. On arrival, his 
body temperature was 38.5°C, his 
heart rate was 117beats/min and 
his blood pressure 110/60 mm Hg. 
He .was awake and alert. A chest 
film confirmed the right pulmonary 
contusion but also showed some 
consolidation of the lower lobe of 
the right lung with mild loss of 
volume. The presence of the previ­
ously noted fractures was also con­
firmed. Abdominal examination elic­
ited marked tenderness in the right 
upper quadrant. There was frank 
hematuria. The hemoglobin level 
was 146 g/L  and the leukocyte 
count was 16 X 109/L  with a 
marked shift to the left. The serum 
aspartate aminotransferase level 
was 417 U/L with an elevated total 
serum bilirubin level of 50 mmol/L. 
Triple-contrast computed tomogra­
phy and retrograde cystography 
were carried out. The retrograde 
cystogram revealed an intact blad­
der with mild, right, renal contu­
sion. There was no evidence of 
pedicle injury. A large amount of 
intraperitoneal fluid, and a hepatic 
contusion and laceration corre­
sponding to hepatic segments six
and seven were noted (Fig. 2). Con­
solidation of the lower lobe of the 
right lung was again noted. Preop- 
eratively, blood samples were drawn 
for culture.
After receiving a loading dose of 
2 m g/kg of gentamicin and 
750 mg of clindamycin the patient 
underwent laparotomy. A right sub­
costal incision with midline exten­
sion to xiphisternum revealed a 
frank hemoperitoneum with a foul 
odour from the right lobe of the 
liver. There was a minimal right 
retroperitoneal hematoma, but the 
retroperitoneal portion of the duo­
denum appeared normal. Mobiliza­
tion of the right lobe of the liver 
revealed a laceration 6 to 8 cm long 
in hepatic segments 6 and 7. The 
surrounding liver tissue was soft, 
yellowish and malodorous. Gas was 
present in the tissue along with 
some pus and a marked bile leak. 
Nonanatomic resectional debride­
ment was carried out until unin­
volved hepatic parenchyma was 
reached. A visible lacerated segmen­
tal bile duct was ligated. An in­
traoperative dose of 6 million units 
of penicillin G was given. A no. 32
French chest tube connected to 
closed suction was used in addition 
to the standard Jackson-Pratt 
drains to provide maximal drainage 
of the subdiagphragmatic space. 
Postoperatively, the patient was 
given penicillin G 20 million 
units/d, clindamycin 750 mg four 
times daily and gentamicin 80 mg 
three times daily. Cultures of both 
blood and resection tissue grew 
Clostridium sp., but as in case 1 the 
culture could not be successfully 
grown out for subtyping. A moder­
ate bile leak resolved spontaneously 
after 3 days, at which time the 
drains were removed. The hematu­
ria resolved spontaneously. Antibi­
otics were discontinued on postop­
erative day 8 after the patient had 
shown no signs of sepsis for 72 
hours. The patient was discharged 
from hospital 11 days after opera­
tion.
Discussion
Blunt abdominal trauma with he­
patic infection has been reported, 
but in most instances the temporal 
relationship of the trauma to the 
development of the infection has 
ranged from 2 weeks to 3 months 
after the inciting event.3 In our 
cases hepatic infection with Clos­
tridium sp. was well established 
within 16 hours of injury. The 
pathogenesis of hepatic infection 
after trauma has yet to be delineat­
ed. Eng, Tecson-Tumang and Cor- 
rado3 have postulated that in nor­
mal circumstances organisms from 
the gastrointestinal tract are carried 
through the portal circulation and 
cleared by the Kuppfer cells of the 
liver. When hepatic trauma occurs 
these organisms multiply in the 
hepatic hematoma or devitalized tis­
sue. They may then elaborate cyto- 
toxins that produce further necrosis 
and extending infection.
The only other reported case of
FIG. 2. Case 2. Computed tomography scan demonstrating laceration in hepatic 
segments 6 and 7, with gas.
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clostridial hepatic infection after 
blunt abdominal trauma is that de­
scribed by Nachman and col­
leagues.4 A 6-year-old child with 
abdominal trauma and hepatic lac­
eration of the right lobe was ma­
naged conservatively, an approach 
that is often successful in children. 
A hepatic infection with Clostridium 
bifermentans developed on the 3rd 
day after injury. The infection was 
successfully treated by resection 
and combination antimicrobial ther­
apy.
Standard surgical treatment of 
clostridial infections includes 
debridement of involved tissue and 
appropriate antibiotics. This may be 
combined with hyperbaric oxygen 
therapy. This protocol also appears 
applicable to traumatic clostridial 
liver infection as well. Mixed anaer­
obic bacteria have been the causa­
tive organisms cultured from many 
hepatic infections, although in 
some instances no organisms could
be demonstrated or cultured.5 Be­
cause of the possibility of a mixed 
infection in our cases we elected to 
use antibiotic coverage appropriate 
for this eventuality. If the mecha­
nism of hepatic infection is via the 
portal venous drainage system, then 
antibiotic coverage of enteric anaer­
obes appears prudent in every in­
stance.
Although the use of hyperbaric 
oxygen therapy remains controver­
sial, its use in all cases of clostridial 
infection following full debridement 
and appropriate antibiotic coverage 
is favoured.6 The cases we have 
described illustrate that hepatic 
clostridal infection after blunt ab­
dominal trauma can be early in 
onset and difficult to diagnose pre- 
operatively. On the basis of our 
experience and the few reports in 
the literature we suggest that trau­
matic hepatic clostridial infection be 
diagnosed by the operative findings 
of foul odour and liver necrosis,
confirmed by Gram’s staining of 
tissue and fluid and treated by re­
sectional debridement or formal re­
section to eliminate nonviable tissue 
along with combination antimicrobi­
al therapy. Hyperbaric oxygen ther­
apy may be a useful adjunct.
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SESAP VII Question /  Question SESAP VII
Item 241
Iatrogenic vascular injuries that result in permanent disability are chiefly related to
(A) the location of the injury
(B) delayed surgical intervention
(C) preexisting atherosclerotic disease
(D) the type of instrument causing the injury
(E) extravasation of material around the injury site
For the incomplete statement above select the one completion that is best of the five given.
For the critique of Item 241 see page 550.
(Reproduced by permission from SESAP '92-'93 Syllabus; Surgical Education and Self-Assessment Program 
No. 7. For enrolment in the Surgical Education and Self-Assessment No. 7. please apply to the American College 
of Surgeons, 55 E Erie St., Chicago, IL 60611.)
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Unusual Isolated Common Bile Duct Injury 
After Blunt Trauma
Peter C.W. Kim, MD, PhD; Thomas Gilas, MD, FRCSC; Michele F.M. Brule, MD
Isolated injury to the extrahepatic biliary tree after blunt trauma is rare. The authors describe the case 
of a 17-year-old boy who suffered such an injury after falling over the handlebar of his motocycle. 
Ultrasonography, computed tomography and abdominal paracentesis were used to make the diagnosis. 
At laparotomy there was a partial tear of the common bile duct at its junction with the cystic duct. A 
cholecystectomy was performed and a T tube inserted. The patient recovered without complication. The 
authors emphasize that only awareness of the condition and diagnostic confirmation by computed 
tomography and abdominal paracentesis can expedite the diagnosis and treatment. The choice of 
surgical repair must be individualized according to the clinical findings and the nature of the injury.
Suite a un traumatisme fem e, il est rare d’observer une lesion isolee des voies biliaires 
extrahepatiques. Les auteurs decrivent le cas d’un garfon de 17 ans qui subit une blessure de ce type 
apres avoir ete projete contre le guidon de sa motocyclette. L’echographie, la tomographie par 
ordinateur et la parencentese abdominale furent toutes utilisees pour le diagnostic. On decouvrit a la 
laparotomie une dechirure du choledoque a sa jonction avec le canal cystique. Une cholecystectomie fut 
pratiquee avec insertion d’un tube en T. Le patient se retablit sans complication. Les auteurs 
soulignent que ce n’est qu’en gardant cette possibility a l’esprit et en recherchant une confirmation 
diagnostique au moyen de la tomographie par ordinateur et par paracentese abdominale que Ton peut 
hater le diagnostic et le traitement. Le traitement chirurgical doit etre choisi en fonction du tableau 
clinique individuel et de la nature de la lesion.
I solated injury to the extrahepatic biliary tree by blunt trauma is 
rare.1' 5 The diagnosis is usually 
made when the injury is found 
incidentally during an urgent ab­
dominal exploration or as a late 
presentation in the form of obstruc­
tive jaundice, resulting from stric­
ture formation.12 The following 
case report illustrates an early diag­
nosis, an unusual site of injury and 
a rational plan for surgical manage­
ment.
Case Report
A 17-year-old boy presented to
our emergency room with moder­
ately severe, vague, epigastric dis­
comfort of less than 2 hours’ dura­
tion, after falling over the handlebar 
of a motorcycle. His body tempera­
ture was 38.2°C, the pulse rate was 
92beats/min, the respiratory rate 
was 35/min, and the blood pres­
sure was 157/55 mm Hg. Findings 
on initial physical examination were 
unremarkable except for a moderate 
degree of tenderness to deep palpa­
tion in the epigastrium. The hemo­
globin level was 147 g/L, leuko­
cyte count was 12.4 X 109/L  with 
the differential of lymphocytes 73% 
and granulocytes 21%; the serum 
amylase level was 135 U/L, serum
aspartate aminotransferase level 
400 U/L, serum alkaline phospha­
tase level 172 U/L, serum creatine 
phosphokinase level 209 U /L and 
serum bilirubin (direct/total) level 
2 /6  jumol/L. The initial chest x-ray 
film and a flat plate of abdomen 
were normal.
Repeat examination of the patient 
6 hours after initial presentation 
demonstrated persistent tenderness 
in the epigastrium without any 
signs of peritoneal irritation. Repeat 
laboratory evaluation revealed a leu­
kocyte count of 15.7 X 109/L  with 
the differential of lymphocytes 12% 
and granulocytes 83%. Ultrasonog­
raphy of the abdomen demonstrated
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a significant amount of free fluid in 
the abdomen. The computed to­
mography scan of the abdomen 
demonstrated a moderate amount of 
free fluid in subhepatic, peri- 
cholecystic and right paracolic gut­
ter spaces (25.5 Housefield units) 
(Fig. 1). Abdominocentesis was per­
formed, and a bilious fluid with a 
bilirubin (direct/total) content of 
119/473 /zmol/L and an amylase 
content of 38 U/L was obtained.
Laparotomy through an upper 
abdominal midline incision 18 hours 
after the initial injury revealed 
500 mL of free bilious fluid in the 
abdomen. There was a substantial 
retroperitoneal collection of bile- 
stained fluid. The only injury dis­
covered after a careful laparotomy 
with special attention to duodenum 
was an isolated partial tear involv­
ing about 25% of the circumference 
of the common bile duct at its
junction with the cystic duct 
(Fig. 2). A cholecystectomy was 
performed, and a no. 10 French T 
tube was inserted into the common 
bile duct at the site of the injury by 
extending the laceration distally. 
Intraoperative cholangiography was 
performed (Fig. 3). The abdomen 
was closed, and a closed drain 
was left at the operative site.
The patient's postoperative 
course was uncomplicated. T-tube 
cholangiography on the 7th postop­
erative day (Fig. 4) gave essentially 
normal results with good flow into 
the duodenum. At the time of dis­
charge on postoperative day 7, the 
patient's leukocyte count was 5.6 X 
109/L  with the differential of lym­
phocytes 30% and granulocytes 
60%, the serum aspartate amino­
transferase level was 130 U/L, the 
serum alkaline phosphatase level 
was 133 U/L, the serum amylase
level was 114 U/L and the serum 
bilirubin (direct/total) level was 
3 /10 nmo\/L. At the time of dis­
charge the patient’s T tube was 
clamped.
Discussion
Injury to gallbladder and ex- 
trahepatic bile duct is uncommon. 
In a recent multicentre review. Cog- 
bill and associates6 reported that an 
associated injury to the gallbladder 
and to extrahepatic bile duct after 
blunt trauma was found in only 5% 
and 3% of cases respectively. Isolat­
ed injury to the extrahepatic biliary 
tree after blunt trauma is rare. Only 
126 cases have been reported in the 
literature since 1 7 9 9 . The low 
incidence has been attributed to the 
location and relative size of the 
extrahepatic biliary tree.2-3
The usual site of injury in these 
cases is at the superior border of 
the pancreas, and the injury usually 
results in a complete transection of 
the common bile duct.2-3 The trans­
mission of maximum stress from a 
lateral shearing force of blunt trau­
ma is thought to occur at the 
superior border of the pancreas due 
to the relative fixity of the intrapan- 
creatic portion of common bile 
duct.2-3 In addition, traumatic de­
compression of the gallbladder into 
the common bile duct and the resul­
tant ductal distension may render 
the biliary tree more susceptible to 
a lateral shearing force.1-3 Only four 
cases have been reported in the
FIG. 2. Schematic diagram of ex­
trahepatic biliary system, demonstrat­
ing site and extent of injury.
FIG. 1. Preoperative computed tomography scan of abdomen demonstrating 
significant subhepatic and pericholecystic free fluid.
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literature involving disruption of 
the common bile duct occurring at 
its junction with the cystic duct.3’8 
We suspect that the injury in our 
patient resulted from an avulsion­
shearing type of force applied crani- 
ally and medially to the distended 
common bile duct at its junction 
with the cystic duct, when the liver 
was displaced by the motorcycle 
handlebar.
Isolated injury of the extrahepat- 
ic biliary tree from blunt trauma 
presents a unique diagnostic chal­
lenge. The delay between clinical 
presentation and surgical interven­
tion in the literature averaged 18 to 
24 days.1-3 The lack of overt perito­
neal irritation by noninfected bile, 
the rarity of the injury and the 
insufficient indications all have been 
thought to contribute to the de­
lay.1'3 Several radiologic modalities, 
including intravenous cholangiogra­
phy, HIDA scanning and angiogra­
phy have been suggested to aid in 
early diagnosis.23'8 Although suffi­
cient reports do not yet exist to 
document that, we agree with the 
suggestion by Michelassi and Ran- 
son3 that ultrasonography and com­
puted tomography of the abdomen 
followed by a radiologically guided 
abdominal paracentesis may be the 
most valuable diagnostic proce­
dures in making an early diagnosis. 
Elevated serum amylase levels in 
the paracentesis fluid may represent 
a confounding variable. However, in 
the hands of those experienced in 
ultrasonography or computed to­
mography, the diagnostic confusion 
should be minimized.
The literature on isolated injury 
to the extrahepatic biliary tree by 
blunt trauma is scarce and provides 
no data on which to make a general 
recommendation for surgical treat­
ment.1'5 Therefore, the choice of 
surgical repair must be individual­
ized according to the clinical sce­
nario and the nature of the injury. 
There appears to be a consensus on 
the treatment of a completely tran­
FIG. 3. Intraoperative cholangiogram through T tube immediately after repair.
sected common bile duct.1' 3 Chole- 
dochoenteric reconstructions have 
provided the best long-term results 
by significantly reducing morbidity 
and mortality associated with stric­
ture formation.1-3-8 Simple axial or 
lateral tear, or common bile duct 
disruption less than 25% of its 
circumference as in our patient can 
be successfully repaired primarily, 
without significant morbidity and 
mortality, with placement of a T 
tube and external drainage of the 
subhepatic area.38 Given the high 
incidence of stricture formation (up 
to 55%) and mortality (up to 40%) 
attributed to primary end-to-end 
anastomosis, any significant bile 
duct disruption after blunt trauma 
should be repaired with choledoch- 
oenteric reconstruction.1-3
FIG. 4. T-tube cholangiogram on post­
operative day 7, demonstrating intact 
extrahepatic biliary tree with good 
flow into duodenum.
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CORRESPONDENCE
continued from page 504
The development of a benign cys­
tic lesion in the thymus after radio­
therapy for Hodgkin’s disease has 
also been reported.9 The lesion is 
usually well-circumscribed with an 
attenuation value close to that of 
water, and gallium scanning is usu­
ally negative. The cyst seems to 
originate from successful radiother­
apy to a thymus previously involved 
with lymphoma. With these find­
ings most patients can be followed 
up without lymphoma therapy or 
biopsy.
Recent studies to evaluate the 
frequency of thymic changes after 
chemotherapy indicated that the 
problem is more common than pre­
viously thought.4'10 With modern 
imaging techniques in the follow-up 
of cancer patients, the clinician will 
face more cases of thymic changes. 
If thymic hyperplasia and benign 
thymic cysts are considered in the 
differential diagnosis of a mediasti­
nal mass recurring after the suc­
cessful treatment of a malignant 
lesion by chemotherapy or radio­
therapy, some patients could be 
saved unnecessary suffering. More­
over, these two conditions should 
be excluded before treatment with 
either chemotherapy or radiothera­
py.5
Elias Abdulnour, MD, FRCSC
Department of Surgery
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ORIGINAL ARTICLES
Prognostic Factors in Metastatic 
Nonseminomatous Germ Cell Tumours
Paul R. Hanson, MD; Philip Belitsky, MD, FRCSC; Oliver H. Millard, MD, FRCSC; Stan G. Lannon, MD
Objective: To determine predictors of prognostic significance for patients with nonseminomatous 
testicular cancer (NSTC) who have advanced disease at the time of presentation.
Design: A chart review with a mean patient follow-up of 5.5 years (range from 0.75 to 13 years). 
Setting: University hospitals in Halifax.
Patients: All patients with NSTC, stages II-B, II-C and III. Patients were excluded if the follow-up 
status at the time the study closed could not be determined. Thirty-three patients were included in the 
study. Current patient status was determined from the clinical charts and personal communication with 
the patients or their physicians.
Interventions: All patients received cisplatinum-based chemotherapy. The extent of the disease was 
assessed by chest radiography or lung tomography, bone scanning, abdominal computed tomography 
or lymphangiography.
Main Outcome Measures: Correlation between levels of /3-human chorionic gonadotropin (BHCG) and 
a-fetoprotein (AFP), comparison of duration of symptoms before initial treatment, response to 
treatment and survival, and relationship between stage, tumour volume and survival.
Results: The 3-year overall survival rate was 76%. Seven of 18 patients with symptoms for more than 
16 weeks died of disease (p < 0.01). Overall complete response was seen in 27 of 33 patients. All initial 
nonresponders died. A survival rate of 93% was seen among initial complete responders (p < 0.01). All 
seven patients with persistent elevation of BHCG levels (p < 0.001) and the two patients with 
persistent elevation of AFP levels (p < 0.01) after the second course of chemotherapy died.
Conclusions: A symptomatic interval of more than 16 weeks, poor response to initial treatment, bulky 
retroperitoneal disease, larger volume lung disease and persistently elevated levels of BHCG and AFP 
were all indicators of poor prognosis.
Objectif: Etablir quels sont les indicateurs previsionnels possedant une signification pronostique pour 
les patients atteints d’un carcinome testiculaire non seminomateux (CTNS) dont la maladie est deja a 
un stade avance lorsqu’ils consultent pour la premiere fois.
Conception : Une etude des dossiers de patients avec une periode de surveillance moyenne de 5,5 
annees (ecart de 0,75 a 13 ans).
Contexte: Les hopitaux universitaires d’Halifax.
Patients : Tous les patients porteurs de CTNS de stades II-B, II-C et III. Furent exclus de l’etude, les 
patients dont 1’evolution de la maladie n’avait pu etre etablie a la fermeture de l’etude. Trente-trois 
patients furent inclus. L’etat actuel des malades fut determine a partir des dossiers medicaux et d’une 
communication personnels des medecins avec leurs malades.
Interventions : Tous les patients avaient re?u une chimiotherapie comprenant du cisplatine. L’etendue 
de la maladie fut evaluee par radiographie thoracique ou tomographie des poumons, scintigraphie 
osseuse, tomographie abdominale par ordinateur ou lymphangiographie.
Principaux effets mesures : La correlation entre les taux de /3-gonadotrophine chorionique humaine 
(BGCH) et ceux d’a-foetoproteine (AFP), la comparaison entre la duree des symptomes precedant le
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traitement initial, la reponse au traitement et la duree de la survie, et le rapport entre le stade 
devolution, le volume de la tumeur et la survie.
Resultats : Le taux de survie global a 3 ans a ete de 76 %. Sept des 18 patients ayant eu un intervalle 
symptomatique de plus de 16 semaines sont morts de la maladie (p < 0,01). Pour l’ensemble, une 
reponse fut obtenue chez 27 des 33 patients. Tous les patients qui n’ont pas repondu initialement au 
traitement sont decedes. On a observe un taux de survie de 93 % chez les patients qui ont eu une 
reponse initiate complete (p < 0,01). Les sept patients qui ont presente des taux eleves de BGCH 
(p < 0,001) et les deux patients qui ont eu des taux eleves persistants d’AFP apres un second cycle de 
chimiotherapie sont decedes.
Conclusions : Un intervalle symptomatique de plus de 16 semaines, une reponse insatisfaisante au 
traitement initial, une masse retroperitoneale importante, des atteintes pulmonaires de volume 
important et la persistance de taux eleves de BGCH et d’AFP sont tous indicateurs d’un mauvais 
pronostic.
P atient survival after treatment for advanced nonseminomatous 
testicular cancer (NSTC) has im­
proved greatly with recent advances 
in treatment.12 The mortality, how­
ever, remains at 25% to 30%.1'2 The 
extent of the disease is universally 
accepted as being the single most 
important prognostic factor.1-5 
There is no consensus as to which 
other factors may identify a patient 
as having a poor prognosis. In an 
effort to determine if other predic­
tors of survival could be found, we 
reviewed the charts of all patients 
with advanced NSTC treated be­
tween 1980 and 1990 at Dalhousie 
University hospitals in Halifax. The 
following factors were considered: 
duration of symptoms before initial 
treatment, response to treatment, 
retroperitoneal tumour volume, ex­
tent of pulmonary metastases, and 
/3-human chorionic gonadotropin 
(BHCG) and a-fetoprotein (AFP) 
levels at the time of diagnosis and 
after treatment.
Patients and Methods
The charts of the 33 patients 
with NSTC, stages II-B (dimension 
of retroperitoneal tumour involve­
ment of 2 to 10 cm), II-C (dimen­
sion of retroperitoneal tumour in­
volvement greater than 10 cm) and 
III (tumour spread beyond retroperi­
toneal lymph nodes),6 were re­
viewed. The mean age of the pa­
tients was 29.7 years (range from 
19 to 57 years). The mean duration 
of symptoms was the time from the 
day that a patient became aware of 
symptoms to the day of presenta­
tion to a physician, rounded off to 
the nearest week. The extent of the 
disease was assessed by physical 
examination, chest radiography or 
lung tomography, or both, bone 
scanning and abdominal computed 
tomography or lymphangiography, 
or both. The mean duration of 
follow-up was 5.5 years (range from 
0.75 to 13 years). Table I shows the 
histologic type of the tumours. 
Serum AFP and BHCG levels were 
measured at the time of initial pre­
sentation and at the start of each 
treatment cycle. All patients re­
ceived chemotherapy (Table II) with 
cisplatin-based drug regimens in 
standard 3-week cycles until tu­
mour-marker levels had normalized 
and there was radiologic evidence 
that the tumour had regressed or 
disappeared or until the degree of 
regression plateaued. The response
Table  1. H is to lo g ic  T ype s  o f A dvanced  
N o n se m in o m a to u s  T e s ticu la r C ancer 
(N S TC ) in 3 3  P atien ts
Histologic type
P atien ts , 
no. (% )
E m bryona l ca n ce r 1 2 (3 6 )
E m bryona l ca n c e r +  
ch o rio ca rc in o m a 1 0 (3 0 )
T era tom a 5 ( 1 5 )
Tera tom a  +  ch o rio ca rc in o m a 3 ( 9 )
Pure c h o rio ca rc in o m a 3 ( 9 )
To ta l 3 3 (1 0 0 )
to chemotherapy was graded as 
follows: complete (disappearance of 
all clinical, radiologic and biochemi­
cal evidence of disease for at least 1 
year), partial (a 50% decrease in 
tumour volume and normal AFP 
and BHCG levels for at least 6 
months) and no response (all other 
types of response).
Student’s t-test was used for sta­
tistical analysis.
Results
The overall 3-year survival rate 
was 76%. Initially, 27 (82%) pa­
tients had a complete response to 
chemotherapy (Table III), and 6 
(18%) patients had no response or a 
partial response; all 6 died of dis­
ease within 2 years. Nine (33%) of 
the 27 patients with initial complete 
response had a subsequent relapse
T a b le  II .  C he m o th e ra p y  R eg im ens U sed on 
33  P a tien ts  W ith  NSTC B etw een  1 9 8 0  and 
1990
C hem otherapy  reg im en
P atien ts , 
no. (% )
C isp la tin , v in b la s tin e , 
b le o m yc in 24  (7 3 )
C isp la tin , cyc lo p h o s p h a m id e , 
v in b la s tin e , b le o m yc in 6 ( 1 8 )
C isp la tin , v in c ris tin e , 
m e th o tre x a te , b le o m yc in , 
a c tin o m y c in  D, 
cyc lo p h o s p h a m id e , 
e to po s id e 2 ( 6 )
C isp la tin , cyc lo p h o s p h a m id e , 
v in b la s tin e , a c tin o m yc in  D, 
b le o m yc in 1 ( 3 )
T o ta l 33  (1 0 0 )
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after 1 year. Of these, seven (78%) 
had a complete response to salvage 
chemotherapy or surgery, or both, 
and at the closing date of this study 
had not had a relapse. A survival 
rate of 93% (25 of 27 patients) was 
observed in those with a complete 
response to initial chemotherapy.
A comparison of mean duration 
of symptoms, treatment response 
and survival revealed that 7 (39%) 
of 18 patients with symptoms for 
longer than 16 weeks died com­
pared with 1 (7%) of 15 patients 
with symptoms for less than 16 
weeks (p < 0.01).
The relationship between stage,
metastatic tumour volume and sur­
vival is shown in Table IV. Three 
deaths (27%) occurred in 11 stage 
II patients with aggregate retroperi­
toneal disease of 5 cm or more in 
diameter; in contrast, no deaths 
occurred in the nine stage II pa­
tients with an aggregate retroperi­
toneal tumour diameter of less than 
5 cm (p < 0.01). A 3-year survival 
rate of 100% was seen in patients 
with unilateral lung metastases less 
than 2 cm in diameter, whereas 
only one (17%) of six patients with 
bilateral lung metastases less than 2 
cm survived (p < 0.01).
No significant correlation be­
tween the degree of initially elevat­
ed AFP or BHCG levels and survival 
was noted (Table V). However, 6 
(21%) of 28 patients with persis­
tently elevated AFP levels after one 
cycle of chemotherapy died of dis­
ease. All patients with elevated AFP 
or BHCG levels, or both, after two 
cycles of chemotherapy died 
(p < 0.001). No patient with normal 
levels of AFP or BHCG after two 
cycles of chemotherapy died of dis­
ease (p < 0.05).
Discussion
Several authors have identified 
prognostic factors in advanced 
NSTC that may identify a patient as 
a poor risk.1-2-5 All agree on the 
importance of tumour bulk at the 
time of diagnosis. However, there is 
no general agreement as to which 
other prognostic factors are truly 
significant.
Among the factors found signifi­
cant in our patients was the correla­
tion between duration of symptoms 
and survival. This has been demon­
strated for advanced NSTC patients 
in other studies.7-12 The increased 
mortality seen with delays in diag­
nosis reinforces the importance of 
self-examination programs.
Several authors13-16 have studied 
the effect of different chemotherapy 
regimens on “poor-risk” groups. 
There was no consensus on the 
constituents of a “poor-risk” group 
in these studies; therefore, it is 
impossible to compare the results 
accurately. No agreement on the 
chemotherapeutic treatment of 
“poor-risk” groups has emerged 
from these and other studies.
Other factors such as retroperito­
neal tumour volume, AFP levels, 
number of pulmonary metastases 
and visceral organ involvement have 
been suggested as characteristics 
defining poor-risk patients. Initial 
complete response rates of up to
Table III. Response to Treatment and Survival of 33 Patients With NSTC
Response to
Initial salvage chemotherapy 3-year
response Relapse and surgery survival
Response No. % No. % No. °/o No. %
Complete 27 82 9/27 33 7/9 78 25/27 93
Partial 2 6 — — 0/2 0 0/2 0
None 4 12 — — 0/4 0 0/4 0
Total 33 100 9/27 33 7/15 47 25/33 76
Table IV. Factors Influencing Survival at 3 Years
Patient survival
Factor Patients, no. No. %
Clinical stage
IIB 15 15 100
IIC 5 4 80
III 13 6 46
Retroperitoneal tumour bulk, cm
Stage II < 5 9 9 100
> 5 11 8 73
Pulmonary metastases, cm
Unilateral <  2 3 3 100
Bilateral < 2 4 1 25
> 2 6 1 17
Table V. Three-Year Survival According to Pretreatment Levels of Serum Tumour Markers
Patient survival
Tumour marker levels Patients, no. No. °/o
a-fetoprotein, ng/mL
5 - 1 0 0 16 12 75
1 0 1 -9 9 9 4 4 100
>1000 5 4 80
/3-human chorionic gonadotropin, ng/mL
2 - 1 0 0 11 10 91
101 -9 9 9 6 4 67
1 0 0 0 -9 99 9 5 4 80
> 10 000 2 1 50
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94% have been found in patients 
considered to be “poor risk” by one 
set of criteria but “good risk” by 
another.17 Retroperitoneal tumour 
volume, number of pulmonary me- 
tastases and AFP and BHCG levels 
have all been demonstrated to be 
significant in other studies.3’41318-22 
We found that persistently elevated 
AFP and BHCG levels after two 
courses of chemotherapy were pre­
dictive of a worse prognosis than 
when the levels normalized.
Large prospective studies using 
multivariate analysis of prognostic 
factors are needed to spare good- 
risk patients from potentially toxic 
chemotherapy and to identify a de­
finitive poor-risk group. This study 
has helped to provide the basis for 
eligibility criteria for such groups.
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T h e Cardiac Surgery Program at the Royal 
Columbian Hospital: Review of the First 
Fiscal Year
Lynn M. Fedoruk, MD; Keir M. Stewart, MD, FRCSC; Robert I. Hayden, MD, CM, FACS, FRCSC
From a budgetary viewpoint, the authors summarize the operative experience of the cardiac surgery 
program at the Royal Columbian Hospital during its first fiscal year of operation. The program was 
funded for 250 cardiopulmonary bypass (CPB) procedures: $16 800 per CPB procedure ($4.2 million 
for the program). The 250 CPB procedures were performed on 248 patients. The 30-day operative 
mortality was 2%. Thirty patients (12.1%) underwent a second operation for complications or delayed 
primary closure of the sternum, or both; the complications included aortic prosthetic perivalvular leaks 
in 2 patients. Eight patients (3.2%) required insertion of an intra-aortic balloon pump preoperatively to 
stabilize their condition; 10 others (4.0%) required intra-aortic balloon pump insertion at surgery to 
correct low-cardiac-output syndrome. Blood products were needed for 149 (59.6%) of the 250 CPB 
procedures. The average hospital stay was 10.4 days for noncoronary procedures and 9.0 days for 
coronary procedures.
Les auteurs resument au plan budgetaire les resultats d’exploitation du programme de chirurgie 
cardiaque du Royal Columbian Hospital durant son premier exercice financier. Le programme a refu 
des fonds pour 250 pontages aortocoronariens (PAC): 16 800 $ par malade ou 4,2 millions de dollars 
pour l’ensemble du programme. Les 250 PAC furent effectues chez 248 patients. La mortalite 
operatoire a 30 jours fut de 2 %. Trente patients (12,1 %) subirent une seconde operation pour des 
complications ou pour defaut de soudure primaire du sternum, ou pour les deux; parmi les 
complications, on a constate des fuites perivalvulaires de la prothese aortique chez deux patients. Huit 
patients (3,2 %) ont necessite l’insertion d’une pompe a ballonnet intra-aortique (PBIA) en 
preoperatoire pour stabiliser leur etat; 10 autres (4,0 %) ont necessite la PBIA durant l’intervention 
pour corriger un syndrome de faible debit cardiaque. Des derives sanguins furent requis pour 149 
(59,6 %) des 250 PAC. Le sejour hospitalier moyen fut de 10,4 jours pour les interventions non 
coronariennes et de 9,0 jours pour les interventions coronariennes.
Because of increasing demand, three new cardiac surgery units 
were established in Canada in 1990 
and 1991. One of these, at the 
Royal Columbian Hospital in New 
Westminster, BC, was established 
to provide community service rather 
than a new teaching program.
In conjunction with the increas­
ing demand for cardiac surgical 
services there is a demand for great­
er fiscal responsibility by all levels 
of health care personnel. The goal 
for the new heart unit set by the
Ministry of Health of British Co­
lumbia was to provide 250 cardi­
opulmonary bypass (CPB) proce­
dures in the first fiscal year, with an 
operating budget of $16 800 per 
procedure (including bridge fund­
ing) — a total of $4.2 million. The 
goal of the Royal Columbian Hospi­
tal was to provide this care with a 
mortality of less than 2%, in a way 
that would have minimal impact on 
the function of other services in the 
institution.
We report on the 250 CPB proce­
dures completed between Apr. 1, 
1991 and Mar. 31, 1992 — the first 
fiscal year of the new cardiac unit.
A number of factors affected the 
provincial government’s decision to 
open a heart unit at the Royal 
Columbian Hospital. An apparent 
increase in the elective waiting list 
for open heart surgery was of in­
creasing concern.1 For several
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months before the government’s de­
cision, the medical staff had worked 
zealously to draw attention to the 
particular needs of the patients at 
the Royal Columbian Hospital and 
the advantages to government in 
locating the heart surgery unit 
there. The provincial government 
had carried out an independent re­
view of the needs for open heart 
surgery in the province of British 
Columbia; this review identified the 
establishment of a cardiac unit at 
the Royal Columbian Hospital as an 
ideal solution to the need for fur­
ther cardiac service in the province. 
A nursing strike and severe short­
age of perfusion personnel thwarted 
the provincial ministry of health’s 
efforts to increase the caseload 
through additional funding in the 
province’s existing heart units. The 
increased expenditures did not re­
duce the waiting list or increase the 
number of procedures performed. 
These factors created a climate of 
scepticism on the part of both the 
Ministry of Health of British Co­
lumbia and the medical community 
and led to the requirement that the 
1st year’s operation of the new unit 
must provide evidence of the ability 
to achieve mutually acceptable 
goals.
The inaugural year was also ex­
pected to attract intense scrutiny 
from the medical staff of the Royal 
Columbian Hospital. They had 
given unanimous approval to the 
hospital’s medical administration to 
establish an open heart surgery 
program that would function within 
an established budget and not 
create demands on the underfunded 
critical care areas of the hospital. 
The medical community in the 
greater referral area was also ex­
pected to monitor the surgical out­
come of the inaugural caseload out 
of genuine concern for the patients. 
For these reasons, and to provide 
reassuring statistics to the general 
community, it was decided to apply
stringent case exclusion criteria for 
the inaugural period.
Exclusion Criteria
These criteria essentially exclud­
ed patients with known risk factors 
that would adversely affect their 
surgical outcome. They included 
patients requiring heart transplants, 
procedures on the thoracic aorta, 
repeat cardiac procedures, proce­
dures for major congenital cardiac 
deformities, emergency procedures 
other than cardiac catheterization 
and patients who had associated 
critical systemic, pulmonary, renal, 
cerebrovascular or hemopoietic dis­
orders. Verbal agreements made 
with established cardiac units in 
British Columbia allowed easy refer­
ral of these higher-risk patients.
Results
Between Apr. 1, 1991, and Mar. 
31, 1992, 250 CPB procedures 
were performed on 248 patients 
(Table I); 2 required a repeat proce­
dure with cardiopulmonary bypass 
before discharge from hospital after 
the initial operation. Patients were 
categorized by age, sex and admis­
sion status (Tables II and III). 
Times spent by the patients on the 
various nursing units and mean 
hospital stays were also recorded. 
Fifteen patients underwent multi­
ple or miscellaneous operations.
Death Rate
Five (2.0%) of the 248 patients
died within 30 days of operation 
(Table IV).
Complications
Patients were returned to the 
operating room on 30 occasions 
because of complications or for fur­
ther management. In 16 cases re­
opening of a recent sternotomy was 
required because of bleeding or 
tamponade. Thirteen patients were 
returned to the operating room for 
delayed primary closure of an open 
sternotomy in the management of 
low-output syndrome. One patient 
was returned to the operating room 
for removal of a foreign body (a 
piece of chest tube). In two patients 
who underwent aortic valve replace­
ment, suture line disruption at the 
site of the first valve insertion ne­
cessitated repeat valve replacement 
with CPB. One of these patients 
was the recipient of a double valve 
implant at the first procedure.
Intra-aortic balloon pumps were 
used on 18 patients (7.2%) to en­
hance myocardial and systemic per­
fusion. In eight cases (3.2%), the 
patient arrived in the operating 
room with the intra-aortic balloon 
pump in situ after it was inserted in 
the catheterization laboratory to 
stabilize the patient’s condition for 
emergency coronary artery bypass 
grafting. This practice provided a 
smooth transition for the patient 
from the catheterization laboratory 
to the operating room, allowing for 
organized operative intervention. 
The remainder of the intra-aortic 
balloon pumps were placed intraop-
Table I. Summary of Cardiopulmonary Bypass Procedures Performed During the First Fiscal Year 
____________  at the Royal Columbian Hospital, New Westminster, BC
Type of procedure No. %
Coronary artery bypass grafting 196 78 4Aortic valve 25 10 0
Mitral valve 10 4 0Atrial septal defect 4 1 6
Combined and miscellaneous 15 6.0
Total 250 100.0
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eratively to manage low-output syn­
drome and facilitate weaning from 
cardiopulmonary bypass.
One patient had a prolonged hos­
pitalization because of dehiscence 
of a leg incision. Two patients were 
readmitted for sternal wound infec­
tion, which required open sternoto­
my, operative debridement and pro­
longed hospitalization with healing 
by secondary intention (0.8% infec­
tion); neither of these patients had 
delayed primary closure of the ster­
num.
Blood Bank Use
During the fiscal year, blood 
transfusions were required during
149 (59.6%) of the 250 CBP proce­
dures (Table V). Overall, 160 
(64.5%) patients required two or 
less units of blood (99 [39.9%] of 
them required no transfusion at all).
Hospital Stay
The average length of hospital 
stay was 10.4 days for noncoronary 
procedures and 9.0 days for CBP 
procedures. This compared with a 
national average of 14 days (HMRI 
data).
Discussion
Our cardiac unit consists of two
fully equipped operating rooms, 
which were used on alternate days 
to complete these procedures and 
ensure that the new equipment was 
functional in both theatres, a car­
diac surgery intensive care unit 
(CSICU) with four beds and a ward 
component consisting of six patient 
beds. The national average of 14 
days from HMRI data was used to 
budget for length of stay. We 
planned for an operative death rate 
of 2% or less in our 1st year, based 
on our case exclusion criteria. The 
30-day death rate was precisely 2%.
Funds were made available for 
the open heart surgery program at 
the Royal Columbian Hospital in its 
first fiscal year from the Ministry of
Tab le  II. Results in Patients Who Underwent Coronary Artery Bypass Grafting
Adm ission M e a n M e a n
Sex category s tay s tay M e a n
No. of No. of M ean in on h o s p ita l
grafts patien ts age, yr M F E U El C S IC U , d w a rd , d s ta y , d
1 8 60.7 4 4 2 4 2 3.87 5.37 9.42
2 26 60.7 20 6 2 15 9 3.07 5.42 8.49
3 50 63.3 38 12 2 44 4 3.48 5.38 8.76
4 55 65.6 38 17 3 48 4 3.38 5.63 9.01
5 37 65.5 29 8 3 31 3 3.62 5.43 9.05
6 17 63.1 16 1 2 14 1 3.64 5.70 9.34
7 2 64.5 2 0 0 1 1 3.50 5.50 9.00
8 1 68.0 1 0 0 1 0 3.00 6.00 9.00
Total/mean 196 63.9 148 48 14 158 24 3.45 5.56 9.01
M  =  male, F = female, E = emergency, U = Urgent, El = elective, Csicu cardiac surgery intensive care unit
T a b le  III. Results in Patients Who Required Procedures Other Than Coronary Artery Bypass Grafting
Sex
Adm ission
category
M ea n
s tay
M e a n
s tay M e a n  
h o s p ita l 
s ta y , d
P rincipal
procedure
No. of 
patien ts
M ean  
age, yr M F E U El
in
C S IC U , d
on
w a rd , d
Mitral valve 
Repair 3 45.0 0 3 0 0 3 2.33 7.33 9.66
Tissue
replacement 2 80.5 1 1 1 1 0 11.50 3.00 14.50
Mechanical
replacement 13 57.6 3 10 1 11 1 5.69 5.84 11.53
Aortic valve 
Tissue 
replacement 3 74.6 1 2 0 3 0 4.00 8.33 12.33
Mechanical
replacement 26 66.5 21 5 1 18 7 4.07 6.23 10.30
Repair of 
atrial septal 
defect 4 50.0 2 2 0 0 4 2.25 4.20 6.45
Removal of 
myxoma 1 67.0 0 1 0 0 1 3.00 5.00 8.00
Total/mean 52 63.0 28 24 3 34 15 4.69 5.70 10.39
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Health of British Columbia 
($15 077 per CPB procedure) and 
from bridge funding provided by the 
Royal Columbian Hospital ($1800 
per CPB procedure). The total of 
$16 800 per procedure was the 
total program budget available for 
the 1st year of operation and 
amounted to $4.2 million. Careful 
cost-centre analysis of the actual 
money spent during the first fiscal 
year indicated that the program had 
an operating surplus of $164 887 
or $659 per procedure. (Cost cen­
tres had been established within 
each hospital department to evalu­
ate the inaugural year of open heart 
surgery experience.) The program 
was managed on a month-to-month 
basis by a program management 
committee, representing key areas 
of the hospital administration, and 
by the open heart surgery team. 
The program management commit­
tee was concerned that as case
exclusion criteria were withdrawn, 
the narrow operating surplus would 
likely preclude a balanced operating 
budget for the program. From a 
hospital accounting viewpoint, how­
ever, the first year’s results were 
obtained with the expenditure of 
$16 141 per procedure of the 
$16 800 funded for each CPB 
procedure.
Review of our findings invites a 
discussion of the principles of case 
selection. It had been our intention 
to provide emergency surgery only 
to patients who encountered misad­
venture during angioplasty proce­
dures and that other patients identi­
fied for urgent or emergent surgery 
would be transferred to the other 
institutions that had supported the 
catheterization laboratory at the 
Royal Columbian Hospital. Within a 
few months of the program’s initia­
tion, however, the scope of emer­
gency support was broadened to
Table IV. Details of Operative Deaths
Patient no. Diagnosis Procedures performed
Postop. 
survival, d
1 Critical aortic and mitral
stenosis, ischemic heart 
disease AVR, MVR, CABG X 3 11
2 Rheumatic valvular heart 
disease AVR, MVR 15
3 Severe mitral insufficiency MVR 2
4 Aortic root aneurysm with 
aortic insufficiency Bentail procedure 20
5 Severe aortic stenosis and 
mitral regurgitation, 
ischemic heart disease AVR, MVR, CABG X 3 18
AVR =  aortic valve replacement, MVR =  mitral valve replacement
include any patients resident in the 
Royal Columbian Hospital whose 
anatomy had been defined and who 
did not have multisystem disease. 
Our intention to avoid repeat sur­
gery similarly had to be disregard­
ed. Four repeat procedures were, 
for various reasons, undertaken in 
the 1st year. As the program gained 
momentum, the intention to avoid 
combined procedures was also dis­
regarded, and complicated multiple- 
procedure cases were included, ac­
counting for 6% of the total.
Nevertheless, patient selection 
was quite strictly applied to the 
candidates for surgery through the 
1st fiscal year. The cooperation of 
the referring cardiologists at the 
Royal Columbian Hospital and the 
surgeons working in established 
programs at other centres, which 
permitted this case selection, must 
have acted favourably on the overall 
results in terms of morbidity and 
mortality. The relatively low use of 
intra-aortic balloon pump support 
(4.0%) in patients not identified as 
candidates for surgery from the 
catheterization laboratory also indi­
cates the favourable effect of case 
selection. This effect is reflected in 
the overall length of patient stay in 
the unit, and also in the CS1CU, the 
costs for which were well below the 
budgeted target for the program 
that had been based on HMRI stan­
dards.
Review of the complications re-
Table V. Blood Transfusion Requirements
Procedure
No. of 
patients
No. (%) of Blood product, mean units/procedure
procedures with 
blood products RBCs Platelets FFP Cryo.
CABG 196 112(57.1) 2.22 0.23 0.62 0.21AVR 25 15(60.0) 4.64 2.24 1.92
MVR 10 6 (60.0) 4.20 2.80 2.40 2.60Atrial septal
defect repair 4 1 (25.0) 0.25 _ _
Combined and
miscellaneous
procedures 15 15(100.0) 6.00 2.00 9.60 1.00
Total/mean 250 149 (59.6) 2.74 0.63 1.34 0.32
RBCs =  red blood cells, FFP =  fresh frozen plasma, Cryo. =  cryoprecipitate
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quiring repeat operative interven­
tion revealed that of the 30 occa­
sions on which this was required, 
13 procedures were for delayed pri­
mary closure of the sternotomy, 
which had been electively packed 
open either at the time of the initial 
procedure due to low-output syn­
drome or at the time of emergency 
sternotomy for hemorrhage or for 
management of diffuse nonspecific 
bleeding. It has been our experience 
in many patients requiring intra­
aortic balloon counterpulsation for 
low-output syndrome that hemody­
namics are markedly improved by a 
decision to delay sternal closure. It 
has also been our experience that 
patients returned to the operating 
room because of hemorrhage or 
tamponade in whom the bleeding 
site is not identified are best treated 
by packing the sternal incision and 
delaying sternal closure for 24 to 
36 hours. This technique has not 
been associated with an increased 
incidence of infection, and we be­
lieve it helped to keep our operative 
mortality at the expected 2%.
In the two patients who did have 
deep sternal wound infection, the 
sternum was closed primarily in one 
instance. The other patient had 
been treated by delayed closure. 
Surgical treatment of both cases 
was accomplished by immediate re­
opening of the entire sternotomy 
wound allowing debridement, irriga­
tion and packing in the operating 
room. Over the following 2 to 3 
weeks’ stay in the Royal Columbian 
Hospital, these patients were ma­
naged by repeated replacment of 
the packing three times a day with 
sponges soaked in quarter-strength 
Dakin’s solution. The patients were 
then transferred to another institu­
tion for long-term sternal wound 
care before being discharged home 
to allow healing by secondary inten­
tion.
Reoperation for periprosthetic 
aortic valve leak was required in
two patients, both of whom had 
rheumatic valvular heart disease 
with severe annular calcification. 
The leaks occurred despite the use 
of pledgeted sutures and care taken 
to control decalcification of the 
heavily calcified annulus.
Sixty-four percent of our patients 
could have been managed without 
the use of any blood bank products 
if there had been a mechanism in 
place for preoperative personal 
blood donation and storage of two 
units. The overall effect of such a 
mechanism would have been a net 
donation to the blood bank. It is 
hoped that such a procedure can be 
provided in the future at our hospi­
tal.
During the 1st fiscal year of 
operation of the new cardiac sur­
gery program, approximately two- 
thirds of the patients identified by 
the cardiac catheterization laborato­
ry at the Royal Columbian Hospital 
as candidates for open heart sur­
gery were referred to other institu­
tions. Some of these referrals were 
arranged as we attempted to meet 
our case exclusion criteria, but the 
bulk of referrals were required be­
cause of the overall ceiling on the 
program of 250 funded CPB proce­
dures. The strains created in the 
Department of Cardiac Sciences by 
referring two-thirds of the surgical 
caseload were considerable, and the 
members of the Department will 
continue to work with the hospital 
administration to expand the pro­
gram as additional ministry of 
health funding is secured.
Conclusions
The inaugural fiscal year of the 
open heart surgery program has 
been viewed as successful by the 
Ministry of Health of British Co­
lumbia, the hospital administration 
and the medical staff both within 
and referring to the Royal Columbi­
an Hospital. The new unit demon­
strated that it could function within 
a budget (250 procedures budgeted, 
250 procedures completed). The 
staff in the program were able to 
control the demands for emergency 
procedures and function within the 
program budget. The program op­
erated without interfering with 
scheduled cases on the main operat­
ing room slate and with little impact 
on the medical and surgical inten­
sive care units or the coronary care 
unit. The professional staff directly 
involved with the program were 
able to work together as a team and 
provide morbidity and mortality re­
sults that would inspire the confi­
dence of colleagues and the com­
munity.
Reflection on the principles in­
volved in planning for a new open 
heart unit at the Royal Columbian 
Hospital reinforces that case exclu­
sion criteria, even if not 100% appli­
cable, were important in achieving 
the program’s goals. Other deci­
sions, including recruitment and 
employment of experienced person­
nel responsible for the initial phase 
of the program, must be viewed as 
another factor responsible for suc­
cess. The decision to manage the 
funding as a separate program out­
side the hospital global budget 
gives the opportunity to measure 
success in financial terms, namely a 
balanced budget. As daunting as 
the prospect may be for the person­
nel handling the initial caseload, the 
anxiety felt by patients having sur­
gery in an untested unit must be 
even greater. If the experience at 
the Royal Columbian Hospital were 
to be followed in opening other new 
units, the patients should be reas­
sured of a satisfactory outcome.
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IM (n=13), Oral (n=12) 
(mean age = 72,
(0,013-0.034) (0.018-0,034) (4,7-8,6) (4.3-7,6)
range = 65-78)
Patients with Hepatic 0.029 0.033 5.4 4.5
Dysfunction IM and Oral 
(n=7)
(0.013-0.066) (0.019-0.051) (2.2-6.9) (1.6-7.6)
Patients with Renal 0.014 0.016 10.3 10.8
Impairment IM and Oral 
(n=9)(serum creatinine 
1.9-5.0 mg/dL)
(0.007-0.043) (0.007-0.052) (8.1-15.7) (3.4-18.9)
Renal Dialysis 0.016 13,6
Patients IM (n=9) (0,003-0.036) (8.0-39.1)
' Estimated from 30 mg single IM doses of ketorolac tromethamine
2 Estimated from 10 mg single oral doses of ketorolac tromethamine
3 Litres/hour/kilogram 
INDICATIONS:
Oral Route: Orally administered Toradol (ketorolac tromethamine) is indicated for the short­
term m anagem ent of mild to  moderately severe pain, including post-surgical pain (such as 
general, orthopaedic and dental surgery), acute musculoskeletal trauma pain and post-par- 
tum uterine cramping pain,
Intramuscular Route: Intramuscular injection o f Toradol is indicated for the short-term man­
agement of moderate to severe pain, including pain following major abdominal, orthopaedic 
and gynecological operative procedures.
CONTRAINDICATIONS:
H ypersensitiv ity : Like o th e r  n o n -s te ro id a l a n t i- in f la m m a to ry  d ru g s , T o ra d o l 
(ketorolac tromethamine) has been associated with hypersensitivity reactions. Toradol should 
not be used when there is a  known or suspected hypersensitivity to  the drug. Because o f the 
possibility o f cross-sensitivity, Toradol should not be used in patients with the complete or partial 
syndrome of nasal polyps, angioedema, bronchospastic reactivity (e.g. asthma) or other aller­
gic manifestations to acetylsalicylic acid  (ASA) or other non-steroidal anti-inflammatory drugs. 
Severe a n d  fa ta l a n a p h y la c to id  re a c tio n s  have  o c c u rre d  in such in d iv idu a ls . 
Gastrointestinal: As with other NSAIDs, Toradol also should not be used in patients with peptic 
ulcer or active inflammatory disease o f the gastrointestinal system. Severe and fatal reactions 
have occurred in such individuals,
WARNINGS:
The lo n g -te rm  adm in is tra tion  o f Torado l (k e to ro la c  tro m e th a m in e ) is n o t recom­
mended. The most serious risks associated with NSAIDs including Toradol are:
Gastrointestinal Ulcerations, Bleeding and Perforation: Serious gastrointestinal toxicity, such 
as bleeding, ulceration, and perforation, can occur at any time, with or without warning symp­
toms, during therapy with non-steroidal anti-inflammatory drugs. To date, studies with NSAIDs have 
not identified any subset o f patients not a t risk for developing peptic ulceration and bleeding 
Post-marketing experience with Toradol suggests that there may be a greater risk of gastrointesti­
nal ulcerations, bleeding, and perforation in the elderly, and most spontaneous reports of fatal 
gastrointestinal events are in the aged population,
LONG-TERM USE OF TORADOL: The oral use of Toradol 10 mg QID on a long-term basis is associat­
ed with more gastrointestinal tract adverse effects than is ASA 650 mg QID.
In a clin ica l trial in 823 patients with chron ic pain states com paring Toradol tablets 10 
mg QID (553 patients) with ASA 650 mg QID (270 patients), during the first week there was a 
2,4% dropout rate because of upper Gl complaints in the Toradol tablets treated patients as 
compared with 0.4% rate in the ASA treated group. After the first 2 weeks, the dropout rates 
due to  Gl pain or discomfort were comparable in both treatment groups. The time-adjusted 
percentages, which are not statistically significantly different, of patients who developed ulcers 
or upper Gl bleeding are as follows:
CUMULATIVE OCCURRENCE
INTERVAL KETOROLAC ASA
S 3 months 0.69* 0*
<6 months 1,59* 0.73*
•There was no statistically significant difference between ketorolac and ASA at either of the 
intervals tested.
PHYSICIANS SHOULD CAREFULLY WEIGH THE POTENTIAL RISKS AND BENEFITS OF USING TORADOL 
TABLETS ON A LONG-TERM BASIS. PATIENTS SHOULD BE INSTRUCTED TO WATCH FOR SIGNS OF 
SERIOUS Gl ADVERSE EVENTS AND THEY SHOULD BE MONITORED MORE CLOSELY THAN IF THEY 
WERE ON ANOTHER NSAID.
Renal Toxicity: The following renal abnorm alities have been associated with Toradol 
and other drugs that inhibit renal prostaglandin biosynthesis: acute renal failure, nephrotic 
syndrome, interstitial nephritis, renal papillary necrosis.
Haemorrhage: Postoperative haematomas and other symptoms of wound bleeding have 
been reported in association with the perioperative use o f intramuscular Toradol. If Toradol is 
to  be administered to patients who have coagulation disorders or who are receiving drug ther­
apy that interferes with haemostasis, careful observation is advised.
Hypersensitivity Reactions: The possibility o f severe or fa ta l hypersensitivity reactions 
should be considered, even for patients with no known history o f previous exposure or hyper­
sensitivity to Toradol or other NSAIDs. As with other NSAIDs, patients should be questioned for 
history of allergy to NSAIDs or ASA or for the syndrome consisting of nasal polyps, ASA allergy 
and asthma before being prescribed Toradol. Asthmatic patients with triad asthma (the syn­
drome of nasal polyps, asthma and hypersensitivity to  ASA or other NSAIDs) may be a t particu­
lar risk for severe hypersensitivity reactions.
Other NSAIDs: Ketorolac tromethamine is not recommended for concurrent use with other 
NSAIDs because of the potential for additive side effects.
Use in Pregnancy and Lactation: The administration of ketorolac tromethamine is not recom­
mended during pregnancy or lactation. After 1 day a t 10 mg QID. oral dosing, Toradol has 
been detected in the milk of lactating women af a maximum concentration of 79 ng/mL,
Use in Labour: Ketorolac trom etham ine is not recom m ended for use as an obstetrical 
preoperative medication or for obstetrical analgesia because of the known effects of NSAIDs 
on uterine contraction and fetal circulation.
Use in Children: Safety and e fficacy in children have not been established. Therefore, 
Toradol is not recommended for use in children under age 16.
Use in the Elderly: Because ketoro lac is c lea red  som ewhat more slowly by the elder­
ly (See PHARMACOKINETICS) who are also more sensitive to  the gastrointestinal and renal 
effects of NSAIDs (See WARNINGS and PRECAUTIONS), extra caution and the lowest effective 
dose (See DOSAGE AND ADMINISTRATION) should be used,
PRECAUTIONS:
Physicians should be alert to  the pharmacologic similarity o f Toradol (ketorolac tromethamine) 
to  other non-steroidal anti-inflammatory drugs that inhibit cyclo-oxygenase, Toradol is not an 
anesthetic agent and possesses no sedative or anxiolytic properties.
Gastrointestinal Effects: Close m e d ica l supervis ion is re co m m en d e d  in p a tien ts  
prone to  gastrointestinal tract irritation, particularly those with a history of peptic ulcer, diver- 
ticulosis or other inflammatory disease of the gastrointestinal tract, In these cases, the physician 
must weigh the benefits of treatment against the possible hazards. Patients ta k in g  any 
NSAID in c lud ing  ke to ro lac  tro m e th a m in e  should be  instructed to contact a physician 
immediately if they experience symptoms or signs suggestive of peptic ulceration or gastroin­
testinal bleeding. These reactions can occur a t any time during the treatment. If peptic ulcer­
ation is suspected or confirmed, or if gastrointestinal bleeding occurs, ketorolac tromethamine 
should be discontinued and appropriate treatment instituted with close patient monitoring. 
Renal Effects: As w ith o ther drugs th a t inh ib it p rostag land in  biosynthesis, elevations 
of blood urea nitrogen (BUN) and creatinine have been reported in clinical trials with (ketoro­
lac tromethamine), Since ketorolac tromethamine and its metabolites are excreted primarily 
by the kidney, the following precautions are indicated for patients with: Severely impaired 
renal function (serum creatinine values greater than 5 mg/dL, 442 pmol/L): Toradol is not rec­
ommended; Moderately impaired renal function (serum creatinine values ranging from 1.9 to 
5.0 mg/dL, 168 to 442 pmol/L) - The tota l daily dose o f ketorolac tromethamine should be 
reduced by half. In these patients the rate o f ketorolac tromethamine clearance was reduced 
to  approximately half of normal. Patients who are volume depleted may be dependent on 
renal prostaglandin production to maintain renal perfusion and, therefore, glomerular filtration 
rate. In such patients, the use of drugs which inhibit prostaglandin synthesis has been associa­
ted with further decreases in renal blood flow. Predisposing factors include sepsis, impaired 
renal function, heart failure, liver dysfunction, diuretic therapy, and advanced age. Caution is 
advised if ketorolac tromethamine is used in such circumstances. Close monitoring of urine out­
put, serum urea and serum creatinine is recommended until renal function recovers.
Hepatic Effects: Meaningful elevations (greater than 3 times normal) of serumtransami- 
nases (glutamate pyruvate (SGPT or ALT) and glutamic oxalacetic (SGOT or AST)), occurred in 
controlled clinical trials in less than 1% of patients. If clinical signs and symptoms consistent with 
liver disease develop, or if systemic manifestations occur (e.g., eosinophilia, rash, etc.), ketoro­
lac tromethamine should be discontinued. Patients with impaired hepatic function from cirrho­
sis do not have any clinically important changes in ketorolac tromethamine clearance. Studies 
in patients with active hepatitis or cholestasis have not been performed.
Fluid and Electrolyte Balance: Fluid retention and edema have been observed in patients 
treated with Toradol. Therefore, as with many other NSAIDs, the possibility of precipitating con­
gestive heart failure in elderly patients or those with compromised cardiac function should be 
considered. Toradol should be used with caution in patients with cardiac decompensation, 
hypertension or other conditions which cause a predisposition to  fluid retention.
Hematologic Effects: Ketorolac tromethamine inhibits platelet function and may prolong 
bleeding time. It does not affect platelet count, prothrombin time (Pi) or partial thromboplas­
tin time (PIT). Unlike the prolonged effects from ASA the inhibition of platelet function by 
ketorolac tromethamine is normalized within 24 to  48 hours after the drug is discontinued. 
Patients on full anti-coagulation therapy (e.g. heparin or dicumarol derivatives) may be at 
increased risk of bleeding if given Toradol concurrently. Thus, the benefit should be weighed 
against this risk. The concomitant use o f Toradol and heparin (5000 U s.c. BID) appears to be 
associated with less risk (see DRUG INTERACTIONS), In patients receiving anticoagulants, the risk 
o f intramuscular haematoma formation from Toradol IM injections may be increased. In post­
marketing experience, postoperative wound haemorrhage has been reported with the use of 
Toradol. Therefore, caution should be exercised when strict haemostasis is critical. Toradol IM is
► not recommended as a pre-operative or intra-operative medication because of the risk of 
excessive bleeding. Blood dyscrasias associated w ith the use o f NSAIDs are rare, 
but could occur with severe consequences.
. Infection: In common with other non-steroidal anti-inflam m atory drugs, ketorolac 
'  tromethamlne may mask the usual signs of infection.
►
►
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►
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►
►
►
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DRUG INTERACTIONS:
Protein Binding: Toradol (ketorolac tromethamine) is highly bound to human plasma 
protein (mean 99.2%) and binding is independent of concentration . As ketorolac 
tromethamine is a highly potent drug and present in low concentrations in plasma, it would not 
be expected to displace other protein-bound drugs significantly. Therapeutic concentrations 
of digoxin, warfarin, acetaminophen, phenytoin, and tolbutamide did not alter ketorolac 
tromethamine protein binding.
Anticoagulant Therapy: Prothrombin time should be carefully monitored in all patients 
receiving oral anticoagulant therapy concomitantly with ketorolac tromethamine. Torado! IM 
given with two doses of 5000 U of heparin to 11 healthy volunteers resulted in a mean tem­
plate bleeding time of 6.4 min (3.2-11.4 min) compared to a mean of 6.0 min (3.4-7.5 min) for 
heparin alone and 5,1 min (3.5-8.5 min) for placebo. The in vitro binding of warfarin to plasma 
proteins is only slightly reduced by ke to ro la c  tromethamine (99.5% control vs. 99.3%) 
at plasma concentrations of 5 to 10 pg/mL.
Digoxin: Ketorolac tromethamine does not alter digoxin protein binding.
Salicylates: in vitro studies indicated that, at therapeutic concentrations of salicylates 
(300 ug/mL), the binding of ketorolac tromethamine was reduced from approximately 99.2% to 
97.5% representing a potential two-fold increase in unbound Toradol plasma levels,
Enzyme Induction: There is no evidence, in anima! or human studies, tha t ketorolac 
tromethamine induces or inhibits the hepatic enzymes capable of metabolizing itself or other 
drugs. Hence, it would not be expected to alter the pharmacokinetics of other drugs due to 
enzyme induction or inhibition mechanisms.
Probenecid: Concomitant administration of ketorolac tromethamine and probenecid 
results in the decreased clearance of ketorolac and a significant increase in ketorolac plasma 
levels (approximately three-fold increase) and terminal half-life (approximately two-fold 
increase).
Furosemide: Ketorolac tromethamine reduces the diuretic response to furosemide 
by approxim ate ly 20% in normovolemic subjects.
Lithium: Some NSAIDs have been reported to inhibit renal lithium clearance, leading to 
an increase in plasma lithium concentrations and potential lithium toxicity. The effect of 
ketorolac tromethamine on lithium plasma levels has not been studied.
Methotrexate: The concomitant administration of methotrexate and some NSAIDs has 
been reported to reduce the clearance of methotrexate, thus enhancing its toxicity. The 
effect of ketorolac tromethamine on methotrexate clearance has not been studied.
Morphine: Intramuscular Toradol has been administered concurrently with morphine 
in several clinical trials of postoperative pain without evidence of adverse interactions,
ADVERSE EVENTS: , , , ,
TORADOL TABLETS: Short-Term Patient Studies - The incidence of adverse reactions in 371 
patients receiving multiple 10 mg doses of Toradol (ketorolac tromethamine) for pain resulting 
from surgery or dental extraction during the post-operative period (less than 2 weeks) is listed 
below, These reactions may or may not be drug related. Incidence between 4 and 9/«: 
Nervous system - somnolence, insomnia, Digestive system - nausea. Incidence between 2 and 
3%: Nervous system - nervousness, headache, dizziness: Digestive system - diarrhea, dyspep­
sia gastrointestinal pain, constipation. Body as a whole - fever. Incidence 1 % or Less: Nervous 
system - abnormal dreams, anxiety, dry mouth, hyperkinesia, paresthesia, increased sweating, 
euphoria, hallucinations; Digestive system - anorexia, flatulence, vomiting, stomatitis, gastritis, 
gastrointestinal disorder, sore throat; Body as a whole - asthenia, pain, back pain; 
Cardiovascular system: vasodilatation, palpitation, migraine, hypertension; Respiratory system - 
cough increased, rhinitis, dry nose; Musculo-skeletal system - myalgia, arthralgia; Skin and 
appendages - rash, urticaria; Special senses - blurred vision, ear pain; Urogenital system: 
dysuria,
Long-Term Patient Study - The adverse reactions listed below were reported to be probably 
k related to study drug in 553 patients receiving long-term oral therapy (approximately 1 year)
, with Toradol. Incidence between 10 and 12%: Digestive system - dyspepsia, gastrointestinal
pain.
k Incidence Between 4 and 9%: Digestive system - nausea, constipation; Nervous system - 
headache. Incidence Between 2 and 3%: Digestive system - diarrhea, flatulence, gastrointesti­
nal fullness, peptic ulcers; Nervous system - Dizziness, somnolence; Metabolic/Nutritional disor­
der - edema. Incidence 1% or Less: Digestive system - eructation, stomatitis, vomiting, anorex-
► ia, duodenal ulcer, gastritis, gastrointestinal haemorrhage, increased appetite, melena, mouth 
ulceration, rectal bleeding, sore mouth; Nervous system - abnormal dreams, anxiety, depres­
sion, dry mouth, insomnia, nervousness, paresthesia; Special senses - tinnitus, taste perversion,
t  abnormal vision, blurred vision, deafness, lacrimation disorder; Metabolic/Nutritional disorder - 
F Weight gain, alkaline phosphatase increase, BUN increased, excessive thirst, generalized 
edema, hyperuricemia; Skin and appendages - pruritus, rash, burning sensation skin; Body as 
t a whole - asthenia, pain, back pain, face edema, hernia; Musculo-skeletal system - arthrai-
► gia, myalgia, joint disorder; Cardiovascular system: chest pain, chest pain substernal, 
migraine; Respiratory system - dyspnea, asthma, epistaxis; Urogenital system - hematuria, 
increased urinary frequency, oliguria, polyuria; Hemic and lymphatic - Anemia, purpura,
► TORADOL IM: The adverse reactions listed below were reported in Toradol IM clinical effica­
cy trials. In these trials patients (n=660) received either single 30 mg doses (n=151) or multiple 
30 mg doses (n=509) over a time period of 5 days or less for pain resulting from surgery.
^  These reactions may or may not be drug related Incidence Between 10 and 13%: Nervous 
System - somnolence; Digestive system - Nausea. Incidence Between 4 and 9%: Nervous sys­
tem - headache; Digestive system - vomiting; Injection site - injection site pain. Incidence
t  Between 2 and 3%: Nervous System - sweating, dizziness; Cardiovascular system - vasodilata­
tion. Incidence 1% or Less: Nervous system - insomnia, increased dry mouth, abnormal 
dreams, anxiety, depression, paraesthesia, nervousness, paranoid reaction, speech disorder, 
euphoria, libido increased, excessive thirst, inability to concentrate, stimulation; Digestive sys-
*  tern - flatulence, anorexia, constipation, diarrhea, dyspepsia gastrointestinal fullness, gastroin­
testinal haemorrhage, gastrointestinal pain, melena, sore throat, liver function abnormalities,
'  rectal bleeding, stomatitis; Cardiovascular system - hypertension, chest pain, tachycardia,
► haemorrhage, palpitation, pulmonary embolus, syncope, ventricular tachycardia, pallor, flush­
ing; Injection site - injection site reaction; Body as a whole - asthenia, fever, back pain, chills, 
pain, neck pain; Special senses - taste perversion, tinnitus, blurred vision, diplopia, retinal
w haemorrhage; Musco-skeletal system - myalgia, twitching; Respiratory system - asthma,
*  cough increased, dyspnea, epistaxis, hiccup, rhinitis; Skin and appendages - pruritus, rash, sub­
cutaneous hematoma, skin disorder; Urogenital system - dysuria, urinary retention, oliguria, 
increased urinary frequency, vaginitis; Metabolic/nutritional disorders - edema, hypokalemia,
► hypovolemia Hemic and lymphatic system - anemia, coagulation disorder, purpura. 
Post-Marketing Experience: The following post-marketing adverse experiences, although 
rare (1% or less), have been reported for patients who have received either formulation of Toradol.
Renal events - acute renal failure, flank pain with or without haematuria and/or azotemia 
Hypersensitivity reactions: bronchospasm, laryngeal edema, hypotension, flushing, rash, and 
anaphylactoid reactions, such reactions have occurred in patients with no prior history of 
hypersensitivity. Gastrointestinal events - gastrointestinal hemorrhage, peptic ulceration, gas­
trointestinal perforation; Hematologic events - postoperative wound haemorrhage, rarely 
requiring blood transfusion (see PRECAUTIONS), thrombocytopenia; Central nervous system- 
convulsions, abnormal dreams, hallucinations, hyperkinesia, hearing loss; Cardiovascular - 
pulmonary edema; Dermatology - Lyell's syndrome, Stevens - Johnson syndrome, exfoliative 
dermatitis, maculopapular rash.
OVERDOSAGE: The absence of experience with acute overdosage precludes characteriza­
tion of sequelae and assessment of antidotal efficacy at this time. In a gastroscopic study of 
healthy subjects, daily doses of 360 mg given over an 8-hour interval for each of five consecu­
tive days (3 times the highest recommended dose) caused pain and peptic ulcers which 
resolved after discontinuation of dosing.
DOSAGE AND ADMINISTRATION:
Adults: Dosage should be adjusted according to the severity o f the pain and the response 
of the patient. Oral: The usual oral dose of Toradol (ketorolac tromethamine) is 10 mg every
4 to 6 hours for pain as required. Doses exceeding 40 mg per day are not recommended. 
Toradol is recommended for short-term use only, i.e„ for a  maximum of a few weeks.
Parenteral: The recommended usual initial dose is 30 mg. Subsequent dosing may be 10 mg 
to 30 mg every 4-6 hours as needed to control pain. It is recommended that the administration 
of Toradol IM be limited to short-term therapy (not over 5 days) and the total daily dose should 
not exceed 120 mg.
This is because the risk of toxicity appears to increase with longer use at recommended doses 
(see WARNINGS and PRECAUTIONS). The administration of continuous multiple daily doses of 
Toradol IM has not been extensively studied. There has been limited experience with intramus­
cular dosing for more than 3 days since the vast majority of patients have transferred to oral 
medication or no longer required analgesic therapy after this time, In the initial post-operative 
period, more frequent dosing (e.g. every 2 hours) may be employed but the total daily dosing 
should not exceed 120 mg/day, If supplementary analgesia is required, a concomitant low 
dose of opiate can be used.
Patients under 50 kg, over age 65 years, or with less severe pain at baseline: the lower end 
of the dosage range (10-15 mg 4 times a day) is recommended.
Impaired Renal Function - Moderate - In patients with impaired renal function (serum 
creatinine values ranging from 1.9 to 5.0 mg/dL or 168 to 442 pmol/L), the total daily dose of 
Toradol should be reduced by half;
Severe - In patients with severely impaired renal function (serum creatinine values greater than
5 mg/dL, or 442 pmol/L) Toradol is not recommended,
Conversion from Parenteral to Oral Therapy: Toradol tablets may be used either as monothera­
py or as follow-on therapy to parenteral ketorolac. Toradol IM should be replaced by an oral 
analgesic as soon as feasible. When Toradol tablets are used as a follow-on therapy to par­
enteral ketorolac, the total combined daily dose of ketoroloc (oral + parenteral) should not 
exceed 120 mg on the day the change of formulation is made. Subsequent oral dosing should 
not exceed the recommended daily maximum of 40 mg.
Directions for Use of the Prefilled Syringes: Insert the plunger into the syringe barrel and thread 
it onto the screw. WITHOUT REMOVING THE NEEDLE GUARD, apply quick, firm pressure to the 
plunger to break the inner seal. (You will feel it let go). Pull back on the plunger slightly to 
relieve pressure. Remove the needle guard by twisting as you pull. Use the unit as you would a 
normal syringe. Dispose of properly. Single use only. Discard Unused Portions. Parenteral drug 
products should be inspected visually for particulate material and discoloration prior to  use. 
Toradol (ketorolac tromethamine) is a  Schedule F drug.
Stability and Storage Recommendations:
Toradol Tablets: Store at room temperature with protection from light.
Toradol IM: Store at room temperature with protection from light.
Availability of Dosage Forms: Toradol (ketorolac tromethamine) is available as 10 mg white 
round film coated tablets containing ketorolac tromethamine, microcrystalline cellulose, lac­
tose and magnesium stearate with one side printed in red with TORADOL inside bold T and 
other side with Syntex, Toradol (ketorolac tromethamine) 10 mg tablets are available in bottles 
of 100 and 500 tablets,
Toradol IM is available in 1 mL ampoules (trays of 10) containing 10 or 30 mg/mt.
Torado! IM is also available in 1 mL syringes (1 / box) containing 15 or 30 mg/mL.
Product Monograph available on request,
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ORIGINAL ARTICLES
Thoracoscopic Intracavitary Drainage 
for Pneumothorax Secondary to Bullous 
Emphysema
John D. Urschel, MD, FRCSC; William J. Dickout, MD, FRCPC
Most patients with spontaneous pneumothorax secondary to bullous emphysema are successfully 
managed by chest-tube drainage. Occasionally a very large air leak prevents full lung expansion. The 
authors report on a patient in whom thoracoscopic intracavitary drainage of a leaking bulla led to rapid 
resolution of the pneumothorax and obliteration of the bulla. A large bronchopleural fistula was 
converted to a controlled bronchocutaneous fistula. The authors conclude that when conventional 
management fails to provide full lung expansion in cases of pneumothorax secondary to bullous 
emphysema, thoracoscopic intracavitary drainage is useful.
La plupart des patients qui subissent un pneumothorax spontane secondaire a un emphyseme bulleux 
sont traites avec succes par drainage thoracique. Occasionnellement, une fuite d’air tres importante va 
empecher l’expansion complete du poumon. Les auteurs decrivent un cas de ce genre oil un drainage 
intracavitaire par thoracoscopie de la bulle responsable de la fuite a resulte en une resolution rapide du 
pneumothorax et en l’elimination de la bulle. Une importante fistule bronchopleurale fut transformee 
en une fistule bronchocutanee controlee. Les auteurs concluent que, quand le traitement traditionnel 
ne suffit pas a permettre l’expansion complete du poumon dans les cas de pneumothorax secondaire a 
un emphyseme bulleux, le drainage intracavitaire par thoracoscopie est utile.
Closed chest-tube drainage is the treatment of choice for patients 
with pneumothorax secondary to 
bullous emphysema. We describe a 
patient in whom we used a thoraco­
scopic modification of an old tech­
nique to manage the pneumotho­
rax. We discuss the place of this 
modified technique, intracavitary 
drainage, in the management of 
pneumothoraces that do not re­
spond to conservative treatment.
Case Report
An 84-year-old man with a histo­
ry of smoking and chronic obstruc­
tive pulmonary disease presented 
with chest pain and dyspnea. Chest 
radiography showed a left pneumo­
thorax and a bulla in the lower lobe 
of the left lung (Fig. 1). Insertion of 
a chest tube resulted in only tran­
sient lung expansion. A massive air 
leak, subcutaneous emphysema and 
collapse of the lung required inser­
tion of a second chest tube. Pleu- 
rodesis with tetracycline was unsuc­
cessful. After 12 days of chest-tube 
drainage, the pneumothorax and air 
leak persisted.
Left thoracoscopy was performed 
under general anesthesia. A rup­
tured bulla was found in the lower 
lobe of the left lung. Because of the 
size of the bulla, intracavitary drain­
age was favoured over endoscopic 
stapling. The bulla was “purse- 
stringed" with an absorbable su­
ture, and a large Foley catheter was 
inserted. Two pleural chest tubes 
were inserted, and the bulla was 
brought up to the chest wall by 
gentle traction on the inflated Foley 
catheter. Air leak from the pleural 
tubes ceased within 24 hours, and a 
postoperative radiograph showed 
lung expansion. A large air leak 
was noted from the intracavitary 
Foley catheter. The pleural tubes
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were removed after several days 
(Fig. 2). Despite the presence of a 
persistent small air leak from the
intracavitary tube, it was removed 
on the 10th postoperative day be­
cause pleural symphysis was as-
F1G. 2. On 7th postoperative day pneumothorax has resolved. Position of 
intracavitary drainage tube is shown by balloon filled with contrast material.
sumed to be present. The bron- 
chocutaneous fistula quickly closed, 
and the pneumothorax did not re­
cur.
Discussion
Most pneumothoraces secondary 
to bullous emphysema resolve with 
a combination of chest-tube drain­
age and patience. If the lung cannot 
be expanded by pleural drainage, 
surgical intervention is necessary. 
Many of these patients are elderly 
and have poor pulmonary function 
so they are not candidates for tho­
racotomy and excision of the bullae. 
Minimally invasive thoracoscopic 
techniques are preferred. These 
techniques include ligation of the 
bullae,1 laser or cautery ablation of 
the bullae23 and endoscopic sta­
pling. Thoracoscopic approaches to 
pleural symphysis, such as pleural 
abrasion, pleural cautery or laser 
pleurodesis,4 pleurectomy1 and talc 
poudrage,5 are useful if the lung 
can be expanded.
Thoracoscopic intracavitary 
drainage is a modification of Monal- 
di’s two-stage procedure for tuber­
culous cavities.6 Intracavitary drain­
age has proved successful in the 
elective treatment of selected symp­
tomatic patients with bullous lung 
disease.7 In the case we have de­
scribed, intracavitary drainage re­
sulted in prompt resolution of the 
pneumothorax and obliteration of 
the bulla. A large bronchopleural 
fistula was converted to a controlled 
bronchocutaneous fistula. This al­
lowed lung expansion and facilitat­
ed the development of pleural sym­
physis. The bronchocutaneous fis­
tula closed spontaneously after re­
moval of the intracavitary tube.
When conventional methods of 
management fail, thoracoscopic in­
tracavitary drainage is a useful op­
tion in the treatment of selected 
patients with pneumothorax sec-
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ondary to bullous emphysema. 
Large bullae are particularly suit­
able for intracavitary intubation.
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SESAP VII Critique /  Critique SESAP VII
Item 241
Iatrogenic vascular injuries are an increasingly common event in hospital practice. Invasive diagnostic and 
therapeutic interventions create situations in which vascular disruption or thrombosis can create acute ischemia, 
hemorrhage, or neurologic deficit. Although the location of the vascular injury and the presence of preexisting 
atherosclerotic disease may complicate the repair, a delay in surgical intervention is the dominant factor in 
predicting permanent disability. That permanent disability is usually a result of the peripheral ischemic 
neurologic deficit. Prompt reversal of the peripheral ischemia lessens the likelihood of permanent neurologic 
damage.
B
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Pica in the Mentally Handicapped: a 15-Year 
Surgical Perspective
Chris J. Decker, MD, FRCSC
Objective: To review the general surgical management of mentally handicapped persons with pica. 
Design: A study of hospital records and a review of the current literature.
Setting: A community hospital.
Patients: Thirty-five patients from a large institution for the mentally handicapped were treated for 
well-documented pica on 56 occasions at the Orillia Soldiers Memorial Hospital between 1976 and 
1991.
Interventions: Endoscopy and laparotomy for the removal of foreign bodies or to close perforations. 
Results: Fourteen (25%) cases of pica were managed by observation only, but 42 (75%) cases required 
surgical intervention. There were 34 laparotomies. The complication rate was 30% and the death rate 
11%.
Conclusions: Pica is a serious health risk for mentally handicapped patients. Diagnosis and 
postoperative care can be difficult. Pica should be suspected in mentally handicapped patients with 
gastrointestinal symptoms.
Objectif: Revoir le traitement chirurgical des handicapes mentaux souffrant de pica.
Conception : Une etude des dossiers d’hopitaux et une revue de la litterature actuelle.
Contexte : Un hopital communautaire.
Patients : Trente-cinq patients d’un important etablissement pour handicapes mentaux furent traites 
pour une pica bien etablie, en 56 occasions, au Orillia Soldiers Memorial Hospital, entre 1976 et 1991. 
Interventions : Des endoscopies et des laparotomies effectives pour retirer des corps etrangers ou pour 
refermer des perforations.
Resultats : Quatorze cas (25 %) de pica furent traites par simple observation mais 42 cas (75 %) 
necessiterent une intervention chirurgicale. II y eut 34 laparotomies. Le taux de complications fut de 
30 % et la mortality, de 11 %.
Conclusions : La pica represente une menace serieuse pour la sante des handicapes mentaux. Le 
diagnostic et les soins postoperatoires peuvent presenter de grandes difficultes. La pica doit etre 
soupconnee chez les handicapes mentaux qui presentent des symptomes gastro-intestinaux.
P ica is a pathologic craving for normal food constituents or for 
substances not commonly regarded 
as food. First defined by Ambrose 
Pare in the 16th century, pica is the 
Latin word for magpie, a bird 
known for its proclivity to pick up 
multiple things to satisfy its hunger 
or curiosity.1
Pica may be seen in four sets of 
circumstances: nutritional disor­
ders, social or cultural mores, men­
tal illness and mental handicap. The 
major nutritional disorder is iron 
deficiency anemia, which results in 
the ingestion of many unusual sub­
stances such as ice, clay, starch or 
lead.2 Cultural practices may in­
volve geophagia (darth eating), 
which is endemic throughout the 
world and is valued as an adjunct to 
religious or magical beliefs in some 
areas.3 Among mentally ill people, 
long-term schizophrenics or those 
with marked personality disorders 
may indulge in pica.4
Pica is said to be the most fre-
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quently seen eating dysfunction in 
the mentally handicapped. Danford 
and Huber5 studied 991 institution­
alized patients over a 2-year period 
and found a 25% incidence of pica. 
It became less frequent as age in­
creased and the level of retardation 
decreased. Food pica was most fre­
quently found in borderline retarded 
patients, whereas non-food pica in­
creased with the severity of retarda­
tion.
The practice of pica was deliber­
ate in every case, and in 56% specif­
ic items such as cigarette butts 
were preferentially sought. Some 
researchers believe that pica is re­
lated to a patient’s inability to dis­
criminate between edible and inedi­
ble items, with an infantile hand to 
mouth response.6 A small group of 
patients may suffer from specific 
brain disorders in the left temporal 
lobe or amygdala, and this can 
cause faulty eating patterns.1
Patients confined to large institu­
tions for the mentally handicapped 
provide an opportunity to study this 
behaviour. Nearby community gen­
eral hospitals are called upon to 
provide surgical care. Orillia Sol­
diers Memorial Hospital (OSMH) 
provides surgical services to the 
Huronia Regional Centre (HRC), a 
large institution for the mentally 
and physically handicapped. In this 
paper we report our experience with 
pica in patients from HRC.
Patients and Methods
A retrospective study of OSMH 
records from Jan. 1, 1976, to Dec. 
31, 1991, identified those patients 
who presented from HRC with doc­
umented pica, foreign bodies in the 
gastrointestinal tract, bowel ob­
struction, peritonitis or perforation 
with transfer from another institu­
tion. Patients who underwent lapa­
rotomy after transfer from another 
institution were also reviewed. Ex­
cluded from analysis were patients 
who presented with aspiration of 
foreign bodies and normal pediatric 
patients with foreign bodies. The 
HRC records of patients with pica 
transferred to OSMH were also 
analysed.
Numerous patients from HRC 
presented to the emergency depart­
ment of OSMH with an acute abdo­
men. Although many were suspect­
ed of pica they were excluded from 
the study if the pica was not clearly 
documented radiographically, if for­
eign bodies were not recovered or if 
ingestion was not witnessed. The 
data assessed included sex, age, 
clinical presentation, hemoglobin 
level and leukocyte count, radiolog­
ic findings, operative findings, type 
of operation, postoperative compli­
cations or death, other diagnoses, 
time from clinical onset to surgery 
and time of year treated.
Findings
From 184 cases identified, 56 
cases of documented pica in 35 
different patients (31 male, 4 fe­
male) were treated at OSMH; 21 
patients had repeat incidents. The 
patients ranged in age from 15 to 
48 years (median 23 years). All 
patients were moderately to severely 
retarded and were usually physically 
handicapped also. Sixteen patients 
(46%) were epileptic and were tak­
ing antiepileptic medications. Two 
had Down’s syndrome, and one 
each had microcephaly, tuberous 
sclerosis, Prader-Willi syndrome 
and congenital rubella. None was 
anemic. In eight cases (14%) the 
patient presented with impaction in 
the oropharynx or esophagus. The 
presenting signs were excessive sal­
ivation with choking or agitation. 
In 5 cases (9%) there was gastric 
outlet obstruction and in 22 cases 
(39%) there was small-bowel ob­
struction.
In nine cases (16%) the patient 
had peritonitis from acute perfora­
tion of the gastrointestinal tract: 
five in the small bowel, three in the 
large bowel and one in the stomach 
(Table 1).
Five patients had asymptomatic 
large foreign bodies in the stomach. 
These were removed when the for­
eign body failed to pass after a 
minimum of 5 to 7 days’ observa­
tion or if the foreign bodies were 
too large to be removed endoscopi- 
cally.
Twenty (36%) of the 56 cases of 
pica occurred in August and Sep­
tember.
Fourteen (25%) cases were treat­
ed nonoperatively. In nine cases 
there was incomplete small-bowel 
obstruction. In two cases, the pa­
tients were seen to ingest foreign 
bodies but had no symptoms, and in 
two other cases, asymptomatic pa­
tients were found to have foreign 
bodies on the x-ray film. One pa­
tient presented in septic shock and 
died.
In three cases foreign bodies 
were removed from the posterior 
oropharynx or hypopharynx laryn- 
goscopically. In another five cases 
esophagoscopy was required for re­
moval of foreign bodies.
Thirty-four laparotomies were 
carried out: 9 involved simple gas- 
trotomy and removal of foreign bo­
dies and 12 involved enterotomy or 
colotomy, or both. In three cases,
Tab le  1. C lin ica l P resen ta tion  o f P ica 
( /V =  56)
Diagnosis
C ases, no. 
(»/o)
Im p a c tio n  in esophagus
o r  h yp o p h a ryn x 9 ( 1 6 )
G a s tr ic  o u tle t o r  s m a ll-b o w e l 
o b s tru c tio n 2 7  (4 8 )
P e rfo ra tio n 9 ( 1 6 )
A s y m p to m a tic , fa ilu re  o f 
fo re ig n -b o d y  passage 5 ( 9 )
O bserved  pica, a sy m p to m a tic 4 ( 7 )
G a s tro in te s tin a l hem orrhage 1 (2 )
In te s tin a l m ass 1 ( 2 )
T o ta l 5 6  (1 0 0 )
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foreign-body perforation of the in­
testine was treated by simple clo­
sure. In seven (21%) of the laparot­
omies the patient required bowel 
resection for removal of long-stand­
ing foreign bodies that could not be 
removed by simple enterotomy, for 
gross perforation of the intestine 
and, in one case, for removal of a 
mass of unknown nature, proven on 
later pathological examination to be 
a foreign body. In two cases, the 
patient required partial gastrecto­
my, for bleeding in one case and for 
perforation in the other. In one 
case, the patient had lysis of adhe­
sions and milking of a foreign body 
into the large bowel. The foreign 
body then passed with no further 
complication.
The types of foreign bodies re­
moved were variable, but plastic 
was the most common, being recov­
ered in 26 cases (46%) (Table II).
There were 17 in-hospital compli­
cations or deaths (30%). Four pa­
tient died (11%). One sustained a 
massive upper gastrointestinal he­
morrhage after endoscopic removal 
of a piece of leather. Autopsy re­
vealed erosion of a pulmonary ar­
tery causing exsanguination. Two 
patients died of septic shock after 
free perforations and generalized 
peritonitis. The fourth patient who 
died was moribund on arrival in the 
Emergency Department and died 
there. Autopsy revealed acute bowel 
obstruction and acute tubular ne­
crosis of the kidneys. There were 
four cases of prolonged ileus be­
yond 7 days. There were four in­
Tab le  II. F ore ign  B od ie s  R ecove red
B ranches P ieces o f c lo th
Canvas Raw  p o ta to e s
G loves R ings
H air ro lle rs S ho e lace s
Hard p la s tic S to n e s
Ja r to p s S ty ro fo a m
Keys T o o th p ic k s
M arb les T o w e ls
M eta l fo il W o o d e n  b a lls
P la s tic  bags W o o d e n  s p a tu la
hospital wound infections, two 
cases of postoperative urinary tract 
infection, two cases of pneumonia 
and one seizure. Four cases of 
small-bowel obstruction developed 
from 7 days to 4 months postopera- 
tively.
Discussion
The gastrointestinal tract has a 
remarkable ability to pass most ob­
jects that enter it: 80% to 90% of all 
foreign bodies will pass, given 
time.7 Although the HRC has 668 
patients, over a 15-year period only 
56 cases of documented pica re­
quired assessment or treatment at 
OSMH. If estimates of 25% inci­
dence are correct, then far more 
pica takes place at chronic care 
institutions than is encountered at 
acute care hospitals. Since foreign 
bodies were recovered endoscopical- 
ly in only 9 (16%) of the 56 cases, 
the other objects, some of which 
were very large (towels, gloves, 
plastic bags), passed uneventfully 
through the esophagus and in some 
cases the pylorus also.
The gastroesophageal junction, 
pylorus, distal ileum and rectosig­
moid are the narrowest areas in the 
gastrointestinal tract,8 but these 
were not the only areas of obstruc­
tion noted, probably because of the 
size or sharpness of some of the 
objects.
In addition to mental handicap, 
the patients in this study, exhibited 
multiple skeletal deformities and 
motor and sensory impairment, and 
were taking numerous medications, 
so history taking and physical ex­
amination could be extremely diffi­
cult. Illness is suspected when 
symptoms of vomiting, distension, 
prolonged constipation, irritability 
and fever are noted. Attendants 
who know the patient are crucial to 
the assessment. Patients can be 
combative, irritable or show no re­
sponse to stimuli that would make 
normal patients extremely uncom­
fortable. Symptomatology does not 
always correlate with the advanced 
condition sometimes encountered. 
The physician must rely on labora­
tory and radiologic data for diagno­
sis. However, of the 34 cases in 
which laparotomy was performed, 
foreign bodies could be seen in only 
12 (35%) of the plain x-ray films. In 
19 patients the development of 
symptoms preceded laparotomy by 
more than 24 hours. Although in 
five cases the patient was observed 
to see if the foreign body would 
pass, 14 (41%) laparotomies were 
delayed because of some doubt 
about diagnosis. Aerophagy is com­
mon in the mentally handicapped, 
hence presentation of patients in 
the emergency department with ab­
dominal distension, vomiting and 
air fluid levels demonstrated radio- 
logically is encountered relatively 
frequently.
The complication and death rate 
was 30%. Most complications were 
relatively minor but did point out 
the difficulties with these patients 
in the postoperative period. Their 
lack of cooperation resulted in na­
sogastric tubes and intravenous 
catheters being removed by the pa­
tient. Chest physiotherapy can be 
impossible. Most of our patients 
were young and did recover, but 
the death rates of 11% in this 
series, 25% reported by Voitk9 
and 33% reported by Teimourian, 
Cigtay and Smyth10 emphasize 
that pica is a significant compli­
cation in this population.
Although anemia is a known 
causal factor in pica, no evidence of 
this was found in the HRC patients, 
the mean hemoglobin level being 
144 g /L  (range from 122 to 
191 g/L). Sixty percent of patients 
were on antiepileptic medication, 
but this has never been implicated 
as a cause of pica in patients of 
normal intelligence.
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Although institutional staff at­
tempt to prevent pica by placing 
high-risk patients in special wards, 
it is virtually impossible to prevent 
all cases.
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N oncemented Stem Tibial Component 
in Total Knee Replacement: the 2- to 6-Year 
Results
Hugh U. Cameron, MB, ChB, FRCSC;* Young B. Jung, MDt
Objective: To determine if the addition of a stem to the tibial component in noncemented total knee 
replacement affects sinkage of that component or micromotion.
Design: A cohort of 176 consecutive cases with no exclusions. Follow-up ranged from 2 to 6 years. 
Setting: A university-affiliated institution specializing in elective orthopedic surgery.
Participants: All 176 patients had arthritis of the knee, mainly osteoarthritis. All agreed preoperatively 
to prolonged postoperative follow-up.
Intervention: Noncemented total knee replacement with the Tricon M long-stem tibial component.
Main Outcome Measures: Hospital for Special Surgery rating system for clinical results and degree of 
tibial sinkage and stem lucency seen radiologically.
Results: Eight (4.5%) of the 176 prostheses required revision, none for sinkage. Of the remaining 168 
knees, 156 (92.9%) scored good or excellent, 6% fair and 1.2% poor. Sinkage occurred in 3%, but was 
not of sufficient severity to require revision. No lucency was visible in 33.8% of stems, partial lucency 
in 62%, complete lucency with the lines being parallel to the stem in 3.5% and complete lucency with 
divergent lines, indicating a loose implant, in 1.7%. Lucency, when present, was seen mainly in the 
lateral view, seldom in the anteroposterior view. There was no correlation between radiologic results 
and clinical results.
Conclusions: The addition of a metaphyseal stem reduces the incidence of sinkage of the tibial 
component in total knee replacement. The stem largely solves the problem of mediolateral micromotion 
but does not completely prevent anteroposterior micromotion.
Objectif: Determiner si 1’addition d’une tige a la partie tibiale d’une prothese totale non cimentee du 
genou affecte l’affaissement de la partie tibiale de la prothese ou les micromouvements du tibia. 
Conception : Une cohorte de 176 cas, sans exclusions. La periode de surveillance s’etend sur 2 a 6 ans. 
Contexte : Un etablissement universitaire specialise en chirurgie orthopedique non urgente. 
Participants : Les 176 patients souffraient tous d’une atteinte arthritique du genou, principalement 
d’arthrose. Tous avaient accepte avant l’operation de participer a un suivi prolonge.
Intervention : Arthroplastie totale non cimentee du genou avec la composante tibiale Tricon M a 
longue tige.
Principaux effets mesures : Evaluation des resultats cliniques a l’aide du systeme «Hospital for Special 
Surgery# et degre d’affaissement du tibia et d’espacement de la tige visible a la radiographie.
Resultats : Huit (4,5 %) des 176 protheses ont necessite une revision, aucune pour affaissement. Des
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168 autres genoux, 156 (92,9 %) ont donne des resultats bons ou excellents, 6 % des resultats moyens 
et 1,2 /&, de mauvais resultats. Un affaissement est survenu dans 3 % des cas mais il ne fut jamais assez 
important pour necessiter une revision. Aucun espacement n’est apparu pour 33,8 % des tiges, un 
espacement partiel a ete vu dans 62 % des cas, un espacement complet avec parallelisme des lignes avec 
la tige dans 3,5 % des cas, et un espacement complet avec divergence des lignes indiquant une prothese 
flottante dans 1,7 % des cas. L’espacement pouvait etre visualise surtout en vue laterale, rarement en 
vue anteroposterieure. On n’a note aucune correlation entre les resutats radiologiques et cliniques. 
Conclusions : L’addition d’une tige metaphysaire reduit la frequence de l’affaissement de la partie 
tibiale d’une prothese totale du genou. La tige resolut en grande partie le probleme des 
micromouvements mediolateraux mais ne previent pas totalement les micromouvements 
anteroposterieurs.
N oncemented total knee replace­ment is now well established, 
although the majority of reported 
studies have a short follow-up.1-5 
Some concern exists about fixation 
of the noncemented tibial compo­
nent.6-7 It has been shown experi­
mentally with micromotion studies8 
and pressure-sensitive-plate film 
studies9 and clinically in one roent­
gen stereophotogrametric analysis 
of a small number of cases10 that 
the addition of a stem to the tibial 
component significantly increases 
initial stability. This in turn may 
reduce the incidence of tibial sink- 
age and the extent of micromotion, 
which is a potent cause of failure of 
bone ingrowth into porous metal 
components.1
Tibial sinkage in noncemented 
total knee replacement usually oc­
curs within 2 years and most often 
in the first 6 months to 1 year.11 
We believed that there were enough 
cases of a noncemented ingrowth 
stem tibial component with a fol­
low-up longer than 2 years to allow 
meaningful examination of tibial 
sinkage.
Micromotion is difficult to study 
on clinical x-ray films. Unless an 
image intensifier is used to ensure 
an edge-on shot of the tibial base 
plate, radiolucency, which is an 
indicator of micromotion, is always 
underestimated: a variation in the 
beam angle of only 3° will obscure 
a radiolucent line.12 Radiolucency 
surrounding a stem prosthesis, as 
for example a hip stem, is not 
nearly as sensitive to minor changes
in beam angle and rotation. Mi­
cromotion of the stem of the tibial 
component can occur in three 
planes: rotation, anteroposterior
toggle and medial lateral toggle. By 
a comparison of anteroposterior and 
lateral x-ray films of the stem tibial 
component we felt useful informa­
tion could be obtained about the 
relative incidence of anteroposterior 
and medial lateral micromotion.
Therefore, all Tricon M (Richards 
Manufacturing Co., Memphis, 
Tenn.) long-stem total knee replace­
ments carried out by the senior 
author (H.U.C.) were studied pro­
spectively. We believed that this 
approach would eliminate variables 
in surgical technique and postoper­
ative management.
Patients, Materials and 
Methods
The 202 patients ranged in age 
from 47 to 83 years (mean, 69.5 
years). Eight patients had rheuma­
toid arthritis, two had post-traumat­
ic arthritis, three had Paget’s dis­
ease13 and one had avascular necro­
sis. The remainder had primary os­
teoarthritis.
There were 212 knees: bilateral 
replacements were done with an 
identical knee (Tricon M prosthesis) 
in 10 patients and with another 
type of knee in 56 patients. All 
numbers will refer to knees with 
Tricon M replacements only and bi­
laterality will be ignored.
Thirty-six knees (17.0%) were
lost to follow-up: 10 (27.8%) of 
them were placed in patients who 
died within 2 years of replacement.
Of the remaining 176 knees, 134 
were replaced in women and 42 in 
men. Thirty-seven knees (21.0%) 
had been operated on previously 
(22 high tibial osteotomies, 6 total 
knee revisions, 2 unicompartmental 
knee replacements, 2 Girdlestone 
procedures, 2 fusions, 1 procedure 
for supracondylar fracture, 1 for 
supracondylar osteotomy and 1 Ma- 
quet procedure (elevation of tibial 
tubercle). The replaced knees were 
evaluated at 3 months and 6 
months after placement and annual­
ly thereafter. They were rated ac­
cording to the Hospital for Special 
Surgery rating system.14 Patients 
were examined radiographically by 
1-m standing anteroposterior, later­
al and skyline views of the knee.
The follow-up ranged from 2 to 6 
years (mean, 3.5 years).
The Prosthesis
The Tricon M prosthesis, a po­
rous coated total knee replacement, 
is designed for use without bone 
cement. The stem design chosen 
was wide in the sagittal plane to 
resist medial lateral loads. It was 
cut in the shape of an I-beam to 
minimize bone resection. It was 
designed to approach the posterior 
tibial endosteal cortex to prevent 
anterior sinkage of the tibial com­
ponent. It was highly polished to 
prevent osseointegration.
Initially, the stem was straight
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posteriorly, but five crack fractures 
of the posterior tibial cortex oc­
curred in the 1st year of use. (These 
cases have been included in this 
study.) Thereafter, the stem was 
bevelled to slide down the posterior 
cortex, and no further fractures 
have occurred (Fig. 1).
Insertion Technique
The tibial plateau was cut at 
right angles to the long axis of the 
tibia and the distal femur in 7° of 
valgus. The ligaments were careful­
ly balanced, releasing the structures 
in the concave side of the deformi­
ty. The tibial components trials 
were sized and positioned to give 
maximum tibial coverage, and when 
trial reductions were complete, the 
hole for the central tibial stem was 
punched out.
Most patients were allowed imme­
diate, full weight bearing. Those 
with tibial crack fractures or bone 
grafts larger than 2 cm2 were re­
stricted to touch weight bearing for 
4 to 6 weeks.
All patellae were resurfaced.
Evaluation of the Prosthesis
Sinkage was measured on serial 
anteroposterior x-ray films. A verti­
cal line was drawn on the long axis 
of the tibia and a horizonal line to 
some recognizable feature, usually 
the top of the fibular head. Another 
line was drawn along the base of 
the metal tibial tray, and the differ­
ence between these two lines mea­
sured. After several measurement 
sessions on serial x-ray films, we 
decided that only sinkage of more 
than 3 mm could be measured reli­
ably.
The stem was examined radiolog- 
ically in anteroposterior and lateral 
views. Any bone change, a visible 
lucent line or a linear increase in 
bone density adjacent to the stem 
was counted as lucency, except for 
changes at the absolute stem tip. 
Lucency was divided into partial 
lucency, when the lucent line was 
only seen around part of the stem, 
and complete lucency, when the 
lucent line extended around the 
whole stem. Note was made of 
whether the complete lucent line
was parallel to or divergent from 
the stem. The lucent line was grad­
ed after the fashion of Engh15 as 
modified by Dorr for noncemented 
total hip replacement:16 type IA rep­
resents no lucency; type IB repre­
sents partial lucency (Fig. 2); type 11 
represents complete lucency with 
the lucent lines parallel to the stem; 
and type III represents complete lu­
cency with the lucent lines diver­
gent from the stem (i.e., the tibial 
component exhibits macromotion 
and is therefore loose [Fig. 3]).
Results
Of the 176 knees available for 
2-year follow-up, 8 (4.5%) were re­
vised. The reasons for revision were 
as follows: sepsis in four knees 
(three early and one late), lost skin 
and subcutaneous tissue over the 
anterior aspect of the knee and 
subsequent dislocation of the knee 
in one patient, sticking of the origi­
nal stem of the prosthesis before 
complete seating in one knee, patel­
lar wear in one knee and patellar 
and tibial wear in one knee.
Of the remaining 168 knees, 127 
(75.6%) knees scored excellent, 29 
(17.3%) scored good, 10 (6%) 
scored fair and 2 (1.2%) scored 
poor. There were no femoral loos- 
enings. Tibial sinkage occurred in 
five (3.0%) knees. Sinkage was less 
than 5 mm in all cases and none 
was of sufficient severity to require 
revision. Sinkage of the patella oc­
curred in two (1.2%) cases and 
reflex sympathetic dystrophy in 
four (2.4%) cases. With use of the 
original stem, there were five crack 
fractures of the tibial cortex at the 
time of stem insertion. Screws were 
inserted in two cases, but the others 
were simply ignored, and the pa­
tient was limited to touch weight 
bearing for 6 weeks. All fractures 
healed without complication. This 
problem did not occur with the
FIG. 1. Stem on this tibial component is bevelled to slide down posterior tibial 
cortex, giving added resistance to anterior sinkage of tibial component. Stem is 
wide in sagittal plane to give medial lateral resistance.
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bevelled stem. Wear of the tibial 
component occurred in two knees, 
one of which was revised, and in 
three patellae, two of which were 
revised. In one case the patellar 
tendon was reinforced with wires at 
the time of the initial replacement. 
The wires were removed later. A 
stress fracture of the tibia of one 
knee was treated conservatively. 
One patient had early sepsis and the 
knee was treated with debridement. 
Although this knee continued to 
function 2 years later, both tibial 
sinkage and patellar sinkage were 
demonstrated, suggesting an ongo­
ing low-grade infection.
According to the modified Engh- 
Dorr classification, 33.8% of tibial 
components were type IA, 62% were 
type IB, 3.5% were type II and 1.7% 
were type III. Stem lucency in the 
anteroposterior x-ray film appeared
complete in 5.2% of cases, partial in 
6.5% and absent in 88.3%. On the 
lateral x-ray film, lucency was com­
plete in 14.3%, partial in 51.9% and 
absent in 33.8%.
Discussion
It has been pointed out11 that 
wear of the plastic component is 
unlikely to be noted before 3 to 4 
years of follow-up and revision is 
unlikely to be needed before 6 years 
from the time of placement. Be­
cause the mean follow-up in this 
study was 3.5 years, no reliable 
conclusions could be drawn regard­
ing wear other than to point out 
that it does exist in both the patel­
lar and tibial components.
Sinkage associated with nonce- 
mented components usually occurs
in the first 6 months after place­
ment of the prosthesis and is non­
progressive.11 Sinkage of the nonce- 
mented tibial component of such 
severity as to require revision is 
uncommon in the short term.1-5 
Sinkage occurred in five knees 
(2.8%) in this series, and one of 
them was probably infected. In no 
case was sinkage of sufficient sever­
ity as to require revision, even 
though 5% of cases had tibial bone 
grafting to some degree. These 
sinkage rates are superior to those 
obtained with the flat-plate version 
of this knee prosthesis, suggesting 
that the stem does indeed aid in 
initial stability.
There seem to be few disadvan­
tages to the use of a stiff meta­
physeal stem. Undoubtedly more 
bone is sacrificed, but this is mostly 
poor-quality subsurface bone. Use 
of a bevelled stem has resolved the
FIG. 3. If undersurface of tibial compo­
nent only is examined, no lucency will 
be seen because beam angle is couple 
of degrees off. This implant might, 
therefore, be regarded as stable. If 
stem is examined, however, radiolu- 
cent lines surrounding it are found to 
be divergent (i.e., Type III). This stem 
is toggling, indicating that implant is 
loose.
FIG. 2. Arrows on stem indicate radiolucent line, which does not extend completely 
around stem. Small arrow indicates radiolucency under base plate anteriorly.
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problem of crack fractures of the 
posterior cortex, which occurred 
with the original stem in five cases. 
No case of end-of-stem pain was 
encountered.
Although the task of seeking 
radiolucency under the tibial plate 
is difficult, radiolucency of the stem 
is easy to identify. In our series 
1.7% of knees could be classified as 
radiologically loose, although there 
was no clinical correlation and x-ray 
films of the base plate did not 
reflect this. Of more significance 
was that the plane of micromotion 
could be identified. In the an­
teroposterior x-ray film, 88.3% of 
knees showed no lucency, indicat­
ing that tibial fixation with beads, 
pegs and stem is sufficient to stop 
micromotion in that plane. Howev­
er, lucency was absent in only 
33.8% in the lateral x-rays, indicat­
ing that micromotion was still oc­
curring in the anteroposterior 
plane. The most likely reason for 
this is that the bone of the anterior 
tibial plateau is very soft.
It could be argued that symptom­
less micromotion is of little signifi­
cance. However, micromotion may 
prevent bone ingrowth into porous 
materials since the acceptable level 
of micromotion is very low, less 
than 100 nm.17 If bone ingrowth is
the goal, research into design 
changes should be done to further 
decrease micromotion at the im­
plant-bone interface.
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Noncemented, Porous Ingrowth Knee 
Prosthesis: the 3- to 8-Year Results
Hugh U. Cameron, MB, ChB, FRCSC;* Young B. Jung, MDf
Objective: To determine the principal long-term problems encountered in noncemented total knee 
replacement.
Design: A cohort of 252 consecutive cases of total knee replacement with no exclusions. Follow-up 
ranged from 3 to 8 years.
Setting: A university-affiliated institution specializing in orthopedic surgery.
Participants: All 252 patients had arthritis of the knee, mainly osteoarthritis. All agreed preoperatively 
to prolonged postoperative follow-up.
Intervention: Noncemented total knee replacement with the Tricon M prosthesis, which has a 
metal-backed patella.
Main Outcome Measures: The Hospital for Special Surgery rating system for clinical results and the 
radiologic results, including reasons for revision surgery.
Results: Thirty-five prostheses were revised: 11 prostheses because of patellar wear only; in 13 
prostheses the tibial component (mainly a 6-mm unit) and patella were revised because of wear; 6 
prostheses were revised for sepsis, 4 for reflex sympathetic dystrophy and 1 only for sinkage of the 
tibial component. Of the remaining 217 prostheses, 88% scored good or excellent, 6% fair and 6% poor. 
Conclusions: The single most common cause of failure was polyethylene wear. This was associated with 
the metal backing of the patella and the use of thin, polyethylene tibial components.
Objectif: Identifier les principaux problemes rencontres a long terme dans les arthroplasties totales 
non cimentees du genou.
Conception : Une cohorte de 252 cas consecutifs d’arthroplastie totale du genou, sans exclusions. Le 
suivi va de 3 a 8 ans.
Contexte : Un etablissement universitaire specialise en chirurgie orthopedique.
Participants : Les 252 patients souffraient tous d’arthrite du genou, principalement d’arthrose. Tous 
avaient accepte avant l’operation de participer a un suivi de longue duree.
Intervention : Arthroplastie totale non cimentee du genou avec la prothese Tricon M qui possede une 
rotule avec armature de metal.
Principaux effets mesures : L’evaluation des resultats cliniques a l’aide du systeme "Hospital for 
Special Surgery» et resultats radiologiques, incluant les raisons des revisions chirurgicales.
Resultats : Trente-cinq protheses durent etre revisees : 11 pour usure de la rotule seulement, 13 pour 
usure de la partie tibiale (principalement une partie de 6 mm) et de la rotule, 6 pour infection de 
prothese, 4 pour dystrophie sympathique reflexe et 1 seulement pour affaissement de la partie tibiale. 
Des 217 autres protheses, 88 % donnerent de bons ou excellents resutats, 6 % des resultats moyens et 
6 %, de mauvais resultats.
Conclusions : La cause la plus frequente d’echec a ete l’usure du polyethylene. Celle-ci est reliee a 
l’armature metallique de la rotule et a l’utilisation d’une partie tibiale de polyethylene mince.
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The noncemented ingrowth type of total knee replacement pros­
thesis was introduced about a de­
cade ago.1-2 The clinical results, 
although short-term, have been rea­
sonably good.3-6 However, there is 
concern about fixation of the tibial 
component7'8 and wear of the patel­
lar component.9-10 Sinkage of 
noncemented components may be 
an early phenomenon, wear is not. 
There are two main components to 
plastic wear: abrasive wear due to 
cement particles and bony impinge­
ment, which may occur at a rela­
tively early stage; and delamination, 
which is the main producer of wear 
debris particles and seldom occurs 
within the first few years.11
Knee replacement is done mainly 
in elderly patients. Thus, it is diffi­
cult to obtain sufficient numbers of 
long-term survivors for study. How­
ever, we believed that a sufficient 
number of 3- to 8-year survivors 
existed for a meaningful study. Re­
placements done by a single sur­
geon only were followed so that 
variations in technique and manage­
ment could be eliminated.
The objective of this study was to 
evaluate sinkage and wear in pa­
tients who received a Tricon M 
(Richards Manufacturing Co., Mem­
phis, Tenn.) noncemented total 
knee prosthesis. This is a porous 
coated ingrowth knee prosthesis. 
Initial fixation of the components is 
by ridged plastic pegs driven into 
undersized holes in the bone.5 
Long-term fixation comes from tis­
sue ingrowth into the implant.
Patients and Methods
Two hundred and fifty-two knees 
(85 in men and 167 in women) 
replaced with the Tricon M prosthe­
sis by one surgeon (H.U.C.) had a 
minimal follow-up of 3 years. The 
patients ranged in age from 36 to 
87 years (mean, 68.5 years). Most
knees were osteoarthritic: 8 (3%) 
had rheumatoid arthritis, 3 (1%) 
had post-traumatic arthritis and 1 
(0.4%) had avascular necrosis. Thir­
ty-nine knees (16%) had previously 
been operated on: tibial osteotomy 
in 29 (12%), unicompartmental 
knee replacement in 6 (2%), total 
knee replacement in 3 (1%) and a 
Maquet procedure (elevation of the 
tibial tubercle) in 1 (0.4%).
The tibial cut was made at right 
angles to the long axis of the tibia 
and the distal femoral cut in 7° of 
valgus with respect to the femur. 
Ligament balancing was carefully 
carried out, with release of the soft 
tissues on the concave side of the 
knee until equal tension was 
achieved. All patellae were resur­
faced with an ingrowth metal- 
backed component (Fig. 1). All pa­
tients were allowed to bear weight 
immediately.
Follow-up was at 3 months, 6 
months and annually, and the knees 
were rated clinically according to 
the Hospital for Special Surgery 
(HSS) rating system.12 They were 
examined radiographically from a 
1-m, standing, anteroposterior x-ray 
film, a lateral view and a skyline 
view. Serial x-ray films were com­
pared to assess sinkage and wear. 
After several trials, it was concluded 
that sinkage of less than 3 mm 
could not be measured reliably.
No attempt was made to look for 
radiolucency. Variation in the beam 
angle of 3° obscures lucency. Un­
less an image intensifier is used to 
ensure an edge-on shot, an impossi­
ble task in the review of a sizeable 
number of patients, radiolucency is 
always so underestimated that the 
findings are useless.
Findings
Revision was required for 35 
(14%) knees. Of the remaining 216 
knees, 75% scored excellent, 13%
good, 6% fair and 6% poor (i.e., 
88% good or excellent according to 
the HSS rating system).
The reasons for revision included 
pain and chronic effusion due to 
patellar wear in 11 knees and patel­
lar and tibial wear in 13 knees. This 
figure is somewhat inflated because 
it has recently become the practice 
of H.U.C. to change the tibial com­
ponent if there is the slightest sign 
of wear when the patella is being 
revised. Revision for tibial compo­
nent wear was carried out an aver­
age of 6.2 years after the initial 
replacement. One knee (0.4%) was 
revised for tibial sinkage. Six knees 
were revised for sepsis, two early, 
one intermediate and three late. The 
knees requiring late revision for 
sepsis showed significant wear of 
the tibial component and had a 
wear debris synovitis. Four knees 
were revised for reflex sympathetic 
dystrophy before knowledge that 
this condition existed. Three pa­
tients required additional surgery 
other than revision, two (0.8%) for 
patellar subluxation, which was 
treated by soft-tissue repair, and 
one for patellar tendon rupture, 
which was treated by wiring.
Of the 217 knees not revised, 14 
(6%) showed evidence of wear of the 
tibial component and 10 (5%) had 
patellofemoral squeak indicating pa­
tellar wear. Twenty (9%) showed 
nonprogressive sinkage of the tibial 
component (i.e., sinkage was noted 
within 2 years but did not change 
further) (Fig. 1). Three knees only, 
including the revised knee, showed 
sinkage of more than 5 mm.
Nine (4%) knees demonstrated 
reflex sympathetic dystrophy: revi­
sion was done in four of them, as 
already noted.
Prior tibial osteotomy is thought 
to influence the outcome of total 
knee replacement.13 Of 29 such 
knees, only 16 (55%) scored good 
or excellent and 13 (45%) scored 
fair or poor. Seven (24%) of these
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29 knees required revision and four 
(14%) had reflex sympathetic dys­
trophy.
Most knees were within 3° and 
9° of valgus. Even the 10% that fell 
outside this range did so only by a 
few degrees. Alignment did not cor­
relate with clinical scores or with 
wear.6
Discussion
films to measure sinkage is not 
ideal. The sinkage rate of 9% refers 
only to patients who showed sink- 
age of more than 3 mm. We could 
not reliably measure sinkage of less 
than this. In keeping with other 
published series,3-6 however, the re­
vision rate for sinkage of nonce- 
mented tibial components was low, 
being only 0.4% in our series. Other 
series of porous coated and even 
press fit prostheses have had similar 
results.14 Indeed, the only series 
evaluating noncemented prostheses
that showed significant revision for 
sinkage was Albrektsson and Herb­
erts’ series of press fit in all poly­
ethylene components.4
In our series, sinkage occurred 
within 6 to 12 months of operation 
and was nonprogressive.
The main problem leading to re­
vision was pain and swelling due to 
polyethylene wear. Wear of metal- 
backed patellae has been reported 
previously, and it is generally rec­
ommended that the use of metal- 
backed patellar components be dis­
continued.9’10 Due to the small con­
tact area of the patella, the service 
loads theoretically exceed the load 
capacity of the plastic so that wear 
is inevitable. For some reason yet to 
be explained, little has appeared in 
the literature on wear of non-metal- 
backed patellae, although this must 
occur. The theoretical advantage of 
metal backing has in practice 
turned out to be a disadvantage, 
perhaps by reducing polyethylene 
thickness.15
The prosthetic patella in this se­
ries was inset into the bone, in 
distinction to customary onset pa­
tellae (Fig. 2). The fact that the 
metal is below the surface of the 
patellar bone should have prevented 
metal-to-metal contact. Unfortu­
nately, the advantage of sinking the 
metal backing well below the level 
of the bony patella was not recog­
nized early in this series. Patellae 
that were deeply sunk have not as 
yet required revision. In another 
study, however, which had a 2-year 
longer follow-up, the durability of 
an identical inset, snap fit, purely 
plastic patella was compared with 
that of a metal-backed patella. Only 
one knee had to be revised for 
patellar wear.16 Because it can be 
difficult to sink the metal backing 
deeply into an eroded patella and 
because the results of the purely 
polyethylene component are just as 
good, use of the metal-backed patel­
la should be discontinued.
The use of standard clinical x-ray
FIG. 1. Tricon M (Richards Manufacturing Co., Memphis, Tenn.) tibial component 
in this bilateral total knee replacement (right) shows 3 mm of medial sinkage, 
which was noted 1 year after replacement and was unchanged thereafter. Knee 
continued to be perfectly functional. Newest version of this knee was inserted on 
left side. Stiff metaphyseal stem with flexible diaphyseal stem extension appears (in 
first 2 years) to have stopped any angular sinkage.
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Few other noncemented series 
have commented on significant tibi- 
al component wear. This is almost 
certainly a function of time since 
delamination is not seen until after 
several years of service.11-17 Revision 
for tibial component wear in our 
series was carried out an average of 
6.2 years after the index operation, 
and short-term studies therefore are 
unlikely to demonstrate significant 
wear.
Twenty-seven tibial components 
showed evidence of wear, and 13 
were revised. This figure is inflated 
because many of these tibial compo­
nents could have lasted several 
more years. Nevertheless, this inci­
dence of wear is a cause for con­
cern. The location of wear in these 
cases was posterior, and significant
FIG. 2. Tricon M patella was designed 
to be inset into bony patella. Sur­
rounding bone protects plastic from 
wear-through because there is some 
rim contact. Outlines of plastic pegs 
that give initial fixation to components 
can dimly be seen.
cold flow occurred. With one excep­
tion all the components were 6 mm 
in thickness. Given that the metal 
back was 3 mm thick, this means 
that the actual thickness of polyeth­
ylene at its thinnest was only 3 mm. 
This was clearly a design error. 
Bartel and colleagues18 and Racher- 
man and colleagues14 have demon­
strated that the minimum polyethyl­
ene thickness should be 6 mm. In 
other words, the minimum total 
component thickness should be 
9 mm when metal backing is used. 
This means that the thickness of 
the tibial cut would have to be 
increased, and the component 
would rest in poorer quality bone, 
which in turn may affect sinkage 
rates.
One interesting observation is
FIG. 3. This knee shows significant 
wear of plastic 5 years after initial 
placement. There is no tibial sinkage. 
Main reason for accelerated wear in 
this case was use of small tibial compo­
nent, which reduced area contact be­
tween femur and tibia. Four years into 
this study femoral component was re­
placed by component that was wider in 
coronal plane and gave increased sur­
face area. Patient remained mainly 
asymptomatic for 1 year after this film 
was obtained, then knee developed an 
acute late infection necessitating revi­
sion.
that an earlier tibial component 
with identical surface geometry had 
no cruciate gap and none of these 
components have required revision 
for wear. Similarly, wear has not 
been a major problem with the 
original total condylar prosthesis, 
which also did not have a cruciate 
gap. All the tibial components in 
this series had a large cruciate gap, 
suggesting that such a gap results 
in lack of support of the posterior 
part of the tibial component, possi­
bly accelerating cold flow. Of 
course, the original noncruciate gap 
implant was not metal backed and 
therefore had 6-mm thick polyethyl­
ene, so that the cruciate-gap factor 
cannot be seen in isolation.
Polyethylene wear on the tibial 
component does not seem to give 
rise to pain until the polyethylene is 
worn through to expose metal. 
Even then, pain may not be a 
striking feature.
When significant wear is first 
noted on routine x-ray films, the 
patient is usually asymptomatic. 
Two to 3 years later the knee 
becomes chronically swollen. Even 
this may not be particularly painful, 
and it is difficult to convince a 
patient who is largely asymptomatic 
to accept a revision. The danger of 
delay, however, is that acute late 
infection superimposed on a wear 
debris synovitis may develop, as in 
three knees in this series (Fig. 3).
Another problem is osteolysis. If 
this condition is ignored, the wear 
debris synovitis may develop into a 
granuloma at the metal-bone junc­
tion.19 This has been well described 
in hips.20 In our series the main 
area of erosion was the posterior 
femoral condyles. This erosion can 
be difficult to see on x-ray films 
because a plate of bone usually 
remains in place. Fortunately the 
grip of the bone to the distal end of 
the prosthesis so far has been suffi­
cient for implant stabilization and 
bone grafting. Bone grafting has
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not been required, and no loosening 
of the femoral component has been 
seen.
One interesting finding in our 
series was the very poor results 
following tibial osteotomy. For 
some time it has been the senior 
author’s practice to reosteotomize 
the tibia before total knee arthro­
plasty as an interval procedure 
when the extra-articular deformity 
is greater than 15°.21 In spite of the 
ability to gain correction and me­
chanical stability, however, the re­
sults are much worse than those 
reported by Amendola and associ­
ates,13 who found reduction in 
range of motion to be the main 
problem. A large percentage (14%) 
of knees subjected to high tibial 
osteotomy did develop reflex sym­
pathetic dystrophy, which suggests 
that perhaps the reflex sympathetic 
dystrophy was unrecognized and 
predated the total knee replace­
ment.
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0VASOTEC
(enalaprilat)
1.25 mg/mL
Angiotensin Converting Enzyme Inhibitor 
INDICATIONS AND CLINICAL USE
VASOTEC® is indicated in the treatment of essential or renovascular 
hypertension; usually administered in association with other drugs, 
particularly thiazide diuretics. Consider the risk of angioedema (see 
WARNINGS). Normally used when a diuretic or beta-blocker was ineffective 
or associated with unacceptable adverse effects. Can also be tried as initial 
agent where a diuretic and/or beta-blocker is contraindicated or could 
cause serious adverse effects.
Oral enalapril is also indicated in the treatment of congestive heart failure, 
as adjunctive therapy in patients not responding adequately to digitalis and 
diuretics.
Use of ACE inhibitors during the second and third trimesters of 
pregnancy can cause injury or death of a developing fetus. 
When pregnancy is detected, discontinue VASOTEC® as soon as 
possible (see WARNINGS; Use in Pregnancy).
VASOTEC® I.V. (enalaprilat) is an active metabolite of enalapril; the onset 
of action after administration occurs within 15 minutes, with the maximum 
effect within 1 to 4 hours.
VASOTEC® I.V. is indicated for the treatment of hypertension when oral 
therapy is not practical. VASOTEC® I.V. has been studied with only one 
other antihypertensive agent, furosemide, which showed additive effects on 
blood pressure. Due to insufficient experience in the treatment of acceler­
ated or malignant hypertension, VASOTEC® I.V. is not recommended in 
such situations (see DOSAGE and ADMINISTRATION),
CONTRAINDICATIONS
Hypersensitivity to any component; history of angioneurotic edema related 
to ACE inhibitor therapy.
WARNINGS
Angioedema, with laryngeal edema and/or shock, have been reported 
and may be fatal. In such cases, discontinue drug promptly and observe 
patient until swelling subsides. Swelling confined to the face, lips, and 
mouth usually resolves without treatment, although antihistamines may be 
useful in relieving symptoms. However, where there is involvement of the 
tongue, glottis and larynx, likely to cause airway obstruction, prompt 
administration of subcutaneous adrenaline (0.5 mL 1:1000) may be 
indicated. Patients with a history of angioedema, unrelated to ACE inhibitor 
use, may be at increased risk (see CONTRAINDICATIONS).
Symptomatic hypotension has occurred, usually during initial therapy 
or when the dose was increased, and is more likely in patients who are 
volume-depleted. In patients with severe congestive heart failure, excessive 
hypotension may be associated with oliguria and/or progressive azotemia. 
For patients in whom the excessive hypotension could result in severe or 
fatal complications, i.e. those with severe congestive heart failure, ischemic 
heart or cerebrovascular disease -  start therapy under close medical 
supervision, usually in a hospital. Such patients should be followed closely 
for the potential fall in blood pressure during first two weeks of therapy or 
when enalapril or a diuretic is increased. If hypotension occurs, place 
patient in supine position and if needed, administer IV infusion of normal 
saline. A transient hypotensive response is not a contraindication to further 
doses of enalapril or enalaprilat.
Neutropenia/agranulocytosis and bone marrow depression have been 
caused by ACE inhib itors. Current experience w ith enalapril shows 
incidence to be rare. Consider periodic monitoring of white blood cell 
counts in patients with collagen vascular disease and renal disease.
Use of ACE inhibitors in pregnancy can cause fetal and neonatal 
m orbidity and mortality. When pregnancy is detected, discontinue 
VASOTEC® as soon as possible. Rarely, no alternatives to an ACE inhibitor 
will be found and mothers should be apprised to the potential hazards to 
the fetus. Ultrasound should be performed to assess fetal development, 
well-being and volume of amniotic fluid. If oligohydramnios is observed, 
discontinue VASOTEC® unless lifesaving for the mother. A non-stress test 
and/or a biophysical profiling may be appropriate however, if concerns 
persist, a contraction stress testing should be considered. O ligo­
hydramnios may only appear after fetus has sustained irreversible injury. 
Closely observe infants exposed in uteroio  ACE inhibitors for hypotension, 
oliguria and hyperkalemia, and initiate appropriate corrective medical 
procedures.
Human Data: Exposure to ACE inhib itors during second and third 
trim esters has been associated w ith  hypotension , neonatal skull 
hypoplasia, anuria, reversible or irreversible renal failure and death of the 
fetus. O ligohydram nios, associated w ith  fetal lim b contractures, 
craniofacial deformation, and hypoplastic lung development also has been 
reported. Prematurity and patent ductus arteriosus also reported but 
unknown if due to ACE inhibitor use. It is not known whether exposure 
limited to the first trimester can adversely affect fetal outcome. 
PRECAUTIONS
Impaired renal function: Renal function should be assessed before 
in itia ting therapy w ith enalapril or enalaprilat. Patients w ith  renal 
insufficiency may require reduced or less frequent doses, and their renal 
function must be monitored appropriately (see DOSAGE). Renal failure, 
which has been reported mainly in patients with severe congestive heart 
failure or underlying renal disease including renal artery stenosis is 
usually reversible when treated promptly.
Some hypertensive patients with no apparent renal disease have developed 
increases in BUN and creatinine while on concurrent diuretic/ enalapril 
therapy. Dosage reduction or discontinuation of one or both drugs may be 
required.
VASOTEC
^Trademark Merck & Co„ Inc./Merck Frosst Canada Inc., R.U.
m
Hyperkalemia: In clinical trials, hyperkalemia (>5.7 mmol/L) was 
observed in approximately 1% of hypertensive patients, and caused 
discontinuation of therapy in 0.28% of such patients. Risk factors for 
hyperkalemia development may include renal insufficiency, diabetes 
m ellitus, and concomitant use of agents to treat hypokalemia (see 
ADVERSE REACTIONS).
Valvular Stenosis: Theoretically, patients with aortic stenosis, who do 
not develop as much afterload reduction, might be at risk of decreased 
coronary perfusion when treated with vasodilators. 
Surgery/Anaesthesia: During major surgery or anaesthesia with 
hypotensive agents, enalapril blocks angiotensin II formation secondary to 
compensatory renin release. Hypotension that develops due to this 
mechanism can be corrected by volume expansion.
Impaired liver function: Hepatitis, jaundice (hepatocellular and/or 
cholestatic),elevation of liver enzymes and/or serum bilirubin, which have 
occurred in patients with or without pre-existing liver abnormalities, were 
usually reversed on discontinuation of enalapril or enalaprilat. For any 
unexplained symptoms, particularly within the first months of treatment, a 
full set of liver function tests and other necessary investigations are recom­
mended. Consider discontinuation of enalapril or enalaprilat when 
appropriate. Use enalapril or enalaprilat with particular caution in patients 
with pre-existing liver abnormalities. Obtain baseline liver function tests 
before initiating drug and monitor response and metabolic effects closely. 
Cough: A dry, persistent cough has been reported, which usually 
disappears after withdrawal or lowering the dose of enalapril or enalaprilat.
Nursing mothers: Enalapril and enalaprilat are secreted in human milk in 
trace amounts therefore, nursing should be interrupted.
Pediatric use: This use is not recommended because enalapril and 
enalaprilat have not been studied in children.
Hemodialysis patients: Anaphylactoid reactions have been reported 
with high-flux membranes (eg. polyacrylonitrile [PAN]) and treated 
concomitantly with an ACE inh ib ito r. If symptoms such as nausea, 
abdominal cramps, burning, angioedema, shortness of breath and severe 
hypotension occur, stop dialysis immediately. The symptoms are not 
relieved by antihistamines and the use of a different type of dialysis 
membrane or class of antihypertensive agent should be considered.
Drug Interactions
Hypotension - Patients on Diuretic Therapy: Particularly when 
diuretics recently initiated, patients occasionally experience hypotension 
after initiating therapy with enalapril or enalaprilat. To minimize the 
hypotensive effects, discontinue the diuretic or increase the salt intake prior 
to starting the drug. If the diuretic cannot be discontinued, patients should 
be placed under close medical supervision for at least one hour after the 
initial dose of enalaprilat (see WARNINGS).
Agents Increasing Serum Potassium: Since enalapril and enalaprilat 
decrease aldosterone production, elevation of serum potassium may occur. 
Diuretics such as spironolactone, triamterene or amiloride, or potassium 
supplements should be given cautiously for documented hypokalemia only 
and should be monitored frequently. Potassium containing salt substitutes 
should be used with caution.
Agents Causing Renin Release: Diuretics, for example, augment the 
antihypertensive effect of enalapril and enalaprilat.
Agents Affecting Sympathetic Activity: Ganglionic blocking agents 
or adrenergic neuron blocking agents, for example, may be used with 
caution. Beta-adrenergic blockers add some further anti hypertensive effect 
to enalapril.
Lithium Salts: Lithium clearance may be reduced; therefore, monitor 
serum lithium levels carefully if they are administered.
ADVERSE REACTIONS
VASOTEC®: In controlled clinical trials involving 2314 hypertensive 
patients and 363 heart failure patients, the most severe adverse reactions 
were: angioedema (0.2%), hypotension (2.3%) and renal failure (5 cases). 
In hypertensive patients, hypotension occurred in 0.9% and syncope in
0.5%, with a discontinuation rate of 0.1% . In heart fa ilure patients, 
hypotension occurred in 4.4% and syncope in 0.8% , w ith a discon­
tinuation rate of 2.5%. The most frequent clinical adverse reactions in 
controlled clinical trials were: headache (4.8%), dizziness (4.6%) and 
fatigue (2.8%). Discontinuation of therapy was required in 6.0% of the 
2677 patients.
Hypertension Heart Failure
% %
(2314 Patients) (3 6 3  Patients)
CARDIOVASCULAR
Hypotension 0.9 4.4
Chest Pain 0.9 1.7
Palpitations 0.6 0.3
Myocardial Infarction, Acute 0.2 0.6
Myocardial Infarction, Recurrent — 0.3
GASTROINTESTINAL
Nausea 1.4 1.1
Vomiting 0.8 1.7
Dysphagia 0.1 —
Diarrhea 1.4 3.0
Abdominal pain 0.7 1.4
RENAL
Renal failure 0.1 0.6
Oliguria 1 case —
Proteinuriat 0.1 —
DERMATOLOGIC
Rash 1.4 1.9
Pruritus 0.4 1.4
NERVOUS SYSTEM
Headache 5.2 2.2
Dizziness 4.3 6.6
Insomnia 0.5 0.3
Nervousness 0.6 —
Somnolence 0.6 —
Paresthesia 0.6 —
ALLERGIC
Cough 1.3 1.4
Angioedema 0.2 —
HEMATOLOGIC
Anemia 0.1 —
Leukopenia 1 case —
MISCELLANEOUS
Muscle cramps 0.6 0.3
Dyspnea 0.6 1.1
MISCELLANEOUS (cont'd)
Hyperhidrosis 0.7 —
Impotence 0.4 0.3
Fatigue 3.0 1.4
Taste disturbance 0.4 0.3
t  Defined as >1 g/24h or >0.5 g/12h on two consecutive measurements,
at least one month apart.
ABNORMAL LABORATORY FINDINGS
Hyperkalemia: (see PRECAUTIONS).
Creatinine, Blood Urea Nitrogen: Increases were reported in about 
20% of patients with renovascular hypertension and about 0.2% of patients 
with essential hypertension on enalapril alone. Increases, which usually 
were reversible upon discontinuation of enalapril or concomitant therapy, 
were reported in 9.7% of heart failure patients who were receiving diuretics 
and/or digitalis.
Hemoglobin and Hematocrit: Decreases (mean approximately 0.34 
g% and 1.0 vol%, respectively) occurred frequently, but were rarely of 
c lin ica l importance. In c lin ic a l tr ia ls , less than 0.1%  of patients 
discontinued therapy due to anemia.
Hepatic: Elevations of liver enzymes and/or serum bilirubin have occurred 
(see PRECAUTIONS).
ADVERSE REACTIONS REPORTED IN UNCONTROLLED TRIALS 
AND/OR MARKETING EXPERIENCE 
With an incidence of 0 .5  to 1%: Insomnia, impotence, renal 
dysfunction, renal failure and oliguria.
With an incidence < 0.5%:
Cardiovascular: Myocardial infarction or cerebrovascular accident, 
possibly secondary to excessive hypotension in high risk patients (see 
WARNINGS); cardiac arrest; pulmonary embolism; rhythm disturbances; 
angina pectoris Gastrointestinal: Anorexia; ileus; pancreatitis; 
dyspepsia; constipation. Hemopoeitic: Neutropenia; thrombocytopenia; 
bone marrow depression. Hepatic: Liver function abnormalities; hepatitis; 
jaundice (hepatocellu la r and/or cho lestatic). Nervous System/ 
Psychiatric: Vertigo; depression; confusion; ataxia. Respiratory: 
Bronchospasm/asthma; rhinorrhea. Other: Erythema m ultiform e; 
exfoliative dermatitis; Stevens-Johnson syndrome; toxic epidermal 
necrosis; urticaria; photosensitivity; alopecia; flushing; tinnitus; hearing 
impairment; glossitis; blurred vision. A symptom complex has been 
reported which may include fever, se ros itis , vasculitis , myalgia, 
arthralgia/arthritis, a positive ANA, elevated erythrocyte sedimentation rate, 
eos in o p h ilia  and leuko cy tos is . Rash, ph o to se n s itiv ity  or other 
dermatologic manifestations may occur. These symptoms have disap­
peared after discontinuation of therapy.
LABORATORY TEST FINDINGS: Hyponatremia 
VASOTEC® I.V .: Since enalapril is converted to enalaprilat, those 
adverse reactions associated with VASOTEC® tablets m ight also be 
expected to occur with VASOTEC® I.V. The incidence of symptomatic 
hypotension is 3.4% with VASOTEC® I.V. Other adverse experiences 
occurring in greater than 1 % of patients were headache (2.9%) and nausea 
(1.1%). Adverse reactions occurring in 0.5 to 1.0% of patients in controlled 
clinical trials include myocardial infarct, fatigue, dizziness, fever, rash and 
constipation.
SYMPTOMS AND TREATMENT OF OVERDOSAGE
Limited human data are available. The m ost likely manifestation of 
overdosage would be hypotension, which can be treated by I.V. infusion of 
normal saline solution. Enalaprilat may be removed from the general 
circulation by hemodialysis.
DOSAGE AND ADMINISTRATION 
VASOTEC® FOR ORAL ADMINISTRATION ONLY
Dosage must be individualized. The absorption of enalapril maleate is not 
affected by food.
HYPERTENSION
Initiation of enalapril requires consideration of extent of blood pressure 
elevation, salt restriction and recently used antihypertensive agents, the 
dosage of which may need to be adjusted.
The recommended initial dose of enalapril maleate in patients not on 
diuretics is 5 mg once a day. Adjust dosage according to blood pressure 
response; the usual range is 10 to 40 mg daily, in a single dose or divided 
in two doses. Some patients on once-daily dosage may have diminished 
anti hypertensive effect toward the end of dosing interval and require an 
increase in dosage, or twice daily administration. If blood pressure is not 
controlled, a diuretic may be added. Raising the daily dose above 40 mg is 
not recommended because adverse reactions may be increased. 
Occasionally symptomatic hypotension may occur following the initia l 
dose, more likely in patients currently taking a diuretic. Therefore, if 
possible, discontinue the diuretic two to three days before initiating 
enalapril therapy (see WARNINGS). If the diuretic cannot be discontinued, 
use an initial dose of 2.5 mg.
In the absence of sufficient experience in the treatment of accelerated or 
malignant hypertension, enalapril is not recommended in such situations. 
Dosage in the Elderly (over 65 years): Start at 2.5 mg daily. Some 
elderly patients may be more responsive than younger patients.
Dosage Adjustment in Renal Impairment: (see PRECAUTIONS -  
Hemodialysis patients)
Guidelines for reducing doses in hypertensive patients:
Renal Status
Creatinine
Clearance
mL/min(mL/s)
Initial Dose 
mg/day
Normal renal 
function
>80 mL/min 
(>1.33 mL/s)
5 mg
Mild impairment < 8 0  >30 mL/min 
(<1.33 >0.50 mL/s)
5 mg
Moderate to 
severe impairment
£ 30  mL/min 
(£0.50 mL/s)
2.5 mg
Dialysis patients 2.5 mg on 
dialysis days*
* Enalaprilat is dialysable. Dosage on nondialysis days should be adjusted 
depending on the blood pressure response.
CONGESTIVE HEART FAILURE
Use in conjunction with a diuretic and digitalis. Initiate therapy under close 
medical supervision, usually in a hospital. Monitor blood pressure and 
renal function before and during treatment with enalapril, because severe 
hypotension, and more rarely, consequent renal failure have been reported 
(see WARNINGS and PRECAUTIONS).
When in itia tin g  enalapril cons ider the recent d iu re tic  therapy and 
possibility of severe salt/ volume depletion. Before beginning enalapril 
reduce diuretic therapy if possible.
The recom m ended in it ia l d a ily  dose is 2.5 mg. W hile  m anaging 
sym ptom atic hypotension, increase dose gradually, depending on 
individual response, to the usual maintenance dose of 10-20 mg daily, 
given in a single dose or divided in two doses. This dose titration may be 
performed over a two- to four-week period, or more rapidly if indicated by 
residual signs and symptoms of heart failure. The maximum daily dose is 
40 mg.
VASOTEC® I.V. FOR INTRAVENOUS ADMINISTRATION ONLY
VASOTEC® I.V. vials should be inspected visually and should not be used 
if particulate matter or discoloration is observed.
VASOTEC® I.V. may be administered intravenously as supplied, or mixed 
with up to 50 mL of one of the following diluents:
5% Dextrose Injection 
0.9% Sodium Chloride Injection 
0.9% Sodium Chloride Injection in 5% Dextrose 
5% Dextrose in Lactated Ringer's Injection 
Diluted solutions should be used within 24 hours.
The dose is 1.25 mg every 6 hours administered intravenously over at least 
5 minutes. A clinical response is usually seen within 15 minutes. Peak 
effects after the first dose may not occur for up to four hours after dosing. 
The peak effects of the second and subsequent doses may exceed those of 
the first.
No dosage regimen for VASOTEC® I.V. has been clearly demonstrated to 
be more effective in treating hypertension than 1.25 mg every 6 hours. 
However, in controlled clinical studies in hypertension, doses as high as 5 
mg every 6 hours were well tolerated for up to 36 hours. There has been 
inadequate experience with doses greater than 20 mg per day.
In studies of patients with hypertension, VASOTEC® I.V. has not been 
administered for periods longer than 48 hours. In other studies, patients 
have received VASOTEC® I.V. for as long as 7 days.
The dose for patients being converted to VASOTEC® I.V. from oral therapy 
for hypertension w ith  enalapril maleate is 1.25 mg every 6 hours 
administered intravenously over at least 5 minutes. For conversion from 
intravenous to oral therapy, the recommended initia l dose of VASOTEC® 
tablets is 5 mg once a day w ith subsequent dosage adjustm ents as 
necessary.
Patients on Diuretic Therapy
For patients on diuretic therapy, the recommended starting dose for 
hypertension is 0.625 mg adm inistered intravenously over at least
5 minutes. A clinical response is usually seen within 15 minutes. Peak 
effects after the first dose may not occur for up to 4 hours after dosing, 
although most of the effect is usually apparent within the first hour. If after 
1 hour there is an inadequate clinical response, the 0.625 mg dose may 
be repeated. Additional doses of 1.25 mg may be administered at 6 hour 
intervals.
For conversion from intravenous to oral therapy, the recommended initia l 
dose of VASOTEC® tablets for patients who have responded to 0.625 mg of 
enalaprilat every 6 hours is 2.5 mg once a day with subsequent dosage 
adjustment as necessary.
Dosage Adjustment in Renal Impairment 
The usual dose of 1.25 mg of enalaprilat every 6 hours is recommended for 
patients with a creatinine clearance >30 mL/min [> 0.50 mL/s] (serum 
creatinine up to approximately 3 mg/dL [265.2 |m o l/L ]). For patients with 
creatin ine clearance <30 m L/m m  [< 0 .5 0  m L/s ] (serum  creatin ine 
>3 mg/dL [>  265.2 pmol/L]), the initial dose is 0.625 mg (see WARNINGS). 
If after 1 hour, there is an adequate clinical response, the 0.625 mg dose 
may be repeated. Additional doses of 1.25 mg may be administered at
6 hour intervals.
For dialysis patients, the initial dose should be 0.625 mg every 6 hours, 
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ASSESSMENT OF UPPER EXTREMITY FUNCTIONAL ABILITY 
IN RELATION TO RESTRICTION OF THE RANGE OF JOINT 
MOTION. Kevin M. Rumball and Alan A. Giachino. Department of 
Surgery, Ottawa General Hospital, Ottawa, Ont.
The purpose of this study was to assess the disability that occurred 
from restriction of upper extremity joint motion and to show which 
joints when freed of restrictions would (a) improve performance on 
objective tests and (b) most restore independence in the activities of 
daily living. For 5 days, 15 healthy subjects wore right-upper-limb 
splints with comparable restrictions of shoulder, elbow, wrist and 
metacarpophalangeal joint motion. Objective and subjective scores were 
recorded with all joints restricted and after alternately freeing of one of 
the four joints. Performance and independence were most improved 
with the metacarpophalangeal joints free.
JACCOUD’S ARTHROPATHY. Lisa M. Ronback and Carolyn L. 
Kerrigan. Division of Plastic Surgery, Royal Victoria Hospital, 
Montreal, Que.
Jaccoud’s arthropathy is a non-erosive, deforming arthropathy seen in 
systemic lupus erythematosus, rheumatic fever and vasculitis. Typical 
deformities include ulnar drift, swan neck, limited metacarpophalangeal 
joint extension, boutonniere and “Z” deformities. Changes appear to 
arise from periarticular inflammation. The literature concerning surgical 
treatment of this arthropathy is extremely limited, but suggested 
options include metacarpal shortening and Silastic arthroplasties. In 
this paper the authors review the literature on Jaccoud’s arthropathy 
and discuss three clinical cases. The charts of patients in the authors’ 
systemic lupus erythematosus registry are reviewed to establish the 
prevalence of Jaccoud’s arthropathy in that population.
CARPOMETACARPAL ARTHROSIS: A QUESTION OF LENGTH? 
Stephen Southerland, Geoffrey H.F. Johnston. Department of Ortho­
pedic Surgery, Royal University Hospital, Saskatoon, Sask.
Osteoarthritis commonly affects the thumb carpometacarpal (CMC) 
joint, although the reason for this is unclear. Biomechanically, longer 
lever arms create greater forces across adjacent joints. The relationship 
between first metacarpal length and thumb CMC arthrosis has not been 
studied. The authors tested the hypothesis that a long first metacarpal 
predisposes its CMC to degenerative change. Measurements of thumb 
metacarpal and phalangeal length from 500 randomly selected radio­
graphs were compared to similar measurements from 50 radiographs in 
patients with thumb CMC osteoarthritis. Results revealed remarkable 
consistency in thumb, index and long finger-length relationships. 
Skeletal length ratios in hands with thumb CMC arthritis were no 
different from those of the controls.
DESIGN RATIONALE FOR A NEW ANATOMIC METACARPO­
PHALANGEAL JOINT PROSTHESIS. Pierre Beaumont, Sylvain 
Gagnon, Jean-M. Page, Yves A. Ratron. Department of Orthopedic 
Surgery, Hopital du Sacre Coeur, Montreal, Que.
The authors described a design for a prototype metacarpophalangeal 
(MCP) joint prosthesis that would restore joint kinematics and balanced 
hand function. Using data from previous studies at the Mayo Clinic on 
MCP joint kinematics, the authors designed a metal-polyethylene, 
uncemented, low constraint, resurfacing prosthesis, which required 
preservation or reconstruction of the capsuloligamentous mechanism. 
Anatomic factors, such as volar displacement of the instant centres of 
rotation in flexion, contact surface profiles and freedom of movement, 
as well as intra-articular forces involved in normal and pathologic 
function, were taken into account. The new implant concept reproduced 
the anatomy of the MCP joint, with the theoretical advantages of lower 
constraint, increased durability, less loosening and better biocompatibili­
ty than silicone.
ASSESSMENT OF PROXIMAL POLE VASCULARITY IN SCAPH­
OID NONUNION: A PRELIMINARY REPORT USING LASER 
DOPPLER FLUOMETRY. Douglas C. Ross, Stuart D. Patterson, 
James H. Roth, Susan E. Vokey. Department of Surgery, University of 
Western Ontario, London, Ont.
Proximal pole vascularity of the ununited scaphoid has been assessed by 
radiography, measurement of intraoperative bleeding and magnetic 
resonance imaging (MRI). Intraoperative laser Doppler fluometry was 
used in five patients with established nonunion. Flow to proximal and 
distal poles was measured with the tourniquet inflated and after 
deflation. The average value per 100 g of tissue for proximal pole flow 
was 0.93 mL/min with the tourniquet inflated and 3.80 mL/min after 
deflation. The ratio of distal pole to proximal pole flow was 1.72. One 
patient with avascularity on MRI exhibited flow by laser Doppler, and 
union was subsequently achieved. The authors conclude that laser 
Doppler fluometry may be a sensitive indicator of proximal pole 
perfusion.
EARLY RESULTS OF MODIFIED SCAPHOLUNATE ADVANCED 
COLLAPSE WRIST RECONSTRUCTION. Gary R. McGillivary. 
Department of Surgery, Dalhousie University, Halifax, NS
Twenty-six consecutive patients with scapholunate advanced collapse 
(SLAC) underwent a modified reconstruction consisting of scaphoid 
excision and four-corner fusion with correction of carpal collapse. All 
patients were then independently evaluated for grip strength, pain and 
range of motion. In 19 patients the follow-up was long enough (range
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from 8 to 38 months, mean 20 months) to permit evaluation. 
Postoperative grip strength was 74% of normal. On average, preopera­
tive range of motion was maintained. All but two patients (89%) were 
pain free. This modified reconstruction for SLAC is an excellent 
alternative to wrist arthrodesis.
RESULTS OF WRIST ARTHODESIS WITH PLATE FIXATION 
AND ILIAC CREST BONE GRAFT. Robin R. Richards, Dorcas E. 
Beaton, Thomas A. Barnhill. Division of Orthopedic Surgery, St. 
Michael’s Hospital, Toronto, Ont.
In a prospective study the authors examined the fusion rate and 
incidence of complications when a plate and bone grafting were used to 
perform wrist arthrodesis in 60 patients: 50 with osteoarthritis, 8 with 
neurologic disorders and 2 with rheumatoid arthritis. The mean age of 
the patients was 32 years and the mean follow-up was 23 months. Each 
wrist was fused in the desired position without subsequent procedures. 
There were no iliac crest complications and no infections. One patient 
had reflex sympathetic dystrophy. Two sustained distal radial fractures 
at the plate-bone junction. Fifteen had plate removal for distal plate 
tenderness. Fourteen had slight flexion contracture of the third 
metacarpophalangeal joint. In conclusion, this technique is reliable, 
assures fusion in the desired position and has a low complication rate.
HISTOLOGIC AND MECHANICAL CHARACTERIZATION OF 
RHEUMATOID WRIST EXTENSORS. Martine J. Breault, David R. 
Pichora, Sandip S. Gupta, Carolyn Small, Tim Bryant. Department of 
Surgery, Queen’s University, Kingston, Ont.
Implants were once used to treat wrist rheumatoid arthritis, but because 
implants migrate and dislocate arthrodesis is now preferred. Wrist 
implant failure may be due to soft-tissue imbalance related to changes in 
the tissue histologic and mechanical properties. A standardized protocol 
was developed for testing wrist extensors harvested from patients who 
underwent wrist arthrodesis. Specimens were examined under light and 
scanning electron microscopy and were tested in a senohydraulic 
Instron Universal Machine (Instron Canada Ltd., Burlington, Ont.). 
Histologic and viscoelastic properties were significantly different be­
tween normal and rheumatoid tissue for the 23 specimens tested. This 
finding has clinical significance for soft-tissue reconstruction during 
wrist surgery and stresses the importance of developing improved 
methods of fixation.
FLEXOR CARPI RADIALIS TO EXTENSOR DIGITORUM COMMU­
NIS TENDON TRANSFER TO RESTORE METACARPOPHALAN­
GEAL JOINT EXTENSION. Robin R. Richards, Dorcas E. Beaton, 
Alan R. Hudson. Division of Orthopedic Surgery, St. Michael’s 
Hospital, Toronto, Ont.
The results of ulnar transfer of flexor carpi radialis to extensor 
digitorum communis were reviewed with a minimum follow-up of 12 
months (mean 20.6 months). Twenty-five patients (mean age 39 years) 
who had no active extension of the metacarpophalangeal joint (MCPJ) 
due to neural injury (8 brachial plexus, 7 radial nerve and 10 posterior 
interosseous nerve) underwent transfer. All recovered active MCPJ 
extension, and patient satisfaction was universal. With the wrist in the 
neutral position, 21 had no extensor lag. Mean grip strength was 
18.8 kg. Functional testing revealed deficits when compared with the 
noninjured side (Jebsen 50.6%: Minnesota Rate of Manipulation Test 
34.7%). No patient had wrist radial or ulnar deviation. The FCR can be 
considered as an alternative method for restoration of MCPJ extension.
RESTORATION OF METACARPOPHALANGEAL EXTENSION IN 
THE RHEUMATOID THUMB. Claude Manueddu, David E. Hastings, 
Earl R. Bogoch. Division of Orthopedic Surgery, Wellesley Hospital, 
Toronto, Ont.
The authors studied rerouting of the extensor pollicis longus muscle by 
the Hastings method to restore active extension to the thumb in 10 
patients with rheumatoid arthritis who had extensor lag and an intact 
metacarpophalangeal joint. Other methods have previously been report­
ed to be unsuccessful. Of the 10 patients, 6 had full active extension of 
the thumb, 2 retained an extensor lag of 23° and 30° but were 
improved from their preoperative state of —30° and —40° and 2 had a 
fixed flexion deformity of 30° and 20° respectively. Preoperative fixed 
flexion deformity is a contraindication to this procedure, and loss of 
cartilage dorsally in the joint lessens the chances of success.
A BIOMECHANICAL ANALYSIS OF PERCUTANEOUS PINNING 
FOR UNSTABLE EXTRA-ARTICULAR FRACTURES OF THE DIS­
TAL RADIUS. James Collicut, Gary R. McGillivary, Michael Gross. 
Department of Surgery, Dalhousie University, Halifax, NS
Percutaneous pinning is advocated for the treatment of unstable distal 
radial fractures. Few guidelines exist for the optimal placement of pins. 
In this study eight pinning configurations were assessed in vitro in 40 
embalmed cadaver radii. Rigidity of intact specimens under axial and 
bending loads in the coronal and sagittal planes was determined. A 
transverse metaphyseal osteotomy was performed, and rigidity was 
reassessed after reconstruction with 0.062-in Kirschner wires. Signifi­
cant reductions were measured in the axial and bending rigidities of the 
reconstructed specimens. No significant differences were observed 
between the rigidity of the four, three and two crossed-pin configura­
tions. Single-pin configurations were grossly unstable.
ABSORBABLE IMPLANTS FOR INTRA-ARTICULAR HAND FRAC­
TURES. Mahmud Kara, Douglas C. Ross, James H. Roth, Robert S. 
Richards. Department of Surgery, University of Western Ontario, 
London, Ont.
The use of absorbable poly-p-dioxanone pins has been recently de­
scribed for both large- and small-bone fractures. The ‘’uinors evaluated 
this technique prospectively in six patients with intra-articular fractures 
of the hand with significant displacement (three proximal interphalan- 
geal joint [PIPJ]; three metacarpophalangeal joint [MCPJ]). The average 
follow-up was 20 weeks. The mean range of movement for the PIPJ 
injuries was good to excellent but was less satisfactory for MCPJ 
injuries. There were no mechanical failures of the implants, and there 
was no evidence of allergic or inflammatory reaction. The authors 
conclude that poly-p-dioxanone pins in the treatment of intra-articular 
fractures can provide stable fixation and are a useful adjunct in the 
treatment of these fractures.
DYNAMIC TRACTION SPLINTING FOR PROXIMAL INTER- 
PHALANGEAL JOINT INJURIES. Kenneth A. Murray. Department 
of Surgery, St. Boniface General Hospital, Winnipeg, Man.
The proximal interphalangeal (PIP) joint is important in the overall 
function of the digit. Injury to this joint can severely affect hand 
function. Early active motion, as with other joint injuries, is important 
in ensuring a good range of motion and functional outcome. The author 
reviews experience of dynamic traction splinting at the PIP joint with a 
variety of injuries. The benefits of this traction system are that it allows 
early, active motion, traction that can aid in reduction of fragments and 
provide a marked decrease in pain. This encourages patient compliance, 
gives early range of motion and an enhanced result.
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THE MANAGEMENT OF METACARPOPHALANGEAL AND PROXI­
MAL INTERPHALANGEAL JOINT ARTICULAR FRACTURES 
USING DYNAMIC SKELETAL TRACTION AND IMMEDIATE MO­
BILIZATION. Stuart D. Patterson, Shrikant Chinchalkar, Douglas C. 
Ross, Carol Weekes, James H. Roth. Department of Surgery, Univer­
sity of Western Ontario, London, Ont.
Twelve patients with joint articular fractures (10 proximal interphalan- 
geal, 1 thumb metacarpophalangeal, 1 fifth digit metacarpophalangeal) 
ranging in age from 8 to 65 years, were treated with dynamic skeletal 
traction and immediate mobilization. All fractures were analysed under 
image intensification, and the distraction force required for reduction 
was determined. A mean force of 329.17 g (range from 200 to 450 g) 
was applied. Active range of movement and tendon gliding were 
undertaken for 6 weeks, resisted motion at 8 to 10 weeks and 
unrestricted use at 12 to 14 weeks. At a minimum follow-up of 6 
months, pain-free motion was present in 11 patients. Mean range of 
movement for the proximal interphalangeal joints was 95.5°, for 
the thumb metacarpophalangeal joint 80° and for the fifth digit 
metacarpophalangeal joint 40°. Complications included two pin- 
tract infections, one mild scissoring and one volar plate contrac­
ture.
EVALUATION OF A NEW ANCHORING DEVICE IN THE DISTAL 
PHALANX. Robert J. Feibel. Department of Surgery, Ottawa General 
Hospital, Ottawa, Ont.
Stainless steel wire (26 gauge) was secured to fresh frozen human 
cadaver distal phalanges by (a) a dorsal tie-over button, (b) a 2-mm 
self-tapping Luhr screw or (c) the Mitek Mini-GII (Mitek Industries, 
Norwood, Mass.) suture anchoring device. The fixation systems were 
stressed to failure along the phalangeal axis. All button tie-over wires 
failed through the wire (mean force of 157.9 N). Screws and Mini-GII 
anchors failed by pullout from bone (mean loads of 83.5 N and 82.3 N 
respectively). There was no significant difference between results with 
the Luhr screw and with the Mini-GII. The Mitek device should be 
considered for repair of an avulsed flexor digitorum profundus, suture 
of a collateral ligament or active Hunter tendon rod to bone and may 
also be used for volar plate arthroplasty for dorsal fracture-dislocations 
of the proximal interphalangeal joints.
OCCUPATIONAL EXPOSURE TO HAND VIBRATION IN NORTH­
ERN ONTARIO GOLD MINERS. Philip P. Narini, Chris B. Novak, 
Susan E. MacKinnon, Cathy Coulson-Roos. Division of Plastic Sur­
gery, Sunnybrook Health Science Centre, Toronto, Ont.
Nineteen underground gold-mine drillers (mean age 35.4 years) who 
operated vibration equipment and a control group of 16 gold mill 
workers (mean age 31.0 years) who did not were evaluated with static 
and moving two-point discrimination, vibration and cutaneous pressure 
thresholds. Provocative tests, including Tinel’s, pressure and Phalen’s 
sign, were also performed. The mean duration of vibration exposure was 
14.3 years. Numbness, pain and weakness were reported in 12 miners 
and 1 control subject. Vibration white finger was reported in 16 miners 
and three control subjects. Miners had a higher incidence of positive 
provocative tests at both carpal and cubital tunnels and higher 
cutaneous pressure thresholds than controls. Significantly higher 
vibration thresholds were found in miners (p < 0.05). A correlation 
relationship between years of vibration exposure and vibration threshold 
was found (r= 0.7).
SAFE AND EFFECTIVE BRACHIAL PLEXUS BLOCKS BY SUR­
GEONS. Daniel S. Thomas, Carolyn L. Kerrigan. Division of Plastic 
Surgery, Royal Victoria Hospital, Montreal, Que.
A quality assurance study was undertaken to establish the safety and 
effectiveness of brachial plexus blocks performed by surgeons for
emergency and elective hand surgery. Forty-five consecutive patients 
received an axillary block consisting of 1% mepivacaine and lidocaine 
hydrochloride. Safety was assessed by electrocardiogram pulse oximetry 
and blood-pressure monitoring. Effectiveness was judged by a pain 
questionnaire and neurologic testing. Eighty-two percent (37 of 45) of 
blocks were completely successful. Supplemental local injections at the 
operative site provided sufficient anesthesia for all other cases. Two- 
thirds of patients judged the block procedure to be less or equal to the 
pain of an intravenous insertion. This experience indicates that hand 
surgeons can perform safe and effective brachial plexus blocks.
PALMAR CUTANEOUS SENSORY BRANCH OF THE MEDIAN 
NERVE PASSING THROUGH THE PALMARIS LONGUS TENDON: 
A CADAVERIC STUDY. Robert S. Richards, Paul Dowdy, Robert M. 
McFarlane. Division of Plastic and Reconstructive Surgery, University 
of Western Ontario, London, Ont.
The relationship of the palmar cutaneous branch of the median nerve to 
the palmaris longus tendon was studied in 52 wrists from 27 preserved 
cadavers. In three wrists the palmaris longus tendon was absent. The 
palmar cutaneous branch arose from the median nerve at a mean of 
4.0 cm proximal to the wrist crease. In two wrists, the palmar 
cutaneous branch passed through the palmaris longus tendon 1.0 cm 
and 1.5 cm proximal to its insertion into the palmar aponeurosis. When 
this anomaly is present, the palmar cutaneous sensory branch of the 
median nerve may be injured during harvesting for tendon grafting if 
transection is not proximal to the insertion into the palmar aponeurosis.
TENOSYNOVIAL CHANGES IN PATIENTS WITH ACTIVITY- 
ASSOCIATED SYMPTOMS OF CARPAL TUNNEL SYNDROME. 
Linda Mrkonjic, Peter T. Cropper, Brent A. Graham. Division of 
Orthopedic Surgery, University of British Columbia, Vancouver 
General Hospital, Vancouver, BC
Activity-associated changes in carpal canal pressures may be secondary 
to dynamic variations in the volume of the flexor synovium. Samples of 
flexor tenosynovium were collected from 21 patients who underwent 
carpal tunnel release. Twelve cadaveric specimens, from individuals with 
no history of carpal tunnel syndrome or inflammatory disease, formed a 
control group. A blinded pathologist graded the histologic findings. 
Synovial fibrosis was the most common histologic finding. Comparison 
of pathologic changes with clinical etiologic factors, indicated that 
patients with symptoms associated with strenuous upper extremity 
activity were more likely to have significant synovial fibrosis than 
patients not engaged in repetitive or vigorous hand use or cadaveric 
controls. The authors conclude that flexor tenosynovial fibrosis in the 
carpal canal may be important in the development of activity-associated 
carpal tunnel syndrome.
RICHE-CANNIEU CONNECTION IN MEDIAN NERVE INJURIES. 
Michelle M. Carr, J. Brian Boyd, C. Vaughan A. Bowen. Department of 
Surgery, Toronto General Hospital, Toronto, Ont.
The Riche-Canriieu connection between the deep branch of the ulnar 
nerve and the recurrent motor branch of the median nerve was 
described 100 years ago. It has been considered rare and unimportant in 
the interim. Electrophysiologists have recently shown that this connec­
tion occurs in the majority of normal people and accounts for a variable 
proportion of motor response in the thenar musculature. The authors 
describe two cases of median-nerve injuries proven by operative 
exploration, both with intact thenar function. They postulate that this 
anomalous clinical presentation is due to the Riche-Cannieu connection 
and present supportive clinical evidence. Such unusual clinical situa­
tions emphasize the need for careful evaluation of nerve injuries.
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A COMPARATIVE STUDY OF STEINDLER AND PECTORALIS 
MAJOR FLEXORPLASTY. Andre Dumont, Dorcas E. Beaton, Alan R, 
Hudson, Robin R. Richards. Division of Orthopedic Surgery, St. 
Michael’s Hospital, Toronto, Ont.
The functional outcomes of two types of elbow flexorplasty performed 
with shoulder arthrodesis for patients with brachial plexus injuries were 
compared. Of 14 patients assessed, 5 had a pectoralis major tendon 
transfer and 9 a modified Steindler flexorplasty. All patients had 
brachial plexus lesions that were irreparable or unresponsive to 
neurolysis, repair or grafting. Average follow-up was 60 months.
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In the patient requiring stabilization of the shoulder and flexorplasty, 
the pectoralis major tendon transfer is at least equivalent, if not 
superior, to the modified Steindler flexorplasty in terms of range of 
motion, strength and subjective measures.
NEUROLOGIC LESIONS WITH SUPRACONDYLAR FRACTURE 
OF THE ELBOW IN CHILDREN. Marc Isler, Constantin Stanciu. 
Department of Orthopedic Surgery, Hopital Sainte-Justine, Montreal, 
Que.
Supracondylar fracture of the elbow in children has a significant 
frequency of neurovascular complications. A prospective study was 
made of 92 supracondylar fractures. Eighteen cases (20%) were 
complicated by neurologic lesions. All fractures were of the extension 
type, grade 2b or 3 (Gartlan classification). All lesions healed completely 
in an average time of 20 weeks. The most frequently involved nerves 
were the radial and median, with an equal incidence. The second most 
frequent pattern was either the ulnar nerve, all three nerves or the 
anterior interosseus nerve, with equal frequency. All other combinations 
were less frequent. Results demonstrated excellent neurologic recovery.
PRIMARY MALIGNANT TUMOURS OF THE HAND. Narayana 
Nandagopal, Alok Shah, Derek Younge. Department of Surgery, King 
Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Thirteen noncutaneous tumours of the hand were studied retrospective­
ly. Eleven tumours arose from soft tissues and 2 from bone. Four 
tumours were located in the fingers and nine in other regions. Two 
cases were staged as IIA, seven as IIB and four as III (metastases on 
presentation). Five patients underwent amputation, four patients had 
wide excision and another four patients underwent biopsy alone. 
Radiotherapy was given to four patients and palliative chemotherapy to 
another four. At follow-up, which ranged from 6 months to 10 years, 
seven patients were alive and disease free and six had died of metastatic 
disease. Functionally, radiotherapy was not detrimental. Wide resection 
followed by radiotherapy may salvage proximal hand tumours, provid­
ing reasonable function without compromising patient survival.
IF IT ISN’T TENNIS ELBOW, WHAT MIGHT IT BE? Donald A. 
Ranney, Richard Wells, Anne Moore. Department of Kinesiology, 
University of Waterloo, Waterloo, Ont.
The musculoskeletal health of 146 female workers in five industries 
characterized by repetitive upper limb activity was assessed clinically at 
the work site and subsequently correlated with a number of ergonomic 
factors. Data were collected on 288 extensor regions and 290 flexor 
regions. Tenderness was found in the lateral epicondyle or common 
extensor tendon, or both, in 26 workers and in the extensor muscle 
bellies in 35. Tenderness was found in the medial epicondyle or common 
flexor tendon, or both, in 12 workers and in the flexor muscle bellies in 
23. Radial tunnel syndrome and pronator syndrome could explain the 
forearm pain in some cases but not in the majority. Muscle ischemia 
from prolonged static contraction was a more likely possibility and 
evidence for this is presented.
EVALUATION OF RADIAL BOWING IN ULNAR CLUB HAND. 
Jean Rousseau, Constantin Stanciu, Benoit Morin. Department of 
Orthopedic Surgery, Hopital Sainte-Justine, Montreal, Que.
Ulnar hypoplasia is a rare congenital defect. The hand is stable on the 
distal radius but syndactyly and absent rays are frequent. The radial 
head is often dislocated or fused to the distal humerus. Radial bowing is 
increased, but the natural history is unknown. Ulnar anlage resection is 
recommend by some authors. Radial bowing was measured in eight 
untreated patients with nine ulnar club hands at a mean follow-up of 5 
years. The radial bowing did not progress in any patient whether the 
radial head was dislocated or fused to the distal humerus. In five of nine 
forearms a slow regression of radial bowing was seen. It was concluded 
that prophylactic release of ulnar anlage is not indicated in ulnar club 
hand.
FRACTIONAL FLEXOR TENDON LENGTHENING FOR SEVERE 
METACARPAL FLEXION CONTRACTURE IN THE RHEUMATOID 
HAND. David R. Pichora. Department of Surgery, Queen’s University, 
Kingston, Ont.
Six patients with severe (90° to 120°) metacarpophalangeal joint 
flexion contractures had Zancolli flexor tendon lengthening with 
standard metacarpal osteotomy and intrinsic release during Swanson 
arthroplasty. At a mean 11-month follow-up, a mean active range of 
movement arc of 61° and a mean passive range of motion arc of 86° 
were noted along with an actual mean active range of motion arc of 4° 
to 63° of flexion. Because of its simplicity and lack of complications, 
fractional flexor tendon lengthening is a successful procedure to correct 
severe flexion deformity in the rheumatoid metacarpophalangeal joint 
and obviates the need for excessive metacarpal resection.
TUBERCULOSIS OF THE HAND. Mohammed A1 Qattan, C. Vaughan 
A. Bowen. Department of Surgery, Toronto General Hospital, Toron­
to, Ont.
Three patients with tuberculosis of hand are described. The first 
presented with recurrent carpal tunnel syndrome with rice bodies 
associated with tuberculous synovitis. The other two patients presented 
with wrist pain and bony destruction with sinuses and successfully 
underwent wrist fusion. A review of the literature is presented and a 
classification for tuberculosis of the hand described. The authors 
conclude that since tuberculosis of the hand is now rarely seen, 
the correct diagnosis is usually delayed. Awareness of the present­
ing features will help in making an earlier and more effective 
diagnosis and in early treatment.
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CRITIQUES DES LIVRES
KNEE MENISCUS: BASIC AND
CLINICAL FOUNDATIONS. Edited by 
Van C. Mow, Steven P. Arnosky and 
Douglas W. Jackson. 204 pp. Illust. 
Raven Press, New York. 1992. $89 
(US). ISBN 0-88167-895-3
It is ironic that a structure that has 
been considered to be a functionless 
remnant of muscle origin, subject to 
quick excision at the mere mention of a 
knee problem now has a book dedicated 
to its structure and function. It seems, 
however, that the days of little respect 
for the meniscus are now officially 
gone. In this book, a well-organized 
attempt is made to demonstrate why the 
meniscus is such an important structure 
and how it functions. The editors have 
recruited contributors who have the 
most experience in the various aspects 
discussed in the book.
The material is well presented. The 
text starts with the basic scientific 
elements, including gross and micro­
scopic anatomy with reference to the 
biochemical and physiologic features 
and the engineering principles. This 
section is strong. The information given 
is based on excellent research that has 
been done in this field. The clinical 
sections of the book, although well 
written, do not solve many of the 
difficult meniscal problems seen in clini­
cal practice. Perhaps this is a reflection 
of how little we know and can do with 
such problems and how much more 
work is necessary in this area.
It is unfortunate that the information 
provided in this text was not available 
at the time when meniscectomy was a 
popular treatment for knee problems. 
This text should be mandatory reading 
for anyone who deals with knee disor­
ders, and the information contained 
therein should at least be understood. 
Fellows and residents in orthopedics as 
well as orthopedic researchers interest­
ed in the meniscus will want this book 
as a reference source. The orthopedic 
surgeon in clinical practice will not find 
this book helpful in handling clinical 
problems. Overall, however, this text is
well written, easy to understand and 
teaches some important lessons about 
the knee meniscus and its function. 
More importantly, it serves as a remind­
er that nothing is without purpose and 
that before excision of any anatomic 
structure the potential complications 
of such excision must be considered.
Anthony Miniaci, MD, FRCSC
Division of Orthopedic Surgery 
University Hospital 
339 Windermere Rd.
London, ON 
N6A 5A5
HIGH TECH UROLOGY. TECHNO­
LOGIC INNOVATIONS AND THEIR 
CLINICAL APPLICATIONS. Joseph 
A. Smith. 362 pp. Illust. W.B. Saun­
ders Co., Philadelphia. 1992. $107 
(US). ISBN 0-7216-3053-7
Rapid technologic advances in urology 
and the flood of new information on 
molecular biology have made it difficult 
for the academic urologist to remain up 
to date in all aspects of the specialty 
and have greatly challenged the com­
munity urologist. Furthermore, with 
knowledge acquired from lay publica­
tions, patients seek reassurance that 
they are being treated appropriately and 
in the most up-to-date fashion. Recog­
nizing the need for an evaluation of new 
technology, Joseph A. Smith has edited 
this excellent text, which contains con­
tributions from leaders in the field in 
the United States. Theoretical and prac­
tical aspects are covered, and there is 
recognition that all that is new is not 
necessarily beneficial.
Stone disease illustrates the far- 
reaching management changes in urolo­
gy over the past decade. The chapter on 
extracorporeal shock-wave lithotripsy 
covers the principles of shock-wave 
physics and the design of the lithotrip- 
ter. The second- and third-wave litho-
tripters are compared and assessed 
against the record of the original Dor- 
nier HM3 lithotripter. An efficiency 
quotient is proposed, but stone-free 
rates are also dependent on the action 
of caliceal contractions as well as 
shock-wave generation. The biologic 
effects of shock waves are dealt with, 
and the status of biliary lithotripsy is 
reviewed.
The chapter on ureteronephroscopy 
is excellent and covers all aspects of the 
intelligent use of both solid and flexible 
instruments. Therapeutic indications for 
the techniques are described. The im­
portance of inserting a safety guide wire 
before the procedure is stressed. The 
risks of using the stone basket, even 
under ureteroscopic control, are empha­
sized; the authors prefer a three- or 
four-pronged grasper, because the 
stone can be released if it proves too 
large to remove intact.
It would have been logical to follow 
these sections with the chapters on 
percutaneous techniques and urologic 
accessory devices, but these chapters 
are placed later in the book. The anato­
my and methods of percutaneous renal 
puncture are well described, and the 
explanation of multiple caliceal punc­
ture by a Y-tract technique is com­
mended. In addition, a method of retro­
grade percutaneous nephrostomy is de­
scribed. Complementary medical man­
agement of stones is also given consid­
eration. Endopyelotomy is discussed, 
and the reasons for the small number of 
failures are detailed. A method for per­
cutaneous management of simple renal 
cysts is described.
The physics of lasers and their appli­
cation to urology is contained in a 
valuable chapter, which brings the read­
er up to date on this expensive tech­
nology.
Urologists are generally poorly in­
structed in the use of ultrasonography 
and interpretation of the findings, so 
the section on ultrasonography is par­
ticularly welcome. It explains the funda­
mentals and physical principles. The 
section on imaging of the prostate
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gland is especially useful. The subject 
of urodynamics is covered concisely, 
and another chapter clarifies the prodi­
gious capabilities of the flow cystome- 
ter.
The chapter on male infertility at­
tempts to place the practising urologist 
back in the forefront of management by 
providing an understanding of recent 
highly specialized techniques of investi­
gation. Especially welcome is the excel­
lent chapter on immunology and mole­
cular biology, which will update and 
solidify the urologist’s understanding of 
this rapidly developing science. The 
book concludes with chapters on the 
practical aspects of stapling devices, 
laparoscopy in urology and innovations 
in pediatric urology.
The editor is to be congratulated on 
producing such a timely work that is 
stimulating and easy to read.
Norman W. Struthers, ChM, FRCSC
Division of urology 
St. Michael’s Hospital 
30 Bond St.
Toronto, ON 
M5B 1W8
ATLAS OF TRANSVAGINAL SUR­
GERY. Shlomo Raz. 262 pp. Ulust. 
W.B. Saunders Company, Philadel­
phia. 1992. $158. ISBN 0-7216- 
2431-6
I began my review of this book with 
considerable scepticism because it is a 
common belief that transvaginal sur­
gery should be performed only by gyne­
cologists. However, Dr. Raz, a urolo­
gist, has demonstrated that this belief is 
incorrect.
The book begins with a description 
of the anatomy of pelvic support and its 
relation to stress incontinence. This is 
followed by a description of the instru­
mentation required and the complica­
tions of vaginal surgery. These chapters 
are extremely well written. They con­
tain the fundamental information re­
quired by all vaginal surgeons and are 
well illustrated, providing easy under­
standing of the complex anatomy and 
physiology of this region.
A wide variety of surgical conditions 
are discussed. Conventional gynecologic 
conditions such as cystocele, rectocele, 
enterocele, vaginal prolapse, uterine 
prolapse and vaginal wall cysts are 
covered in detail. Conventional lower 
urinary tract conditions such as vesico­
vaginal fistula, urethral diverticula, in­
fected Skene gland and urethral carun­
cle are also thoroughly discussed.
The chapter on treatment of urinary 
incontinence, for which the author is 
well known, provides great detail; surgi­
cal photographs and schematic dia­
grams are used for increased under­
standing. This chapter should be partic­
ularly interesting to gynecologists since 
they have probably not been exposed to 
many of the surgical techniques de­
scribed.
Only a few reference books have 
been written on transvaginal surgery, 
and most have been written by gynecol­
ogists. This book provides an entirely 
different approach and should therefore 
be of great interest to the gynecologist.
This should be the reference text of 
choice on transvaginal surgery for both 
gynecologists and urologists.
Stephen S. Im, MD, FRCSC, FACOG
Department of Obstetrics and Gynecology 
St. Michael’s Hospital 
30 Bond St.
Toronto, ON 
M5B 1W8
ENDOSCOPIC PARANASAL SINUS 
SURGERY. 2nd edition. Dale H. Rice 
and Stephen D. Schaefer. 256 pp. 
Illust. Raven Press Ltd., New York. 
1992. $115 (US). ISBN 0-88167-946-1
Limited access surgery has attracted 
much attention in all the surgical spe­
cialties. With appreciation of the signifi­
cance of previously described physiolo­
gy of the paranasal sinuses and the 
advent of coronal computed tomogra­
phy (CT) in the evaluation of sinus 
disease, the application of limited access 
surgery has led to important advances 
in the management of acute and chron­
ic sinus conditions.
The authors cannot be credited with 
the increased interest in this branch of 
rhinologic surgery, which has had a 
strong following in Europe for over a 
decade. They nevertheless produced the 
first comprehensive review of the sub­
ject in the initial edition of this book.
The second edition covers every as­
pect of the anatomy, physiology and 
evaluation of patients who may benefit 
from endoscopic sinus surgery. There is 
a detailed account of surgical tech­
nique. At present there are two recog­
nized approaches, the first popularized 
by Messerklinger, who proposed an 
anterior to posterior procedure primari­
ly for the ostiomeatal complex with 
persisting disease of frontal, anterior 
ethmoidal and maxillary sinuses. Wi- 
gand proposed a posterior to anterior 
approach for diseases of the sphenoid 
and posterior ethmoid system. This text 
shows how these techniques may be 
applied after assessment of the patient 
from the history, endoscopic examina­
tion and interpretation of the CT scan.
One of the strengths of this edition 
and the first one has been the photo­
graphs of fresh cadaver dissections, 
which are photographed from both the 
best anatomic perspective and the 
endoscopic view. The photographs 
are interpreted by clear line draw­
ings, allowing an excellent apprecia­
tion of the paranasal sinus anatomy.
There are numerous CT scans, which 
show not only the normal anatomy but 
also the commonly seen pathologic fea­
tures.
The title suggests that this text 
describes primarily the operative proce­
dure. However, the approach to the 
subject is balanced with chapters on the 
management of pediatric sinus disease, 
a comprehensive account of medical 
management and a review of complica­
tions, which are relatively uncommon to 
well-trained surgeons but which can 
lead to significant morbidity and have 
given rise to medicolegal concerns. The 
authors have been ably helped by five 
experts who have provided contribu­
tions with respect to the radiologic 
aspects, the medical management and 
the accompanying diagrams.
Each chapter either gives specific 
references or lists cited publications.
The book contains only 256 pages,
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and although many of these are taken 
up with well-reproduced photographs 
and diagrams the text is comprehensive 
and has probably already established 
itself as the pre-eminent reference for 
those wishing to further their knowl­
edge in this expanding area of otor­
hinolaryngology.
This book is a virtual necessity for 
rhinologic surgeons, and all otolaryn­
gologists will find it extremely interest­
ing. Although no text can take the 
place of good training, the inclusion of 
a chapter on the selection of instru­
ments and the descriptions of operative 
techniques will enable otolaryngologists 
to apply this surgery to their practice. 
Neurosurgeons and respirologists will 
likely find it of interest since many of 
the procedures described are applicable 
to their patients.
This is a clearly written, excellently 
illustrated text that can be highly rec­
ommended.
Ronald S. Fenton, MB, BS, FRCSC
Associate professor in otolaryngology 
University of Toronto.
Department of Otolaryngology 
St. Michael's Hospital 
30 Bond St.
Toronto, ON 
M5B 1W8
MECHANICS OF HUMAN JOINTS — 
PHYSIOLOGY, PATHOPHYSIOLO­
GY AND TREATMENT. Edited by 
Verna Wright and Eric L. Radin. 480 
pp. Illust. Marcel Dekker Inc., New 
York. 1993. $185 (US). ISBN
0-8247-8763-3
This book is coedited by two recognized 
experts in the field of biomechanics. 
Verna Wright is from the University of 
Leeds, England, and Eric Radin is from 
the Henry Ford Hospital in Detroit. 
Contributions have been made by a 
team of authors — anatomists, bioengi­
neers, biologists, orthopedic surgeons 
and physicians. The text is subdivided 
into major sections that include the
physiology of joints, mechanics, neuro­
physiology, pathophysiology and treat­
ment. The book is well illustrated and 
referenced. Interestingly, there no sec­
tions written by Verna Wright.
The anatomy and function of joints is 
described in great detail in the mechan­
ics section. Jacqueline Perry's descrip­
tion of the mechanics of gait is excel­
lent. However, only normal gait is de­
scribed, which is disappointing since 
orthopedic surgeons deal primarily with 
disorders characterized by abnormal 
gait. This is particularly relevant in 
reconstructive surgery where abnormal 
gait can affect implant loading. The 
energy cost of walking is discussed with 
reference to oxygen consumption dur­
ing abnormal gait but is not discussed 
in detail.
The chapter on knee-ligament recon­
struction gives emphasis to the anterior 
cruciate ligament and provides a good 
general review of the topic but is lack­
ing in specifics. The lack of illustrations 
in this chapter is a major omission. I 
enjoyed reading this section but did not 
feel that it helped to resolve the uncer­
tainty associated with the management 
of isolated injuries of the anterior cruci­
ate ligament.
There is a superb chapter by Antho­
ny Unsworth in which he describes the 
lubrication of the human joints. A natu­
ral extension of this section would have 
been an analysis of wear mechanisms in 
artificial joints.
The section describing the properties 
and physiologic functions of synovial 
fluid in health and disease is excellent 
and should be of particular interest to 
orthopedic surgeons. The chapters re­
lating to muscle physiology, elec­
tromyelography and joint innervation 
are also valuable.
There is an interesting chapter on 
the pathophysiology of intervertebral 
disc herniation. It describes the effect of 
vibration on joints and the relation 
between occupation and spinal prob­
lems. The theories of vibration are 
presented, but they are complex and 
may be difficult for the average reader 
to understand.
Finally, the treatment section is di­
vided into two areas: the principles of 
joint prostheses, by J.D. Blaha, and
physiologically based treatments, by P. 
Maquet. The joint replacement portion 
is disappointingly brief. Little informa­
tion is provided about joint wear and 
implant failure. Maquet's description of 
physiologically based treatments, how­
ever, provides the reader with a well- 
illustrated description of the treatment 
of osteoarthritis of the hip and knee by 
osteotomy and soft-tissue release proce­
dures. The biomechanical principles in­
volved are clearly described and well 
illustrated. Case reports are also used to 
illustrate the biomechanical principles 
involved in treatment.
The preface indicates that this book 
is intended for physicians, orthopedic 
surgeons, rehabilitationists and funda­
mental scientists. Overall, there is too 
much detail in some sections and not 
enough in others to make the book of 
compelling interest to practising ortho­
pedic surgeons. Residents in orthopedic 
surgery may find it useful as a musculo­
skeletal basic science reference text, but 
its main appeal, I suspect is for those 
involved in research. The book is a 
suitable addition to a hospital library, 
but regrettably I think it has limited 
interest for the average orthopedic sur­
geon.
Ian J. Harrington, MD, FRCSC
Division of Orthopedic Surgery 
Toronto East General 
& Orthopaedic Hospital Inc. 
University of Toronto 
825 Coxwell Ave.
Toronto, ON 
M4C 3E7
ORTHOPAEDIC TRAUMA PROTO­
COLS. Edited by S.T. Hansen Jr. and 
M.F. Swiontkowski. 393 pp. Illust. 
Raven Press, New York. 1993. $150 
(US). ISBN 0-88167-994-1
This book is edited by two orthopedic 
surgeons with extensive experience in 
the management of orthopedic and mul­
tiple trauma. They have used their 
experience at the Harborview Medical
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Center in Seattle, Wash., to put togeth­
er a comprehensive text on the manage­
ment of orthopedic trauma.
The book is divided into two main 
sections. The first, 75 pages long, de­
tails general considerations in the man­
agement of trauma. These include mus­
culoskeletal traumatology, the role of 
the trauma surgeon in the management 
of orthopedic trauma, nursing stan­
dards (to which considerable attention 
is given), anesthesia and rehabilitation. 
All of these chapters are succinctly 
written for the treating surgeon rather 
than for the appropriate nonphysician 
health care provider. However, the sec­
tion on nursing is excellent for the 
non-nursing health care provider.
The second main section of the text 
is devoted to regional fracture manage­
ment. The editors have selected a group 
of contributors with recognized exper­
tise in the management of musculoskel­
etal trauma in the specific body parts to 
be discussed. The depth and breadth of 
the program at Harborview Medical 
Center is reflected in that all of the 
contributors work at this centre. Each 
chapter is well illustrated with both line 
drawings and appropriate radiographs; 
because a single person provided all the 
illustrations, the quality greatly exceeds 
that found in most multiauthored 
books. The surgical technique, where 
appropriate, is well described, with ex­
cellent preoperative and postoperative 
examples. The references for each chap­
ter are appropriate but not excessive.
This book will be of considerable 
value to both orthopedic surgeons and 
nonorthopedic surgeons involved in 
trauma care. For the orthopedic sur­
geon the book provides a succinct refer­
ence manual for many specific fracture 
types; it is also an excellent source of 
reference material and illustrations. The 
book will be of particular value to 
residents in orthopedics for fracture 
classification and treatment. For no­
northopedic surgeons involved in the 
management of polytrauma patients 
with musculoskeletal injuries, this text 
provides excellent topical suggestions 
with respect to appropriate fracture 
management.
The editors are to be congratulated 
on producing a topical, well-illustrated
uniform text. I predict that this will be a 
standard fracture textbook for many 
years to come.
James P. Waddell, MD, FRCSC
Director, Trauma Services 
St. Michael’s Hospital 
30 Bond St.
Toronto, ON 
M5B 1W8
LASERS IN HEAD AND NECK SUR­
GERY. Edited by Edward C. Weisberg- 
er. 293 pp. Illust. Igaku-Shoin Medical 
Publishers Inc., New York/HBJ-Holt- 
Saunders Distribution Services, To­
ronto. 1991. $87. ISBN 0-89640-181-2
This text provides an overview of the 
current usage of lasers in the manage­
ment of benign and malignant lesions in 
the head and neck. Although the book 
concentrates primarily on the proven 
modalities of argon, carbon dioxide and 
neodymium : yttrium-aluminum-garnet 
lasers, the potential of new lasers such 
as the potassium-titanyl-phosphate 
(KTP), Excimer, gold vapour and tun­
able dye lasers is also discussed.
The introductory chapters contain 
descriptions of the physical character­
istics of surgical lasers and the interac­
tion of tissue with a variety of laser 
wavelengths. This section is clear and 
concise without the inclusion of com­
plex mathematical formulae. There is 
an excellent summation of the advan­
tages and disadvantages of various 
modes of operation: continuous, pulsed 
and Q-switching. Following this section 
are detailed descriptions of the neces­
sary safety precautions and special 
anesthetic requirements.
The book continues with a detailed 
discussion of laser use in specific areas 
of the head and neck. Individual chap­
ters are devoted to lasers in dermatolog­
ic surgery, rhinologic and paranasal 
sinus surgery, surgery of the oral cavity 
and pharynx, otologic and laryngologic 
surgery, surgery on the tracheobronchi­
al tree and surgery for palliation of 
esophageal carcinoma.
The final two chapters cover the
possible future applications of lasers in 
photodynamic therapy in head and neck 
cancer, and in microvascular laser weld­
ing of blood vessels and nerves.
As with most multiauthored books 
there is some repetition. A major over­
sight is the absence of any discussion of 
lasers in ophthalmic surgery. Aside 
from these shortcomings, this book is 
an excellent introduction to current 
laser use. The contributors are to be 
commended for their detailed recom­
mendations on laser type, power set­
tings, mode of operation and spot size 
in dealing with specific lesions, a very 
valuable resource for the reader with 
limited previous experience.
This book would be a valuable addi­
tion to the library of all surgeons who 
deal with lesions in the head and neck 
as well as their colleagues in anesthesia 
and dermatology.'
Ralph R.F. Ruby, MD, FRCSC, FACS
Department of Otolaryngology/Audiology
St. Joseph’s Health Centre
The University of Western Ontario
Third Floor
900 Richmond St.
London, ON 
N6A 5B3
SURGICAL DECISION MAKING. 3rd 
edition. Edited by L.W. Norton, G. 
Steele Jr. and B. Eiseman. 342 pp. 
Illust. W.B. Saunders Company/Har- 
court Brace Jovanovich, Inc., Philadel­
phia. 1992 . $75  (US). ISBN
0-7216-6498-5
This edition of Surgical Decision Mak­
ing follows a similar pattern to the two 
previous editions in that individual sur­
geons have been asked to provide their 
personal approaches to a multiplicity of 
surgical problems. In this edition, the 
authors have been asked to justify their 
choices not only on the basis of their 
experience and current published infor­
mation but also on the basis of cost and 
outcome.
This edition has been expanded by 
the inclusion of sections on transplanta­
tion surgery and perioperative manage-
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ment; more than one-third of the au­
thors are making their “first appear­
ance" in this textbook.
The text is divided into a section on 
surgery in general, followed by sections 
on head and neck, cardiopulmonary, 
gastrointestinal, breast, endocrine, vas­
cular, pediatric and transplantation sur­
gery. Subspecialty interest is seen in 
sections on urology, gynecology and 
fracture management. Under each of 
these headings a specific topic is ap­
proached by a short narrative section 
that is accompanied on the facing page 
by an algorithm that is referenced to 
the text. Therefore, in the narrative on 
the left-hand page a specific paragraph 
will be labelled with a letter that can be 
found in the algorithm. Review of the
algorithm allows the reader to get an 
overview of the problem and the think­
ing behind the author’s problem-solving 
exercise; the thinking for each step in 
the algorithm can be obtained from the 
narrative. Although this may result in 
some oversimplification of complex 
problems, the editors point out that this 
text is not intended to be definitive on 
the problems discussed but to help the 
reader understand the logic of the ap­
proach used by recognized experts with 
respect to each condition covered.
The value of this writing technique is 
immediately evident when the reader 
peruses unfamiliar specialty sections. 
By reading the short narrative text, 
reviewing the algorithm and returning 
to the narrative text, the reader can,
within a few minutes, get a good grasp 
of the basic steps in dealing with many 
common surgical problems.
This text will be of great value to 
trainees in surgery and to surgeons 
who are occasionally required to care 
for patients with problems that are 
outside that surgeon’s area of expertise. 
It will be a valuable addition to the 
library of any hospital in which surgical 
procedures are performed.
James P. Waddell, MD, FRCSC
Professor of surgery 
University of Toronto 
St. Michael’s Hospital 
30 Bond St.
Toronto, ON 
M5B 1W8
Do you have a bright ^  
idea that’s being put to 
use in Canada? Know of 
anyone else who has? If ^  
so, the Ernest C. Manning 
Awards Foundation wants to 
hear from you now. *
You can nominate someone for ^  
the 1994 Manning Awards, including 
a Principal Award of $100,000, a $25,000 
Award of Distinction and two $5,000 
Innovation Awards.
oJJLLv
vV ' we'llN ^  
g i v e  y o u  
$100,000 
FO R A  
USED 
ONE
THE
MANNING
AWARDS
^  The idea may relate 
to virtually any aspect 
^  of Canadian life. It can be 
^  a new concept, process 
or product that’s in use or 
development and of benefit 
to Canadians.
^  Nominations close February 11,1994.
For your nomination form, call or write: 
THE MANNING AWARDS, 3900, 421-7 Ave. 
S.W., Calgary, Alberta T2P 4K9, Telephone: 
(403) 266-7571 FAX (403) 266-8154.
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ORTHOPEDIC SURGEON
Cambridge Memorial Hospital is seeking a 
Canadian certified, Ontario licensed, 
recent graduate in orthopedic surgery to 
join the existing complement of two other 
orthopedic surgeons. The candidate must 
have a broad interest in orthopedics (no 
subspecialty needed) and a willingness 
to assume regular on-call duties in a 
353-bed accreditated hospital.
Cambridge is in the heart of southwestern 
Ontario and provides a high standard of 
living, including excellent social, recre­
ational and educational facilities.
For more information, contact: Dr. J.K. 
Stapleton, Chief, Department of Surgery, 
tel (519) 623-7200; or send a resume to:
Secretary, Orthopaedic 
Surgeon Search Committee 
Cambridge Memorial Hospital 
700 Coronation Blvd. 
Cambridge, ON
N1R3G2 S93-166
Fort St. 
John is a 
progressive 
community
northeastern
British
Columbia
offering a
variety of
cultural
and
sporting 
activities 
and daily 
air service 
to
Vancouver
and
Edmonton.
A full-time permanent General Surgeon 
with F.R.C.P.C. qualification is required to 
provide general surgical and m inor 
orthopedicservices in our 64 bed accredited 
acute care Hospital located in the City of 
Fort St. John serving a population of 
approximately 25,000. This is a private 
practice position (fee for service). Gross 
annual earnings are approxim ate ly  
$200,000 to $250,000. There are two 
qualified General Surgeons in Dawson 
Creek, a community 50 miles away, which 
would allow a call schedule for weekend 
and vacation relief. There is an Obstetrician/ 
Gynecologist, Radiologist and Pathologist 
on staff with excellent family physician 
support. (Recruiting to replace the Medical 
Internist is underway.)
Please contact: 
Administrator.
Mrs. M. Asling,
S93-167
Fort St. John General Hospital
9636 - 100th Ave., Fort St. John, B.C. V1J 1Y3 
Tel: (604) 785-6611 Local 260 Fax: (604) 785-4060
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ship studies confirm the best and most cost efficient way to reach Canadian surgeons is through the pages of CJS.
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CLASSIFIED ADVERTISING
POSITION WANTED -  GENERAL AND 
VASCULAR SURGEON: -  FRCSC certified in 
general and vascular surgery, wishes to relo­
cate. Well-trained, energetic, with 2 years 
experience. Would like to keep a combined 
practice in general and vascular surgery. 
Reply to: Box 524, CJS. -S93-169
GENERAL SURGEON: ON -  Well-estab­
lished group practice is looking to replace a 
retiring partner/surgeon to serve a communi­
ty of 30 000 + located 25 minutes west of 
London. Town population 10 000+ . Fully 
computerized, modern clinic adjacent to a 
fully accredited, well-equipped hospital using 
116 acute care beds. Busy emergency de­
partment. Preference will be given to or- 
thopedics/gynecology. Essentials include la­
paroscopy skills and fellowship status. One- 
in-three on-call schedule for this pleasant 
community. Large referral base guaranteed. 
Associate to full partnership attainable. 
Please contact or send CV to: Steven Wong, 
c/o Strathroy Medical Clinic, 376 Carrie 
St., Strathroy, ON N7G 3E3; tel (519) 
245-0430. -S92-128
GENERAL SURGERY PRACTICE FOR 
SALE: ON -  Southern Ontario community. 
"Cap”  reached yearly. Orthopedic experience 
beneficial. Send CV to: Box 519, CJS.
-S93-171
GENERAL SURGEON
A great opportunity to join a Toronto clinic 
with an international reputation as a leader 
in new techniques. Our client seeks an 
additional, competent, compatible and 
adaptable MD, FRCSC to join their team.
Learn new skills in office outpatient and 
colon surgery, as well as video 
colonoscopy, and step into a busy practice 
with a large existing patient load.
Some of the many benefits include regular 
hours, with rare emergency or night work, 
and no administrative burden.
If you value a stimulating and supportive 
environment, with above-average fee-for- 
service income potential, this could be a 
rewarding way to advance your medical 
career and improve the quality of your life.
Interested candidates are invited to submit 
a current curriculum vitae, 
in CONFIDENCE to
Juergen K. Mueller 
Senior Consultant
CanMed Consultants Inc.
62 Queen Street South, Mississauga, Ontario L5M 1K4 
Tel. (9 0 5 ) 567 1 0 8 0  Fax (905 ) 5 6 7 -10 81
Please quote Assignment No. 93026
—S93-163
GENERAL SURGEON: MICHIGAN, US -
Wanted for third partner by two busy Ameri­
can surgeons in large midwestern city. Must 
be US graduate; willingness to work hard a 
must. Competitive salary with benefits for 1 
year, associate status may be offered after 1 
year to appropriate individual. Must be BE/BC 
with strong interest in trauma and critical 
care. Additional interest in laparoscopy, en­
doscopy or breast surgery is a plus. No 
vascular or gynecology. Position available 
Jan. 1, 1994. Send CV to: Box 525, CJS.
-S93-170
GENERAL SURGEON
THE WINNIPEG CLINIC, a large multispecial­
ty clinic with a full range of ancillary services 
has an opening for a GENERAL SURGEON.
Must have Canadian fellowship and Canadi­
an citizenship or landed immigrant status.
We ofer a full range of benefits with a 
negotiable financial arrangement.
Interested applicants are invited to contact 
Dr. V. Taraska, Chairman 
Recruitment Committee 
The Winnipeg Clinic 
425 St. Mary Ave.
Winnipeg, Manitoba 
R3C 0N2
Fax: (204) 943-2164
-S93-172
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FELLOWSHIP IN 
ENDOUROLOGY AND ESWL
This 1-year postgraduate fellowship offers a 
wide range of clinical experience in en- 
dourology including percutaneous surgery, 
ureteroscopy, ESWL and laparoscopic sur­
gery in urology. Approximately 50% of the 
fellow's time will be spent in the laboratory 
participating in projects related to en- 
dourologic and shock wave lithotripsy re­
search. Salary will commensurate with the 
level of training.
Please reply with curriculum vitae to:
Dr. John Denstedt 
Chief of Urology 
St. Joseph's Health Centre 
268 Grosvenor St.
London, ON N6A 4V2 -S93-163
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